June 30, 2012 10-Q

0001078782-12-002971.txt : 20121121 0001078782-12-002971.hdr.sgml : 20121121 20121121140219 ACCESSION NUMBER: 0001078782-12-002971 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20120630 FILED AS OF DATE: 20121121 DATE AS OF CHANGE: 20121121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001419051 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 331176182 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54554 FILM NUMBER: 121220776 BUSINESS ADDRESS: STREET 1: 4093 OCEANSIDE BLVD, SUITE B CITY: OCEANSIDE STATE: CA ZIP: 92056 BUSINESS PHONE: (760) 295-7208 MAIL ADDRESS: STREET 1: 4093 OCEANSIDE BLVD, SUITE B CITY: OCEANSIDE STATE: CA ZIP: 92056 FORMER COMPANY: FORMER CONFORMED NAME: Friendly Auto Dealers, Inc. DATE OF NAME CHANGE: 20071120 10-Q 1 f10q060312_10q.htm JUNE 30, 2012 10-Q June 30, 2012 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

X .

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO ________

Commission File Number: 000-54554

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada

45-1226465

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

4093 Oceanside Blvd, Suite B

Oceanside, California 92056

(Address of principal executive offices, including zip code)

(760) 295-7208

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes . No X .

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes . No X .

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.


	Large Accelerated Filer .	Non-Accelerated Filer .
		(Do not check if a smaller reporting company)

	Accelerated Filer .	Smaller reporting company X .

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes . No X .

As of November 19, 2012, the Registrant had 305,458,333 outstanding shares of Common Stock with a par value of $0.001 per share.

IMPORTANT PREFATORY NOTE

On August 24, 2012, we entered into a Master Dispute Resolution Agreement (the “MDRA”) with James P. Boyd (“Boyd”), Boyd Research, Inc. (“Boyd Research”) and TMD Courses, Inc. (“TMD” and together with Boyd and Boyd Research, the “Boyd Parties”) and Timothy G. Dixon (“Dixon”) and Gerry B. Berg (“Berg”), and on August 24, 2012 we also entered into a License Agreement with Boyd Research and TMD (the “New License Agreement”), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent (the “Escrow Agreement”), and a Voting Agreement with Boyd (the “Voting Agreement”). We filed Form 8-K’s with the Securities and Exchange Commission on August 28, 2012, August 29, 2012 and August 30, 2012 in regard to these matters.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this report and the information incorporated by reference herein may contain “forward-looking statements” (as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These statements, which involve risks and uncertainties, reflect our current expectations, intentions, or strategies regarding our possible future results of operations, performance, and achievements. Forward-looking statements include, without limitation: statements regarding future products or product development; statements regarding future selling, general and administrative costs and research and development spending; statements regarding our product development strategy; and statements regarding future financial performance, results of operations, capital expenditures and sufficiency of capital resources to fund our operating requirements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and applicable rules of the Securities and Exchange Commission and common law.

These forward-looking statements may be identified in this report and the information incorporated by reference by words such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “plan”, “predict”, “project”, “should” and similar terms and expressions, including references to assumptions and strategies. These statements reflect our current beliefs and are based on information currently available to us. Accordingly, these statements are subject to certain risks, uncertainties, and contingencies, which could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, such statements.

The following factors are among those that may cause actual results to differ materially from our forward-looking statements:

•

Limited operating history in our new business model;

•

Limited experience introducing new products;

•

Limited operating history in international markets;

•

Our ability to successfully expand our operations and manage our future growth;

•

Difficulty in managing our growth and expansion;

•

Limited capital resources;

•

Dilutive effects of any potential need to raise additional capital;

•

The deterioration of global economic conditions and the decline of consumer confidence and spending;

•

Material weaknesses reported in our internal control over financial reporting;

•

Our ability to retain independent distributors or to hire new independent distributors on an ongoing basis;

•

The potential for government or third party actions against us resulting from independent distributor activities that violate applicable laws or regulations;

•

Our ability to protect our intellectual property rights and the value of our product;

•

The potential for product liability claims against us;

•

Our dependence on third party manufacturers to manufacture our product;

•

Our common stock is currently classified as a penny stock

•

Our stock price may experience future volatility;

•

The illiquidity of our common stock;

•

Substantial sales of shares of our common stock;

•

Other factors not specifically described above, including the other risks, uncertainties, and contingencies described under “Description of Business”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Items 1 and 7 of our Annual Report on Form 10-K for the year ended December 31, 2011.

When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. We have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of this report.

Actual results may vary materially from those in such forward-looking statements as a result of various factors. No assurance can be given that the risk factors described in this Quarterly Report on Form 10-Q are all of the factors that could cause actual results to vary materially from the forward-looking statements. References in this Quarterly Report on Form 10-Q to the “Company,” “TSOI,” “we,” “our,” and “us” refer to Therapeutic Solutions International, Inc.

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

INDEX


PART 1. Financial	PAGE

Item 1. Financial Statements	5

Consolidated Balance Sheets as of June 30, 2012 (unaudited) and December 31, 2011	5
Consolidated Statements of Operations (unaudited) for the three and six months ended June 30, 2012 and June 30, 2011	6
Consolidated Statements of Cash Flows (unaudited) for the six months ended June 30, 2012 and June 30, 2011	7
Notes to Consolidated Financial Statements (unaudited)	8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3. Quantitative and Qualitative Disclosures about Market Risk	20

Item 4. Controls and Procedures	20

PART 2. Other Information

Item 1. Legal Proceedings	20

Item 1A. Risk Factors	20

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	20

Item 3. Defaults upon Senior Securities	20

Item 4. Mine Safety Disclosures	20

Item 5. Other Information	20

Item 6. Exhibits	21

Signatures	21

PART I Financial Information

Item 1.

Financial Statements


THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
(Formerly Splint Decisions Inc.)
Consolidated Balance Sheets

		June 30, 2012		December 31, 2011
		(Unaudited)		(Audited)
ASSETS

Current assets:
	Cash and cash equivalents	$	85,851	$	87,976
	Accounts receivable, net		28,576		37,416
	Inventories		43,498		48,198
	Prepaid expenses and other current assets		12,164		490,037
	Total current assets		170,088		663,627

Other non-current assets			17,390		12,350
Property and equipment, net			188,303		7,639
Licensing agreement, net			2,625,000		2,775,000

Total assets		$	3,000,781	$	3,458,616


LIABILITIES AND SHAREHOLDERS' DEFICIT

Current liabilities:
	Accounts payable	$	36,544	$	56,777
	Accrued expenses and other current liabilities		32,728		39,155
	Due to related parties		3,180,000		3,004,090
	Other related party current liabilities		47,201		56,211
Total liabilities			3,296,473		3,156,233


Shareholders' deficit
	Preferred stock, $.001 par value; 5,000,000 shares authorized		-		-
	Common stock, $.001 par value; 700,000,000 shares authorized, 305,458,333 issued and outstanding at June 30, 2012 and December 31, 2011, respectively		305,458		305,458
	Additional paid-in capital		1,115,546		975,281
	Deficit accumulated		(1,716,695)		(978,356)

Total shareholders' deficit			(295,691)		302,383

Total liabilities and shareholders' deficit		$	3,000,781	$	3,458,616

See accompanying notes to financial statements.


THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
(Formerly Splint Decisions Inc.)
Consolidated Statements of Operations
(Unaudited)


			For the Three Months ended June 30, 2012		For the Three Months ended June 30, 2011		For the Six Months ended June 30, 2012		For the Six Months ended June 30, 2011

Net domestic revenues		$	454,897	$	456,618	$	961,519	$	457,108
Net international revenues			144,828		94,323		245,980		94,323
	Total revenues		599,725		550,941		1,207,499		551,431
Cost of goods sold			13,753		17,269		27,616		17,343
Gross profit			585,972		533,672		1,179,884		534,089

Operating expenses:
	Selling		28,179		44,169		50,828		47,366
	General and administrative		31,327		31,694		70,322		31,719
	Salaries, wages, and related costs		285,294		254,549		605,947		254,549
	Royalties		175,579		160,231		354,315		160,231
	Amortization and depreciation		76,049		76,893		152,098		76,893
	Consulting fees		218,621		18,708		478,761		18,708
	Legal and professional fees		135,725		32,136		221,774		39,136
	Total operating expenses		950,774		618,380		1,934,045		628,602

Loss from operations			(364,802)		(84,708)		(754,161)		(94,513)

Other income (expense):
	Net other income		7,100		35,652		18,832		35,652
	Interest expense		(3,001)		(142)		(3,010)		(277)
	Total other income (expense)		4,099		35,510		15,822		35,375
Net loss		$	(360,703)	$	(49,198)	$	(738,339)	$	(59,138)

Basic and diluted loss per common share		$	(0.0012)	$	(0.0002)	$	(0.0024)	$	(0.0004)

Weighted average shares outstanding			305,458,333		296,549,542		305,458,333		168,949,899

See accompanying notes to financial statements.


THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
(Formerly Splint Decisions Inc.)
Consolidated Statements of Cash Flows
(Unaudited)
			For the Six Months Ended June 30, 2012		For the Six Months Ended June 30, 2011
Cash flows from operating activities
Net loss			$	(738,339)	$	(59,138)
	Adjustments to reconcile net loss to net cash provided by operating activities:
		Non-cash expenses:
		Amortization		150,000		75,000
		Depreciation		2,098		1,893
		Stock based compensation to officers		-		42,000
		Stock based compensation to consultants		-		1,012,000
		Compensation expense - employee stock option plan		140,265		-
		Changes in operating assets and liabilities:
		(Increase) decrease in inventory		4,700		(63,305)
		(Increase) decrease in accounts receivable		8,840		(20,043)
		(Increase) decrease in prepaid expenses and other current assets		477,873		(1,017,678)
		(Increase) decrease in other assets		(5,040)		(10,000)
		Increase (decrease) in accounts payable		(20,233)		1,061
		Increase (decrease) in accrued expenses and other current liabilities		(6,427)		61,444
		Increase (decrease) in other related party liabilities		(13,100)		-
Net cash provided by operating activities				637		23,234

Cash flows from investing activities
		Acquisition of fixed assets		(182,763)		(8,827)
Net cash used by investing activities				(182,763)		(8,827)

Cash flows from financing activities
		Note payable to related party		180,000		-
		Borrowing and other advances		-		69,562
		Repayments		-		(21,750)
Net cash provided by financing activities				180,000		47,812

		Increase in cash		4,061		62,219
		Cash at beginning of period		87,976		2,366
		Cash at end of period	$	85,851	$	62,219

Supplemental disclosure of non-cash investing and financing activities:
	Increase in liabilities from acquisition		$	-	$	35,101
	Increase in License agreement and due to related party			-		3,000,000

Supplemental Cash Flow Information:
	Cash paid for interest		$	3,010	$	181
	Cash paid for income taxes		$	800	$	-

See accompanying notes to financial statements.

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

NOTES TO THE FINANCIAL STATEMENTS

As of and for the six months ended June 30, 2012

(Unaudited)

These unaudited Financial Statements and Notes should be read in conjunction with the audited financial statements and notes of Therapeutic Solutions International, Inc. as of and for the year ended December 31, 2011 included in its Annual Report on Form 10-K.

Note 1 – Organization and Presentation Basis

The consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the management of Therapeutic Solutions International, Inc. (the “Company”), these interim Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair presentation of the Company’s financial position as of June 30, 2012, and the results of operations and cash flows for the three and six-months ended June 30, 2012. Interim results are not necessarily indicative of results for a full year or for any future period.

The consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in our audited financial statements and notes for the fiscal year ended December 31, 2011 pursuant to the rules and regulation of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended December 31, 2011, and included in the Annual Report on Form 10-K on file with the SEC.

Therapeutic Solutions International, Inc. (the “Company”) was organized August 6, 2007 under the name Friendly Auto Dealers, Inc. under the laws of the State of Nevada. In the first quarter of 2011 the Company changed its name from Friendly Auto Dealers, Inc. to Therapeutic Solutions International, Inc., and acquired Splint Decisions Inc., a California corporation organized September 21, 2010 (“Splint”). Splint is treated as the “accounting acquirer” in the accompanying financial statements. In the transaction, the Company issued 250,523,333 common shares to the shareholders of Splint; such shares represented, immediately following the transaction, 85% of the outstanding shares of the Company. The transaction was accounted for as a “reverse merger” and a reverse recapitalization and the issuances of common stock were recorded as a reclassification between paid-in-capital and par value of Common Stock.

After June 30, 2012, on August 24, 2012, the Company entered into a Master Dispute Resolution Agreement (the “MDRA”) with James P. Boyd (“Boyd”), Boyd Research, Inc. and TMD Courses, Inc. (together with Boyd, the “Boyd Parties”) and Timothy G. Dixon (“Dixon”) and Gerry B. Berg, and on August 24, 2012, the Company also entered into a License Agreement with Boyd Research, Inc. and TMD Courses, Inc. (the “New License Agreement”), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent (the “Escrow Agreement”), and a Voting Agreement with Boyd (the “Voting Agreement”).

Before the New License Agreement, the Company and certain Boyd Parties were party to an Exclusive License Agreement dated April 1, 2011, as amended on November 1, 2011 (the “2011 Agreement”), and the Company’s predecessor Splint Decisions Inc. and certain Boyd Parties were party to an Exclusive License Agreement dated October 22, 2010, as amended on July 8, 2011 (together with the 2011 Agreement, the “Exclusive Agreements”), which granted the Company an exclusive worldwide license to certain Boyd Parties patent rights and related technology. Since April 1, 2011, essentially the Company’s entire active business has consisted of the manufacture and sale of Anterior Midpoint Stop Appliance intraoral devices (“AMPSA Products”) as authorized by the Exclusive Agreements.

The New License Agreement terminated the Exclusive Agreements. However, the New Licensee Agreement grants the Company new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell the Company’s existing chairside AMPSA Products (but not any such products other than the Company’s currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.

The New License Agreement essentially carries forward the Exclusive Agreements’ terms as to sales to the US market, except that under the New License Agreement the Company’s rights to sell AMPSA Products to the US market will expire at the end of 2012. Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.

For sales of the existing AMPSA Products to non-US markets, the New License Agreement grants the Company an exclusive license, which converts to a non-exclusive license on January 1, 2013. Under the New License Agreement, the Company must pay a 30% royalty on 2012 net sales of the existing AMPSA Products to most non-US markets, but, under the New License Agreement, after 2012 the Company’s net sales to non-US markets will be royalty-free.

The Company had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.

The Company expects that the Boyd Parties will manufacture and, beginning on January 1, 2013, sell to the US market the AMPSA Products which the Company had previously sold to the US market (and which, beginning on that date, the Company will no longer be allowed to sell to the US market) and maybe new AMPSA Products as well. The Company also expects that the Boyd Parties may compete with the Company in the manufacture and sale to some or all non-US countries, from and after January 1, 2013, of the AMPSA Products which the Company had previously sold to the US and non-US markets, and the Boyd Parties could sell new AMPSA Products there as well.

Beginning January 1, 2014, the Company will no longer be able to use the in-licensed “NTI” trademark for its AMPSA Products.

In the transition from the Exclusive Agreements to the New License Agreement, the Company is giving up its license rights to the “Total Splint System” intraoral devices (which the Company has not successfully commercialized) and to all potential chairside AMPSA Products which could have been commercialized using the Company’s Exclusive Agreements rights but which the Company is not currently selling.

See Note 9 – Subsequent Events, for additional information.

Note 2 – Significant Accounting Policies

Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash

For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of June 30, 2012. Other assets include restricted cash of $10,000 that is used to secure a company credit card.

Inventory

Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at June 30, 2012.

Depreciation and Amortization

Depreciation is calculated using the straight line method over the estimated useful lives of the assets. Amortization is computed using the straight line method over the term of the agreement.

Intangible Assets

Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any intangible assets. However, the Company entered into the Exclusive Agreements on October 22, 2010 and April 1, 2011, which gave the Company respectively (i) the exclusive worldwide license to make and sell the “Total Splint System” and (ii) the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company that is solely owned by James P. Boyd, the majority shareholder of the Company. The Exclusive Agreements require a deferred $3,000,000 license inception fee, which the Company is amortizing over a ten year period using the straight line method of amortization. See Note 5 – License Agreements.

Income Taxes

The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.

Going Concern

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Under the New License Agreement the Company’s rights to sell AMPSA Products to the US market (81% of total revenue for fiscal 2011) will expire at the end of 2012. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Share Based Expenses

ASC 718 "Compensation - Stock Compensation," which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See Note 6 – Equity Transactions.

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 "Equity - Based Payments to Non-Employees," which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date. See Note 6 – Equity Transactions.

Recently Implemented Standards

In January 2010, the FASB issued guidance to amend the disclosure requirements related to recurring and nonrecurring fair value measurements. The guidance requires a roll forward of activities on purchases, sales, issuance, and settlements of the assets and liabilities measured using significant unobservable inputs (Level 3 fair value measurements). The guidance was effective for the Company with the reporting period beginning January 1, 2011. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

Note 3 – Restricted Cash

Other non-current asset is a $10,000 certificate of deposit with an annual interest rate of .6%. This certificate matures on June 17, 2013, and is used as collateral for a Company credit card, pursuant to a security agreement dated June 20, 2011.

Note 4 – Equipment

The cost and accumulated depreciation of fixed assets and equipment at June 30, 2012 and December 31, 2011 are summarized below:


		June 30, 2012		December 31, 2011
		(unaudited)		(audited)
Computer Hardware	$	7,374	$	4,612
Office Furniture and Equipment		3,639		3,639
Production Molds		180,000		-
Shipping and Other Equipment		1,575		1,575
Total		12,588		9,826
Accumulated Depreciation		( 4,285)		(2,187)
Property and Equipment, net	$	188,303	$	7,639

Depreciation is calculated using the straight line method over the estimated useful lives of the assets.

Note 5 – License Agreements

The Exclusive Agreements granted the Company an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions) and a deferred $3,000,000 license inception fee. From April 1, 2011 through June 30, 2012, essentially the Company’s entire active business consisted of the manufacture and sale of AMPSA Products as authorized by the Exclusive Agreements. The Exclusive Agreements licensor is wholly owned by Boyd, the Company’s majority stockholder.

See Note 9 – Subsequent Events, for additional information.

Note 6 – Equity Transactions

Preferred Stock

The Company is authorized to issue 5,000,000 shares of $.001 par value preferred stock. The Company has not issued any preferred stock.

Common Stock

The Company is authorized to issue 700,000,000 shares of $.001 par value common stock. All shares have equal voting rights, are non-assessable, and have one vote per share. Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all of the directors of the Company.

In the first quarter of 2011 the Company issued 250,523,333 shares of common stock to James P. Boyd and Timothy G. Dixon, the shareholders of Splint Decisions Inc., to acquire Splint Decisions Inc.

Warrants

The fair value of each compensatory warrant granted is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. Expected volatilities are based on volatilities from the Company's traded common stock since June 27, 2008.

The risk-free rate for the periods within the contractual life of the compensatory warrants is based on the U.S. Treasury bond rate in effect at the time of grant for bonds with maturity dates at the estimated term of the options.

The following values were used to calculate the intrinsic values of the Company’s outstanding compensatory warrants as of their issuance dates:


Expected volatility	136.53% - 217.26%
Expected dividends	0
Expected term (in years)	2 - 4
Risk-free rate	1.29% - 1.86%

A summary of the compensatory warrants outstanding at June 30, 2012 and changes during the period then ended is presented below:


Warrants	Shares	Weighted- Average Exercise Price	Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value
Exercisable at December 31, 2011	450,000	$0.78	1.26	$34,653
Granted	0
Exercised	0
Canceled	0
Exercisable at June 30, 2012	450,000	$0.78	0.76	$34,653

See Note 9 – Subsequent Events, for additional information.

Stock Based Compensation

On August 31, 2011, the Company issued options to purchase an aggregate of 7,950,000 shares of the Company’s common stock with an estimated fair value of $636,000 to its officers and employees. The options have an exercise price of $0.08 per share. As of June 30, 2012, 2,428,000 options have vested and no options were exercised. Subject to continuation of service, the remaining option shares vest monthly over the next 26 months; and the options expire ten years from the date of grant unless earlier terminated. Compensation cost, using the graded vesting attribute method in accordance with ASC 718, is recognized over the requisite service period during which each tranche of shares is earned (36 months). The value of each tranche is amortized on a sum of the years digits basis; $60,938 was expensed for the three-months ended June 30, 2012 and $140,265 for the six-months ended June 30, 2012.

The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with dividend yield of 0%; expected volatility of 191%; risk-free interest rate of 2.23%; contractual life of ten years; and an exercise price ($0.08) equal to 100% of the grant-date common stock fair market value. Expected volatility is calculated based on the stock market closing prices for the 406 trading days preceding the grant date.

The expected term of options granted is estimated at half of the contractual term as noted in the individual option agreements and represents the period of time that options granted are expected to be outstanding.

The following table summarizes information regarding stock options outstanding as of June 30, 2012:


		Options Outstanding						Options Exercisable
Exercise prices		Number Outstanding		Weighted average remaining contractual life (years)		Weighted average exercise price		Number exercisable		Weighted average remaining contractual life (years)		Weighted average exercise price

$	0.08		6,900,000		9.17	$	0.08		2,428,000		9.17	$	0.08

A summary of the stock options available under the 2009 Stock Incentive Plan at June 30, 2012 and changes during the period then ended is presented below:


Available at December 31, 2011		10,000,000
Option shares granted before December 31, 2011		(7,950,000)
Granted		-
Exercised		-
Canceled		1,050,000
Available at June 30, 2012		3,100,000

Note 7 – Related Party Transactions

At June 30, 2012, under the 2011 Agreement, the Company was obligated for a license inception fee to a related party in the amount of $3,000,000. This inception fee is being amortized over a ten-year period using the straight line method of amortization. The unamortized balance at June 30, 2012 was $2,625,000. See Note 9 – Subsequent Events, for additional information.

Under the 2011 Agreement, the Company incurred royalty expenses of $175,579 payable to a related party for the three-months ended June 30, 2012. The royalty accrued but unpaid at June 30, 2012 was $47,201. See Note 9 – Subsequent Events, for additional information.

On April 26, 2012, the Company acquired certain production molds from a related party in exchange for a $180,000 promissory note. The note bears 10% interest per annum and the maturity date of the note is April 26, 2014. See Note 9 – Subsequent Events, for additional information.

Note 8 – Geographic Information

The following table provides information related to the Company’s revenues for the three and six-months ended June 30, 2012 and June 30, 2011.


Net Revenues		Three Months		Three Months		Six Months		Six Months
		June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net domestic revenues	$	454,897	$	456,618	$	941,519	$	457,108
Net international revenues		144,828		94,323		245,980		94,323
Total	$	599,725	$	550,941	$	1,207,499	$	551,431

Note 9 – Subsequent Events

On August 24, 2012, the Company entered into the MDRA, the New License Agreement, the Escrow Agreement and the Voting Agreement.

Under the MDRA, Boyd agreed to surrender 223,991,933 shares of Company common stock and resigned as a director of the Company. The MDRA also provided that Boyd’s employment with the Company shall continue throughout 2012, with his salary rate reduced to $100,000 per annum as of the date of the MDRA. Also, the Boyd Parties agreed never to directly and/or indirectly sell into the public market, in any rolling 90-day period, more than 1% of the Company’s then-outstanding common stock; and they agreed to a 10-year standstill prohibiting them from further acquisitions of Company stock and from seeking or assisting to acquire or gain control of the Company. And, the Boyd Parties agreed not to, except in conjunction with other stockholders (unaffiliated with them) holding at least 1,000,000 shares of Company common stock, exercise any stockholder rights other than the right to vote.

Before the New License Agreement, the Company and certain Boyd Parties were party to the Exclusive Agreements. Since April 1, 2011, essentially the Company’s entire active business has consisted of the manufacture and sale of AMPSA Products as authorized by the Exclusive Agreements.

The Exclusive Agreements provided for a $3,000,000 inception fee to be paid by the Company to Boyd Research, Inc. The Company did not pay the inception fee and did not have the funds to do so. The Boyd Parties threatened to sue the Company for payment of the inception fee and/or seek to terminate the Exclusive Agreements and seek an injunction against the Company to prevent further sales of products licensed by Boyd Research, Inc., all on the ground that the inception fee had not been paid. The Company believes it had valid defenses but determined that it was in the Company’s best interest to, instead of putting the Company’s defenses to the test, enter into the MDRA and the New License Agreement.

The New License Agreement essentially carries forward the Exclusive Agreements’ terms as to sales to the US market, except that under the New License Agreement the Company’s rights to sell AMPSA Products to the US market will expire at the end of 2012. Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory semi-custom AMPSA Products field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.

The Company has been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.

The MDRA and New License Agreement contain various provisions pertaining to the transition of US market sales of the existing chairside AMPSA Products from the Company to a Boyd Party on January 1, 2013, joint access to chairside AMPSA Products production molds, website and toll-free telephone number transition, regulatory matters, etc. The Company will provide a limited supply of the existing chairside AMPSA Products to the Boyd Parties so they can begin selling and shipping without interruption effective January 1, 2013.

Under the MDRA, the Company’s April 26, 2012 purchase of certain production molds from a Boyd Party for a $180,000 promissory note was rescinded. Under the MDRA, the Company is entitled to continue to use those molds to manufacture AMPSA Products.

In addition, the Company agreed under the MDRA to make deferred payments totaling $140,000 to the Boyd Parties. The Company agreed to pay $10,000 per month for five months beginning September 1, 2012, and $5,000 per month for 18 months beginning July 1, 2013. These obligations do not bear interest and are unsecured. As of November 1, 2012 the Company has made $30,000 of such payments.

And, as part of the MDRA, Dixon dismissed litigation he brought against Boyd pertaining to TMD Courses, Inc., Dixon transferred his shares of TMD Courses, Inc. to Boyd (making Boyd the sole stockholder of TMD Courses, Inc.), and Boyd transferred 5,000,000 shares of Company common stock to Dixon.

All parties to the MDRA granted general releases to each other.

Boyd has placed the 223,991,933 shares of Company common stock, referred to above, in escrow pursuant to the Escrow Agreement, to be released to the Company for cancellation when the Company finishes making timely estimated minimum royalties and other payments, all totaling $351,000, into the escrow for the benefit of Boyd, which the Company expects to finish doing no later than January 2013. $301,000 of the $351,000 consists of estimated minimum royalty payments which roughly correspond to the anticipated amount of the 30% royalty on AMPSA Products net sales which the Company would owe anyway for the remainder of 2012, and the other $50,000 is a portion of the $140,000 of deferred payments referred to above. As of November 1, 2012 the Company has made $177,000 of the required $351,000 payments.

Boyd agreed, in the Voting Agreement and in a related irrevocable proxy, to vote the escrowed 223,991,933 shares in favor of any Company-proposed authorized shares change and to abstain on all other stockholder-vote matters for the duration of the escrow.

As a result of the MDRA, Boyd’s beneficial ownership percentage of Company common stock will decrease from 78% to 11%, and Dixon’s beneficial ownership percentage of Company common stock will increase from 5.5% to 26.5%. Also, all of the Company’s other stockholders’ beneficial ownership percentage of common stock will increase substantially as a result of the MDRA because the Company’s outstanding common shares will be reduced from 305,458,333 to 81,466,400. (The figures in this paragraph give immediate effect to Boyd’s surrender of 223,991,933 shares of Company common stock, which in fact will not occur until the Company makes estimated minimum royalties and other payments, all totaling $351,000, to the Escrow Agreement escrow for the benefit of Boyd, which the Company expects to finish doing no later than January 2013; and such figures also give effect to the other transactions contemplated by the MDRA.) This increase in Dixon’s beneficial ownership, viewed together with his Board of Directors seat and his positions as the Company’s Chairman and President, may be considered to constitute a change in control of the Company, in favor of Dixon.

This summary of the material terms of the MDRA, the New License Agreement, the Escrow Agreement, the Voting Agreement and the Exclusive Agreements does not purport to be exhaustive, and is qualified in its entirety by reference to the complete text of these agreements as filed by the Company with the Securities and Exchange Commission on August 30, 2012.

Also, on August 24, 2012, Gerry B. Berg was elected as a director of the Company. Mr. Berg also serves as the Company’s Chief Financial Officer. As noted above, James P. Boyd resigned as a director of the Company on August 24, 2012 in connection with the MDRA.

Future Development of the Company’s Business.

Sales of chairside AMPSA Products to the US market have constituted over 80% of the Company’s AMPSA Products business to date. The Company’s challenge will be to counter the loss of the Company’s AMPSA Products sales to the US market and the loss of the ability to introduce new chairside products based on Boyd Party technology, by increasing sales of the Company’s AMPSA Products to non-US markets and/or by successfully introducing into the US and non-US markets new products which do not require licenses from the Boyd Parties. On the other hand, the Company’s business in 2013 and thereafter will be free of Boyd Parties royalty obligations and will not be subject to any Boyd Parties inception fee, and the Company also believes that not having a majority shareholder should increase the financing and acquisition opportunities available to the Company.

Warrant issuance

The Company entered into an Investor Relations Consulting Agreement dated November 5, 2012 with Constellation Asset Advisors, Inc. (“CAA”). CAA agreed to provide investor relations consulting services over a period of six months (through May 4, 2013), and in exchange the Company issued to CAA a warrant to purchase 2,000,000 shares of Company common stock at an exercise price of $0.05 per share cash, expiring November 5, 2013.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis contains forward-looking statements within the meaning of the federal securities laws. The safe harbor provided in section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 ("statutory safe harbors") shall apply to forward-looking information provided pursuant to the statements made in this filing by the Company. We urge you to carefully review our description and examples of forward-looking statements included in the section entitled “Cautionary Note Regarding Forward-Looking Statements” at the beginning of this report. Forward-looking statements speak only as of the date of this report and we undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this report. Actual events or results may differ materially from such statements. In evaluating such statements, we urge you to specifically consider various factors identified in this report, any of which could cause actual results to differ materially from those indicated by such forward-looking statements. The following discussion and analysis should be read in conjunction with the accompanying financial statements and related notes, as well as the Financial Statements and related notes in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 and the risk factors discussed therein.

General

This Quarterly Report on Form 10-Q, and the financial statements included herein, reflect the treatment of Splint Decisions Inc. as the “accounting acquirer” in the first quarter 2011 transaction involving the two companies. Our principal executive office is located at 4093 Oceanside Blvd., Suite B, Oceanside, California 92056, our telephone number is (760) 295-7208 and our website is www.therapeuticsolutionsint.com. The reference to our website does not constitute incorporation by reference of the information contained on our website.

We file our quarterly and annual reports with the Securities and Exchange Commission (“SEC”), which the public may view and copy at the SEC’s Public Reference Room at 100 F Street, N.E. Washington D.C. 20549, on official business days during the hours of 10 a.m. to 3 p.m. The public may obtain information on the operation of the SEC’s Public Reference Room by calling the SEC at 1–800–SEC–0330. The SEC also maintains an Internet site, the address of which is www.sec.gov, which contains reports, proxy and information statements, and other information regarding issuers which file electronically with the SEC. The periodic and current reports that we file with the SEC can also be obtained from us free of charge by directing a request to Therapeutic Solutions International, Inc., 4093 Oceanside Blvd, Suite B, Oceanside, California 92056, Attn: Corporate Secretary.

General / 2012 Change in Key Business Rights and Obligations/ Trends and Uncertainties

We were organized on August 6, 2007 under the name Friendly Auto Dealers, Inc. Our initial business strategies included developing and brokering the design, manufacturing and sale of promotional and corporate branded products for sale first to the Chinese automobile industry then internationally. We took steps from 2008 through 2009 to implement our strategies by hiring a Pacific Rim business consultant and, along with management, traveling to the People’s Republic of China and meeting with automobile industry representatives in order to establish relationships from which our business strategies could begin. These efforts proved unsuccessful. We also suffered from an inability to raise capital from which we could launch our business strategies. These factors, in combination with the worldwide economic downturn that began in 2009, led us to begin to explore other business models and strategies.

In the first quarter of 2011 we acquired Splint Decisions Inc., a California corporation organized on September 21, 2011 to engage in the intraoral products business.

On April 1, 2011, we entered into an Exclusive License Agreement (as amended on November 1, 2011, the “2011 Agreement”) with Boyd Research, Inc. (“Boyd Research”); and our predecessor, Splint Decisions Inc., and Boyd Research and TMD Courses, Inc. (“TMD” and together with Boyd and Boyd Research, the “Boyd Parties”), were party to an Exclusive License Agreement dated October 22, 2010, as amended on July 8, 2011 (together with the 2011 Agreement, the “Exclusive Agreements”). The Exclusive Agreements provided us with, among other things, an exclusive worldwide license for all legal right, title and interest to certain technology including patents, patent applications, know-how and inventions concerning Anterior Midpoint Stop Appliances (“AMPSA Products”), including all know-how, technical data, or other information of any kind regarding the design, manufacture, operation, use, or sale of the AMPSA Products for use in any field incorporating or based on United States Patent No. 6,666,212, foreign counterparts of this patent, or of the applications leading to such patents, and any other patents owned or controlled by Boyd Research or based on any products sold by Boyd Research, and any modification or improvements thereto made by us or Boyd Research. The only exception to such worldwide exclusivity is that Keller Laboratories, Inc. has the exclusive right to manufacture and distribute laboratory fabricated semi-custom versions of the AMPSA Products in the United States. Since entering into the Exclusive Agreements, essentially our entire active business has consisted of the manufacture and sale of AMPSA Products.

On August 24, 2012, we entered into a Master Dispute Resolution Agreement (the “MDRA”) with James P. Boyd (“Boyd”), Boyd Research, TMD, Timothy G. Dixon (“Dixon”) and Gerry B. Berg (“Berg”), and on August 24, 2012 we also entered into a License Agreement with Boyd Research and TMD (the “New License Agreement”), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent (the “Escrow Agreement”), and a Voting Agreement with Boyd (the “Voting Agreement”).

Under the MDRA, Boyd agreed to surrender 223,991,933 shares of our common stock and resigned as a director of the Company. The MDRA also provided that Boyd’s employment with us shall continue throughout 2012, with his salary rate reduced to $100,000 per annum as of the date of the MDRA. Also, the Boyd Parties agreed never to directly and/or indirectly sell into the public market, in any rolling 90-day period, more than 1% of our then-outstanding common stock; and they agreed to a 10-year standstill prohibiting them from further acquisitions of our stock and from seeking or assisting to acquire or gain control of us. Further, the Boyd Parties agreed not to, except in conjunction with other stockholders (unaffiliated with them) holding at least 1,000,000 shares of our common stock, exercise any stockholder rights other than the right to vote.

Before the New License Agreement, we and certain Boyd Parties were party to the Exclusive Agreements, which granted us an exclusive worldwide license to certain Boyd Parties patent rights and related technology (but no license for the US dental-laboratory field).

The Exclusive Agreements provided for a $3,000,000 inception fee to be paid by us to Boyd Research. We did not pay the inception fee and did not have the funds to do so. The Boyd Parties threatened to sue us for payment of the inception fee and/or seek to terminate the Exclusive Agreements and seek an injunction against us to prevent further sales of products licensed by Boyd Research, all on the ground that the inception fee had not been paid. We believed that we had valid defenses but determined that it was in our best interest to, instead of putting our defenses to the test, enter into the MDRA and the New License Agreement.

The New License Agreement terminated the Exclusive Agreements. However, the New Licensee Agreement grants us new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell our existing chairside AMPSA Products (but not any such products other than our currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.

The New License Agreement essentially carries forward the Exclusive Agreements’ terms as to sales to the US market, except that under the New License Agreement our rights to sell AMPSA Products to the US market will expire at the end of 2012. Specifically, for AMPSA Products sales to the US market, the New License Agreement grants us an exclusive license (but no license for the US dental-laboratory field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.

For sales of the existing AMPSA Products to non-US markets, the New License Agreement grants us an exclusive license, which converts to a non-exclusive license on January 1, 2013. Under the New License Agreement, we must pay a 30% royalty on 2012 net sales of the existing AMPSA Products to most non-US markets, but, under the New License Agreement, after 2012 our net sales to non-US markets will be royalty-free.

We had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.

We expect that the Boyd Parties will manufacture and, beginning on January 1, 2013, sell to the US market the AMPSA Products which we had previously sold to the US market (and which, beginning on that date, we will no longer be allowed to sell to the US market) and maybe new AMPSA Products as well. We also expect that the Boyd Parties may compete with us in the manufacture and sale to some or all non-US countries, from and after January 1, 2013, of the AMPSA Products which we had previously sold to the US and non-US markets, and the Boyd Parties could sell new AMPSA Products there as well.

In the transition from the Exclusive Agreements to the New License Agreement, we are giving up our license rights to the “Total Splint System” intraoral devices (which we have not successfully commercialized) and to all potential AMPSA Products which could have been commercialized using our Exclusive Agreements rights but which we are not currently selling.

Sales of chairside AMPSA Products to the US market have constituted over 80% of our business to date. Our challenge will be to counter the loss of our AMPSA Products sales to the US market and the loss of the ability to introduce new products based on Boyd Party technology, by increasing sales of our existing AMPSA Products to non-US markets and/or by successfully introducing into the US and non-US markets new products which do not require licenses from the Boyd Parties. On the other hand, our business in 2013 and thereafter will be free of Boyd Parties royalty obligations and will not be subject to any Boyd Parties inception fee.

The MDRA and New License Agreement contain various provisions pertaining to the transition of US market sales of the existing AMPSA Products from us to a Boyd Party on January 1, 2013, joint access to AMPSA Products production molds, website and toll-free telephone number transition, regulatory matters, etc. We will provide a limited supply of the existing AMPSA Products to the Boyd Parties so they can begin selling and shipping without interruption effective January 1, 2013.

Under the MDRA, our April 26, 2012 purchase of certain production molds from TMD for a $180,000 promissory note was rescinded. However, the MDRA entitles us to continue to use those molds to manufacture AMPSA Products.

In addition, we agreed under the MDRA to make deferred payments totaling $140,000 to the Boyd Parties. We agreed to pay $10,000 per month for five months beginning September 1, 2012, and $5,000 per month for 18 months beginning July 1, 2013. These obligations do not bear interest and are unsecured.

Also, as part of the MDRA, Dixon dismissed litigation he brought against Boyd pertaining to TMD, Dixon transferred his shares of TMD to Boyd (making Boyd the sole stockholder of TMD), and Boyd transferred 5,000,000 shares of our common stock to Dixon.

All parties to the MDRA granted general releases to each other.

Boyd has placed the 223,991,933 shares of Company common stock in escrow pursuant to the Escrow Agreement, to be released to us for cancellation when we finish making timely estimated minimum royalties and other payments, all totaling $351,000, into the escrow for the benefit of Boyd, which we expect to finish doing no later than January 2013. $301,000 of the $351,000 consists of estimated minimum royalties payments which roughly correspond to the anticipated amount of the 30% royalty on AMPSA Products net sales which we would owe anyway for the remainder of 2012, and the other $50,000 is a portion of the $140,000 of deferred payments referred to above.

Boyd agreed, in the Voting Agreement and in a related irrevocable proxy, to vote the escrowed 223,991,933 shares in favor of any Company-proposed authorized shares increase and to abstain on all other stockholder-vote matters for the duration of the escrow.

As a result of the MDRA, Boyd’s beneficial ownership percentage of our common stock will decrease from 78% to 11%, and Dixon’s beneficial ownership percentage of our common stock will increase from 5.5% to 26.5%. Also, all of our other stockholders’ beneficial ownership percentage of common stock will increase substantially as a result of the MDRA because our outstanding common shares will be reduced from 305,458,333 to 81,466,400. (The figures in this paragraph give immediate effect to Boyd’s surrender of 223,991,933 shares of Company common stock, which in fact will not occur until we make estimated minimum royalties and other payments, all totaling $351,000, to the Escrow Agreement escrow for the benefit of Boyd, which we expect to finish doing no later than January 2013; and such figures also give effect to the other transactions contemplated by the MDRA.) This increase in Dixon’s beneficial ownership, viewed together with his Board of Directors seat and his positions as our Chairman and President, may be considered to constitute a change in control of us, in favor of Dixon.

Boyd resigned as a director of the Company on August 24, 2012 in connection with the MDRA; and on the same date Berg was elected as a director of the Company. Berg also serves as our Chief Financial Officer.

Results of Operations

You should read the following discussion of our financial condition and results of operations together with the unaudited financial statements and the notes to the unaudited financial statements included in this quarterly report. This discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results may differ materially from those anticipated in these forward-looking statements.

For the three and six months ended June 30, 2012 and June 30, 2011

Net revenues for the three-month periods ended June 30, 2012 and 2011were $599,725 and $550,941. The increase of approximately $50,000 for the three-months ended June 30, 2012 was mainly due to the increase of international revenues. We derived 24% of our revenue from international sales in the 2012 three-month period versus 17% in the 2011 period. Net revenues for the six-month periods ended June 30, 2012 and 2011 were $1,207,499 and $551,431, respectively. We derived 20% of our revenue from international sales in the 2012 six-month period versus 17% in the 2011 period. International revenues derive mostly from distributors’ orders and therefore tend to be “lumpy” and can vary from quarter to quarter due to timing differences. We had no active business in the 2011 first quarter. Revenues for the three and six-months ended June 30, 2012 and for the three-months ended June 30, 2011 related primarily to AMPSA Products.

Operating expenses for the three-months ended June 30, 2012 and June 30, 2011 were approximately the same except for consulting fees and legal and professional fees, as slight increases in salaries /wages/ related costs and royalties offset a slight decrease in selling expenses. Consulting fees in the 2012 second quarter represented approximately $0.2 million of expense as we recognized a pro rata portion of the $1.0 million of common stock we issued to our investor relations consultant in June 2011 as compensation under a 12-month consulting agreement. The entire $1.0 million was completely recognized as expense by mid-June 2012. Legal and professional fees increased approximately $0.1 million in the 2012 three-month period versus the 2011 three-month period. This increase was primarily due to negotiations during the quarter which ultimately resulted in the MDRA and the New License Agreement.

Total operating expenses for the six-months ended June 30, 2012 and June 30, 2011 were $1,934,045 and $628,602, an increase of approximately $1.3 million in the 2012 period. We did not have any active business for the three-months ended March 31, 2011. As a result, many of our revenues and expense items for the first half of 2012 were approximately double those for the first half of 2011. However, consulting fees increased by approximately $0.46 million, representing recognition of the pro rata portion of the $1.0 million of common stock we issued to our investor relations consultant in June 2011; and legal and professional fees increased approximately $0.18 million, with the increase being due to negotiations during the 2012 six-month period which ultimately resulted in the MDRA and the New License Agreement. Cash constraints and uncertainty about our future business led us to keep our marketing expenditures low during the first half of 2012. In addition, these uncertainties rendered us unable to gain advantage during the 2012 six-month period from the investor relations consulting services.

We paid approximately $175,000 of royalties to Boyd Research, a related party, for the three-months ended June 30, 2012 and approximately $354,000 of royalties to Boyd Research for the six-months ended June 30, 2012, under the Exclusive Agreements authorizing us to sell AMPSA Products. We also paid approximately $34,000 and $70,000 for the three and six-months ended June 30, 2012 for James P. Boyd’s salary and related benefits compared to $35,000 and $35,000 for the three and six-months ended June 30, 2011.

The $3.0 million note payable to related parties shown on our balance sheet represents the license inception fee called for by the 2011 Agreement. There is a corresponding asset (net of amortization) on the balance sheet as well. As noted above, the 2011 Agreement was terminated in August 2012. Although we have had a high gross profit margin on our AMPSA Products revenues since April 1, 2011, our net revenues have not provided enough economies of scale to put us in a position to pay the license inception fee.

As noted above, the nature and conditions of our business will change substantially on January 1, 2013, due to contract changes.

Our net loss for the three-months ended June 30, 2012 was $360,703 as compared to $49,198 for the three-month period ended June 30, 2011, and our net loss for the six-months ended June 30, 2012 was $738,339 as compared to $59,138 for the six-month period ended June 30, 2011.

Liquidity and Capital Resources

We did not begin commercial operations until April 1, 2011. Net cash provided by operating activities totaled $637 for the six-months ended June 30, 2012, despite our six-month loss of $738,339, primarily due to non-cash items totaling approximately $0.77 million which included approximately a $0.48 million reduction of prepaid expenses for stock issued in June 2011 to Constellation Asset Advisors, Inc., an investor relations consulting firm, the expense of which is amortized over the 12 month term of the consulting agreement; $0.14 million for stock options vesting, and $0.15 million for amortization of the 2011 Agreement’s license inception fee.

We had no material commitments for capital expenditures at June 30, 2012. During the second quarter of 2012 we acquired from TMD, a related party, in exchange for a $0.18 million promissory note, certain production molds in order to ensure our ability to continue to use them in the future to manufacture our AMPSA Products. After June 30, 2012, the MDRA rescinded this purchase transaction, but instead provided us with a contractual right to continue to access the molds to manufacture our AMPSA Products.

As of June 30, 2012, we had approximately $86,000 of cash. We had no cash equivalents at the end of the quarter. Based upon our current plans, we believe that our existing capital resources will be sufficient to meet our operating expenses into early 2013. However, changes in our product development or marketing plans or other events affecting our operating expenses may result in the expenditure of such cash before that time.

In view of the MDRA and the New License Agreement, we believe we will need outside financing to execute our business plan in 2013 and beyond. There is no guarantee we will receive the required financing to complete our business strategies, and it is uncertain whether future financing will be available to us on acceptable terms. If financing is not available on satisfactory terms, we may be unable to continue, develop or expand our operations. Our auditor has stated in their opinion on our 2011 annual financial statements that there is substantial doubt about our ability to continue as a going concern.

Off Balance Sheet Arrangements

We currently do not have any off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

No disclosure required.

Item 4. Controls and Procedures

A. Disclosure Controls and Procedures

As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, or Exchange Act, our principal executive officer and principal financial officer evaluated our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of June 30, 2012. Based on this evaluation, these officers concluded that as of the end of the period covered by this Quarterly Report on Form 10-Q, these disclosure controls and procedures were adequate to ensure that the information required to be disclosed by the Company in reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and include controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

B. Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended June 30, 2012 that materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

As previously noted, the 2011 Agreement provided for a $3,000,000 license inception fee to be paid by us to Boyd Research. We did not pay the inception fee and did not have the funds to do so. The Boyd Parties threatened to sue us for payment of the inception fee and/or seek to terminate the Exclusive Agreements and seek an injunction against us to prevent further sales of products licensed by Boyd Research, all on the ground that the inception fee had not been paid. We resolved this dispute (and other matters) by entering into the MDRA, the New License Agreement, the Escrow Agreement and the Voting Agreement on August 24, 2012.

Item 1A. Risk Factors

No disclosure required.

Item 2. Unregistered Sales of Equity Securities

No disclosure required.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits


EXHIBIT NUMBER	DESCRIPTION
3.1 3.1.1 3.1.2	Articles of Incorporation (incorporated herein by reference to Form 10-K filed October 31, 2012) Articles of Merger, filed February 22, 2011 (incorporated herein by reference to Form 10-K filed October 31, 2012) Certificate of Amendment to Articles of Incorporation filed October 15, 2012 (incorporated herein by reference to Form 8-K filed October 17, 2012)
3.2	Bylaws (incorporated herein by reference to Form SB-2 filed November 21, 2007)
3.2.1	Bylaws amendments adopted August 22, 2012, August 24, 2012 and September 26, 2012 (incorporated herein by reference to Form 10-K filed October 31, 2012)
31.1 31.2	Rule 13a-14(a)/Section 302 Certification of Principal Executive Officer Rule 13a-14(a)/Section 302 Certification of Principal Financial Officer
32.1	Certification pursuant to 18 U.S.C. Section 1350/Rule 13a-14(b)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.





Date: November 21, 2012	By: /s/ Timothy G. Dixon
	Timothy G. Dixon
	President and Chief Executive Officer (Principal Executive Officer)

Date: November 21 , 2012	By: /s/ Gerry B. Berg
	Gerry B. Berg
	Chief Financial Officer (Principal Financial Officer)

EX-31.1 2 f10q060312_ex31z1.htm EXHIBIT 31.1 SECTION 302 CERTIFICATION Exhibit 31.1 Section 302 Certification

Exhibit 31.1

Section 302 Certification of Principal Executive Officer

I, Timothy G. Dixon, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Therapeutic Solutions International, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: November 21, 2012

/s/ Timothy G. Dixon

Timothy G. Dixon

President and

Chief Executive Officer

(Principal Executive Officer)

EX-31.2 3 f10q060312_ex31z2.htm EXHIBIT 31.2 SECTION 302 CERTIFICATION Exhibit 31

Exhibit 31.2

Section 302 Certification of Principal Financial Officer

I, Gerry Berg, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Therapeutic Solutions International, Inc.

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: November 21, 2012

/s/ Gerry Berg

Gerry Berg

Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 f10q060312_ex32z1.htm EXHIBIT 32.1 SECTION 906 CERTIFICATIONS Exhibit 32.1 Section 906 Certifications

Exhibit 32.1

SARBANES-OXLEY SECTION 906 CERTIFICATION

In connection with the Quarterly Report on Form 10-Q of Therapeutic Solutions International, Inc. (the "Company") for the period ending June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy G. Dixon, Chief Executive Officer and President of the Company, and I, Gerry Berg, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 21, 2012

By: /s/ Timothy G. Dixon

Timothy G. Dixon

Chief Executive Officer and President

(Principal Executive Officer)

By: /s/ Gerry Berg

Gerry Berg

Chief Financial Officer

(Principal Financial Officer)

EX-101.INS 5 tsoi-20120630.xml XBRL INSTANCE DOCUMENT 10-Q 2012-06-30 false THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. 0001419051 --12-31 305458333 Smaller Reporting Company Yes No No 2012 Q2

85851

87976

28576

37416

43498

48198

12164

490037

170088

663627

17390

12350

188303

7639

2625000

2775000

3000781

3458616

36544

56777

32728

39155

47201

56211

3296473

3156233

305458

1115546

975281

-1716695

-978356

-295691

302383

3000781

3458616

0.001

5000000

0.001

700000000

305458333

454897

456618

961519

457108

144828

94323

245980

94323

599725

550941

1207499

551431

13753

17269

27616

17343

585972

533672

1179884

534089

28179

44169

50828

47366

31327

31694

70322

31719

285294

254549

605947

254549

175579 160231 354315 160231

76049

76893

152098

76893

218621 18708 478761 18708

135725

32136

221774

39136

950774

618380

1934045

628602

-364802

-84708

-754161

-94513

7100

35652

18832

35652

-3001

-142

-3010

-277

4099

35510

15822

35375

-360703

-49198

-738339

-59138

0.00

305458333 296549542 305458333 168949899

-738339

-59138

150000

75000

2098

1893

42000

1012000

140265

4700

-63305

8840

-20043

477873

-1017678

-5040

-10000

-20233

1061

-6427

61444

-13100

637

23234

-182763

-8827

-182763

-8827

69562

-21750

180000

47812

4061

62219

2366

62219

0 35101 0 3000000

3010

181

800

Note 1 Organization and Presentation Basis   The consolidated financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC).  In the opinion of the management of Therapeutic Solutions International, Inc. (the Company), these interim Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair presentation of the Companys financial position as of June 30, 2012, and the results of operations and cash flows for the three and six-months ended June 30, 2012. Interim results are not necessarily indicative of results for a full year or for any future period.   The  consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in our audited financial statements and notes for  the fiscal year ended December 31, 2011 pursuant to the rules and regulation of the SEC.  For further information, refer to the financial statements and notes thereto as of and for the year ended December 31, 2011, and included in the Annual Report on Form 10-K on file with the SEC.   Therapeutic Solutions International, Inc. (the Company) was organized August 6, 2007 under the name Friendly Auto Dealers, Inc. under the laws of the State of Nevada. In the first quarter of 2011 the Company changed its name from Friendly Auto Dealers, Inc. to Therapeutic Solutions International, Inc., and acquired Splint Decisions Inc., a California corporation organized September 21, 2010 (Splint).  Splint is treated as the accounting acquirer in the accompanying financial statements.  In the transaction, the Company issued 250,523,333 common shares to the shareholders of Splint; such shares represented, immediately following the transaction, 85% of the outstanding shares of the Company.  The transaction was accounted for as a reverse merger and a reverse recapitalization and the issuances of common stock were recorded as a reclassification between paid-in-capital and par value of Common Stock.   After June 30, 2012, on August 24, 2012, the Company entered into a Master Dispute Resolution Agreement (the MDRA) with James P. Boyd (Boyd), Boyd Research, Inc. and TMD Courses, Inc. (together with Boyd, the Boyd Parties) and Timothy G. Dixon (Dixon) and Gerry B. Berg, and on August 24, 2012, the Company also entered into a License Agreement with Boyd Research, Inc. and TMD Courses, Inc. (the New License Agreement), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent (the Escrow Agreement), and a Voting Agreement with Boyd (the Voting Agreement).   Before the New License Agreement, the Company and certain Boyd Parties were party to an Exclusive License Agreement dated April 1, 2011, as amended on November 1, 2011 (the 2011 Agreement), and the Companys predecessor Splint Decisions Inc. and certain Boyd Parties were party to an Exclusive License Agreement dated October 22, 2010, as amended on July 8, 2011 (together with the 2011 Agreement, the Exclusive Agreements), which granted the Company an exclusive worldwide license to certain Boyd Parties patent rights and related technology.  Since April 1, 2011, essentially the Companys entire active business has consisted of the manufacture and sale of Anterior Midpoint Stop Appliance intraoral devices (AMPSA Products) as authorized by the Exclusive Agreements.   The New License Agreement terminated the Exclusive Agreements.  However, the New Licensee Agreement grants the Company new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell the Companys existing chairside AMPSA Products (but not any such products other than the Companys currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.     The New License Agreement essentially carries forward the Exclusive Agreements terms as to sales to the US market, except that under the New License Agreement the Companys rights to sell AMPSA Products to the US market will expire at the end of 2012.  Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.   For sales of the existing AMPSA Products to non-US markets, the New License Agreement grants the Company an exclusive license, which converts to a non-exclusive license on January 1, 2013.  Under the New License Agreement, the Company must pay a 30% royalty on 2012 net sales of the existing AMPSA Products to most non-US markets, but, under the New License Agreement, after 2012 the Companys net sales to non-US markets will be royalty-free.   The Company had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.   The Company expects that the Boyd Parties will manufacture and, beginning on January 1, 2013, sell to the US market the AMPSA Products which the Company had previously sold to the US market (and which, beginning on that date, the Company will no longer be allowed to sell to the US market) and maybe new AMPSA Products as well. The Company also expects that the Boyd Parties may compete with the Company in the manufacture and sale to some or all non-US countries, from and after January 1, 2013, of the AMPSA Products which the Company had previously sold to the US and non-US markets, and the Boyd Parties could sell new AMPSA Products there as well.   Beginning January 1, 2014, the Company will no longer be able to use the in-licensed NTI trademark for its AMPSA Products.     In the transition from the Exclusive Agreements to the New License Agreement, the Company is giving up its license rights to the Total Splint System intraoral devices (which the Company has not successfully commercialized) and to all potential chairside AMPSA Products which could have been commercialized using the Companys Exclusive Agreements rights but which the Company is not currently selling.   See Note 9 Subsequent Events, for additional information.

Note 2 Significant Accounting Policies   Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   Cash For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of June 30, 2012.  Other assets include restricted cash of $10,000 that is used to secure a company credit card.   Inventory Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at June 30, 2012.   Depreciation and Amortization Depreciation is calculated using the straight line method over the estimated useful lives of the assets.  Amortization is computed using the straight line method over the term of the agreement.   Intangible Assets Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any intangible assets. However, the Company entered into the Exclusive Agreements on October 22, 2010 and April 1, 2011, which gave the Company respectively (i) the exclusive worldwide license to make and sell the Total Splint System and (ii) the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company that is solely owned by James P. Boyd, the majority shareholder of the Company. The Exclusive Agreements require a deferred $3,000,000 license inception fee, which the Company is amortizing over a ten year period using the straight line method of amortization.     See Note 5 License Agreements.   Income Taxes The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 Accounting for Uncertainty in Income Taxes an Interpretation of FASB Statement No. 109. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.   Going Concern The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.  Under the New License Agreement the Companys rights to sell AMPSA Products to the US market (81% of total revenue for fiscal 2011) will expire at the end of 2012.  The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.   Share Based Expenses ASC 718 "Compensation - Stock Compensation," which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights.  Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See Note 6 Equity Transactions.   The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 "Equity - Based Payments to Non-Employees," which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date.  See Note 6 Equity Transactions.   Recently Implemented Standards In January 2010, the FASB issued guidance to amend the disclosure requirements related to recurring and nonrecurring fair value measurements. The guidance requires a roll forward of activities on purchases, sales, issuance, and settlements of the assets and liabilities measured using significant unobservable inputs (Level 3 fair value measurements). The guidance was effective for the Company with the reporting period beginning January 1, 2011. The adoption of this guidance did not have a material impact on the Companys consolidated financial statements.   Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Companys consolidated financial statements upon adoption.

Note 3 Restricted Cash   Other non-current asset is a $10,000 certificate of deposit with an annual interest rate of .6%.  This certificate matures on June 17, 2013, and is used as collateral for a Company credit card, pursuant to a security agreement dated June 20, 2011.

Note 4 Equipment   The cost and accumulated depreciation of fixed assets and equipment at June 30, 2012 and December 31, 2011 are summarized below:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2012</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> December 31, 2011</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (unaudited)</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (audited)</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Computer Hardware </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 7,374</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 4,612</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Office Furniture and Equipment</td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 3,639</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 3,639</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Production Molds </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 180,000</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> -</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Shipping and Other Equipment </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1,575</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1,575</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Total</td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 12,588</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 9,826</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Accumulated Depreciation </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> ( 4,285)</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (2,187)</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Property and Equipment, net</td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="117" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 188,303</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="123" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 7,639</td></tr></table></div>

Note 5 License Agreements   The Exclusive Agreements granted the Company an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions) and a deferred $3,000,000 license inception fee.  From April 1, 2011 through June 30, 2012, essentially the Companys entire active business consisted of the manufacture and sale of AMPSA Products as authorized by the Exclusive Agreements.  The Exclusive Agreements licensor is wholly owned by Boyd, the Companys majority stockholder.   See Note 9 Subsequent Events, for additional information.

Note 6  Equity Transactions   Preferred Stock The Company is authorized to issue 5,000,000 shares of $.001 par value preferred stock. The Company has not issued any preferred stock.   Common Stock The Company is authorized to issue 700,000,000 shares of $.001 par value common stock.  All shares have equal voting rights, are non-assessable, and have one vote per share.  Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all of the directors of the Company. In the first quarter of 2011 the Company issued 250,523,333 shares of common stock to James P. Boyd and Timothy G. Dixon, the shareholders of Splint Decisions Inc., to acquire Splint Decisions Inc.   Warrants The fair value of each compensatory warrant granted is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. Expected volatilities are based on volatilities from the Company's traded common stock since June 27, 2008.   The risk-free rate for the periods within the contractual life of the compensatory warrants is based on the U.S. Treasury bond rate in effect at the time of grant for bonds with maturity dates at the estimated term of the options.   The following values were used to calculate the intrinsic values of the Companys outstanding compensatory warrants as of their issuance dates:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Expected volatility</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 136.53% - 217.26%</td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Expected dividends</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 0</td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Expected term (in years)</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 2 - 4</td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Risk-free rate</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 1.29% - 1.86%</td></tr></table></div>   A summary of the compensatory warrants outstanding at June 30, 2012 and changes during the period then ended is presented below:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="235" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Warrants</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Shares</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted- Average Exercise Price</td> <td width="76" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted-Average Remaining Contractual Term</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Aggregate Intrinsic Value</td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercisable at December 31, 2011</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 450,000</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $0.78</td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1.26</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $34,653</td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Granted</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercised</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Canceled</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercisable at June 30, 2012</td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 450,000</td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $0.78</td> <td width="76" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.76</td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $34,653</td></tr></table></div>   See Note 9 Subsequent Events, for additional information.   Stock Based Compensation On August 31, 2011, the Company issued options to purchase an aggregate of 7,950,000 shares of the Companys common stock with an estimated fair value of $636,000 to its officers and employees.  The options have an exercise price of $0.08 per share.  As of June 30, 2012, 2,428,000 options have vested and no options were exercised.  Subject to continuation of service, the remaining option shares vest monthly over the next 26 months; and the options expire ten years from the date of grant unless earlier terminated.  Compensation cost, using the graded vesting attribute method in accordance with ASC 718, is recognized over the requisite service period during which each tranche of shares is earned (36 months). The value of each tranche is amortized on a sum of the years digits basis; $60,938 was expensed for the three-months ended June 30, 2012 and $140,265 for the six-months ended June 30, 2012.    The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with dividend yield of 0%; expected volatility of 191%; risk-free interest rate of 2.23%; contractual life of ten years; and an exercise price ($0.08) equal to 100% of the grant-date common stock fair market value.  Expected volatility is calculated based on the stock market closing prices for the 406 trading days preceding the grant date.   The expected term of options granted is estimated at half of the contractual term as noted in the individual option agreements and represents the period of time that options granted are expected to be outstanding.   The following table summarizes information regarding stock options outstanding as of June 30, 2012:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="258" colspan="10" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:193.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Options Outstanding</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="249" colspan="10" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:186.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Options Exercisable</td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercise prices</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="83" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:62.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Number Outstanding</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average remaining contractual life (years)</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average exercise price</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="74" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:55.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Number exercisable</td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average remaining contractual life (years)</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average exercise price</td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="83" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:62.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="74" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:55.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.08</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 6,900,000</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 9.17</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.08</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 2,428,000</td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 9.17 </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.08</td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr></table></div>   A summary of the stock options available under the 2009 Stock Incentive Plan at June 30, 2012 and changes during the period then ended is presented below:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Available at December 31, 2011</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 10,000,000</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Option shares granted before December 31, 2011</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (7,950,000)</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Granted</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> -</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Exercised</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> -</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Canceled</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1,050,000</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Available at June 30, 2012</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 3,100,000</td></tr></table></div>

Note 7 Related Party Transactions   At June 30, 2012, under the 2011 Agreement, the Company was obligated for a license inception fee to a related party in the amount of $3,000,000.  This inception fee is being amortized over a ten-year period using the straight line method of amortization.  The unamortized balance at June 30, 2012 was $2,625,000.  See Note 9 Subsequent Events, for additional information.   Under the 2011 Agreement, the Company incurred royalty expenses of $175,579 payable to a related party for the three-months ended June 30, 2012. The royalty accrued but unpaid at June 30, 2012 was $47,201.   See Note 9 Subsequent Events, for additional information.   On April 26, 2012, the Company acquired certain production molds from a related party in exchange for a $180,000 promissory note.  The note bears 10% interest per annum and the maturity date of the note is April 26, 2014.   See Note 9 Subsequent Events, for additional information.

Note 8 Geographic Information   The following table provides information related to the Companys revenues for the three and six-months ended June 30, 2012 and June 30, 2011.     <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Net Revenues</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Three Months</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Three Months</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Six Months</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Six Months</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2012</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2011</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2012</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2011</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Net domestic revenues</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 454,897</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 456,618</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">     941,519</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 457,108</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Net international revenues</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 144,828</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">     94,323</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">   245,980</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">    94,323</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Total</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 599,725</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 550,941</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  1,207,499</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 551,431</td></tr></table></div>

Note 9 Subsequent Events     On August 24, 2012, the Company entered into the MDRA, the New License Agreement, the Escrow Agreement and the Voting Agreement.   Under the MDRA, Boyd agreed to surrender 223,991,933 shares of Company common stock and resigned as a director of the Company.  The MDRA also provided that Boyds employment with the Company shall continue throughout 2012, with his salary rate reduced to $100,000 per annum as of the date of the MDRA.  Also, the Boyd Parties agreed never to directly and/or indirectly sell into the public market, in any rolling 90-day period, more than 1% of the Companys then-outstanding common stock; and they agreed to a 10-year standstill prohibiting them from further acquisitions of Company stock and from seeking or assisting to acquire or gain control of the Company.  And, the Boyd Parties agreed not to, except in conjunction with other stockholders (unaffiliated with them) holding at least 1,000,000 shares of Company common stock, exercise any stockholder rights other than the right to vote.     Before the New License Agreement, the Company and certain Boyd Parties were party to the Exclusive Agreements.  Since April 1, 2011, essentially the Companys entire active business has consisted of the manufacture and sale of AMPSA Products as authorized by the Exclusive Agreements.   The Exclusive Agreements provided for a $3,000,000 inception fee to be paid by the Company to Boyd Research, Inc.  The Company did not pay the inception fee and did not have the funds to do so.  The Boyd Parties threatened to sue the Company for payment of the inception fee and/or seek to terminate the Exclusive Agreements and seek an injunction against the Company to prevent further sales of products licensed by Boyd Research, Inc., all on the ground that the inception fee had not been paid.  The Company believes it had valid defenses but determined that it was in the Companys best interest to, instead of putting the Companys defenses to the test, enter into the MDRA and the New License Agreement.   The New License Agreement terminated the Exclusive Agreements.  However, the New Licensee Agreement grants the Company new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell the Companys existing chairside AMPSA Products (but not any such products other than the Companys currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.     The New License Agreement essentially carries forward the Exclusive Agreements terms as to sales to the US market, except that under the New License Agreement the Companys rights to sell AMPSA Products to the US market will expire at the end of 2012.  Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory semi-custom AMPSA Products field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.   For sales of the existing AMPSA Products to non-US markets, the New License Agreement grants the Company an exclusive license, which converts to a non-exclusive license on January 1, 2013.  Under the New License Agreement, the Company must pay a 30% royalty on 2012 net sales of the existing AMPSA Products to most non-US markets, but, under the New License Agreement, after 2012 the Companys net sales to non-US markets will be royalty-free.   The Company has been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.   The Company expects that the Boyd Parties will manufacture and, beginning on January 1, 2013, sell to the US market the AMPSA Products which the Company had previously sold to the US market (and which, beginning on that date, the Company will no longer be allowed to sell to the US market) and maybe new AMPSA Products as well.  The Company also expects that the Boyd Parties may compete with the Company in the manufacture and sale to some or all non-US countries, from and after January 1, 2013, of the AMPSA Products which the Company had previously sold to the US and non-US markets, and the Boyd Parties could sell new AMPSA Products there as well.   In the transition from the Exclusive Agreements to the New License Agreement, the Company is giving up its license rights to the Total Splint System intraoral devices (which the Company has not successfully commercialized) and to all potential chairside AMPSA Products which could have been commercialized using the Companys Exclusive Agreements rights but which the Company is not currently selling.   The MDRA and New License Agreement contain various provisions pertaining to the transition of US market sales of the existing chairside AMPSA Products from the Company to a Boyd Party on January 1, 2013, joint access to chairside AMPSA Products production molds, website and toll-free telephone number transition, regulatory matters, etc.  The Company will provide a limited supply of the existing chairside AMPSA Products to the Boyd Parties so they can begin selling and shipping without interruption effective January 1, 2013.   Under the MDRA, the Companys April 26, 2012 purchase of certain production molds from a Boyd Party for a $180,000 promissory note was rescinded.  Under the MDRA, the Company is entitled to continue to use those molds to manufacture AMPSA Products.   In addition, the Company agreed under the MDRA to make deferred payments totaling $140,000 to the Boyd Parties.  The Company agreed to pay $10,000 per month for five months beginning September 1, 2012, and $5,000 per month for 18 months beginning July 1, 2013.  These obligations do not bear interest and are unsecured.  As of November 1, 2012 the Company has made $30,000 of such payments.   And, as part of the MDRA, Dixon dismissed litigation he brought against Boyd pertaining to TMD Courses, Inc., Dixon transferred his shares of TMD Courses, Inc. to Boyd (making Boyd the sole stockholder of TMD Courses, Inc.), and Boyd transferred 5,000,000 shares of Company common stock to Dixon.     All parties to the MDRA granted general releases to each other.   Boyd has placed the 223,991,933 shares of Company common stock, referred to above, in escrow pursuant to the Escrow Agreement, to be released to the Company for cancellation when the Company finishes making timely estimated minimum royalties and other payments, all totaling $351,000, into the escrow for the benefit of Boyd, which the Company expects to finish doing no later than January 2013.  $301,000 of the $351,000 consists of estimated minimum royalty payments which roughly correspond to the anticipated amount of the 30% royalty on AMPSA Products net sales which the Company would owe anyway for the remainder of 2012, and the other $50,000 is a portion of the $140,000 of deferred payments referred to above.  As of November 1, 2012 the Company has made $177,000 of the required $351,000 payments.   Boyd agreed, in the Voting Agreement and in a related irrevocable proxy, to vote the escrowed 223,991,933 shares in favor of any Company-proposed authorized shares change and to abstain on all other stockholder-vote matters for the duration of the escrow.   As a result of the MDRA, Boyds beneficial ownership percentage of Company common stock will decrease from 78% to 11%, and Dixons beneficial ownership percentage of Company common stock will increase from 5.5% to 26.5%.  Also, all of the Companys other stockholders beneficial ownership percentage of common stock will increase substantially as a result of the MDRA because the Companys outstanding common shares will be reduced from 305,458,333 to 81,466,400.  (The figures in this paragraph give immediate effect to Boyds surrender of 223,991,933 shares of Company common stock, which in fact will not occur until the Company makes estimated minimum royalties and other payments, all totaling $351,000, to the Escrow Agreement escrow for the benefit of Boyd, which the Company expects to finish doing no later than January 2013; and such figures also give effect to the other transactions contemplated by the MDRA.)  This increase in Dixons beneficial ownership, viewed together with his Board of Directors seat and his positions as the Companys Chairman and President, may be considered to constitute a change in control of the Company, in favor of Dixon.   This summary of the material terms of the MDRA, the New License Agreement, the Escrow Agreement, the Voting Agreement and the Exclusive Agreements does not purport to be exhaustive, and is qualified in its entirety by reference to the complete text of these agreements as filed by the Company with the Securities and Exchange Commission on August 30, 2012.   Also, on August 24, 2012, Gerry B. Berg was elected as a director of the Company.  Mr. Berg also serves as the Companys Chief Financial Officer.  As noted above, James P. Boyd resigned as a director of the Company on August 24, 2012 in connection with the MDRA.   Future Development of the Companys Business.   Sales of chairside AMPSA Products to the US market have constituted over 80% of the Companys AMPSA Products business to date.  The Companys challenge will be to counter the loss of the Companys AMPSA Products sales to the US market and the loss of the ability to introduce new chairside products based on Boyd Party technology, by increasing sales of the Companys AMPSA Products to non-US markets and/or by successfully introducing into the US and non-US markets new products which do not require licenses from the Boyd Parties.  On the other hand, the Companys business in 2013 and thereafter will be free of Boyd Parties royalty obligations and will not be subject to any Boyd Parties inception fee, and the Company also believes that not having a majority shareholder should increase the financing and acquisition opportunities available to the Company.   Warrant issuance   The Company entered into an Investor Relations Consulting Agreement dated November 5, 2012 with Constellation Asset Advisors, Inc. (CAA). CAA agreed to provide investor relations consulting services over a period of six months (through May 4, 2013), and in exchange the Company issued to CAA a warrant to purchase 2,000,000 shares of Company common stock at an exercise price of $0.05 per share cash, expiring November 5, 2013.

Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of June 30, 2012.  Other assets include restricted cash of $10,000 that is used to secure a company credit card.

Inventory Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at June 30, 2012.

Depreciation and Amortization Depreciation is calculated using the straight line method over the estimated useful lives of the assets.  Amortization is computed using the straight line method over the term of the agreement.

Intangible Assets Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any intangible assets. However, the Company entered into the Exclusive Agreements on October 22, 2010 and April 1, 2011, which gave the Company respectively (i) the exclusive worldwide license to make and sell the Total Splint System and (ii) the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company that is solely owned by James P. Boyd, the majority shareholder of the Company. The Exclusive Agreements require a deferred $3,000,000 license inception fee, which the Company is amortizing over a ten year period using the straight line method of amortization.     See Note 5 License Agreements.

Income Taxes The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 Accounting for Uncertainty in Income Taxes an Interpretation of FASB Statement No. 109. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.

Going Concern The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business.  Under the New License Agreement the Companys rights to sell AMPSA Products to the US market (81% of total revenue for fiscal 2011) will expire at the end of 2012.  The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Share Based Expenses ASC 718 "Compensation - Stock Compensation," which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights.  Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See Note 6 Equity Transactions.   The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 "Equity - Based Payments to Non-Employees," which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date.  See Note 6 Equity Transactions.

Recently Implemented Standards In January 2010, the FASB issued guidance to amend the disclosure requirements related to recurring and nonrecurring fair value measurements. The guidance requires a roll forward of activities on purchases, sales, issuance, and settlements of the assets and liabilities measured using significant unobservable inputs (Level 3 fair value measurements). The guidance was effective for the Company with the reporting period beginning January 1, 2011. The adoption of this guidance did not have a material impact on the Companys consolidated financial statements.   Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Companys consolidated financial statements upon adoption.

The cost and accumulated depreciation of fixed assets and equipment at June 30, 2012 and December 31, 2011 are summarized below:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2012</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> December 31, 2011</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (unaudited)</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (audited)</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Computer Hardware </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 7,374</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 4,612</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Office Furniture and Equipment</td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 3,639</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 3,639</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Production Molds </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 180,000</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> -</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Shipping and Other Equipment </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1,575</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1,575</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Total</td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 12,588</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 9,826</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Accumulated Depreciation </td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> ( 4,285)</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (2,187)</td></tr> <tr> <td width="205" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:153.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Property and Equipment, net</td> <td width="22" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:16.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="117" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 188,303</td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="123" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 7,639</td></tr></table></div>

The following values were used to calculate the intrinsic values of the Companys outstanding compensatory warrants as of their issuance dates:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Expected volatility</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 136.53% - 217.26%</td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Expected dividends</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 0</td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Expected term (in years)</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 2 - 4</td></tr> <tr> <td width="190" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:142.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Risk-free rate</td> <td width="124" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:93pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> 1.29% - 1.86%</td></tr></table></div>

A summary of the compensatory warrants outstanding at June 30, 2012 and changes during the period then ended is presented below:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="235" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Warrants</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Shares</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted- Average Exercise Price</td> <td width="76" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted-Average Remaining Contractual Term</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Aggregate Intrinsic Value</td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercisable at December 31, 2011</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 450,000</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $0.78</td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1.26</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $34,653</td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Granted</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercised</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0</td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Canceled</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0</td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="235" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:176.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercisable at June 30, 2012</td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 450,000</td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $0.78</td> <td width="76" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.76</td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $34,653</td></tr></table></div>

The following table summarizes information regarding stock options outstanding as of June 30, 2012:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="258" colspan="10" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:193.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Options Outstanding</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="249" colspan="10" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:186.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Options Exercisable</td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Exercise prices</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="83" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:62.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Number Outstanding</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average remaining contractual life (years)</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average exercise price</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="74" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:55.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Number exercisable</td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average remaining contractual life (years)</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Weighted average exercise price</td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="83" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:62.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="74" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:55.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="76" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.08</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 6,900,000</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 9.17</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.08</td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 2,428,000</td> <td width="3" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:2.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="8" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:6pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="69" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:51.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 9.17 </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="6" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:4.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="65" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:48.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 0.08</td> <td width="5" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:3.75pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td></tr></table></div>

A summary of the stock options available under the 2009 Stock Incentive Plan at June 30, 2012 and changes during the period then ended is presented below:   <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Available at December 31, 2011</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 10,000,000</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Option shares granted before December 31, 2011</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> (7,950,000)</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Granted</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> -</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Exercised</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> -</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Canceled</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 1,050,000</td></tr> <tr> <td width="331" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:248.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Available at June 30, 2012</td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="84" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:63pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 3,100,000</td></tr></table></div>

The following table provides information related to the Companys revenues for the three and six-months ended June 30, 2012 and June 30, 2011.     <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Net Revenues</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Three Months</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Three Months</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Six Months</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> Six Months</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2012</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2011</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2012</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> June 30, 2011</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Net domestic revenues</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 454,897</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 456,618</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">     941,519</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 457,108</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Net international revenues</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 144,828</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">     94,323</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">   245,980</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  </td> <td width="98" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">    94,323</td></tr> <tr> <td width="169" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:126.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> Total</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 599,725</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 550,941</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom">  1,207,499</td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> $</td> <td width="98" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:73.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> 551,431</td></tr></table></div>

3180000

3004090

10000

7374

4612

3639

180000

12588

9826

-4285

-2187

3000000

0.06 1575 1575 188303 7639 5000000 0.001 700000000 0.001 0.5 250523333 1.3653 2.1726 0 2 4 0.0129 0.0186

450000

0.78

1.26

34653

450000

0.78

0.76

34653

7950000 636000 0.08 2428000 0.00 1.91 0.0223 10 0.08 60938 140265 0.08 6900000 9.17

0.08

2428000

9.17 0.08 10000000 -7950000 0 0 1050000 3100000 3000000 2625000 47201 180000 0.1 175579

454897

456618

941519

457108

144828 94323 245980 94323

599725

550941

1207499

551431

223991933 301000 177000 50000 0.11 0.265 81466400 2000000 0.05 223991933 100000 100000 3000000 180000 140000 10000 5000 30000 5000000

180000

0001419051 2012-01-01 2012-06-30 0001419051 2012-11-19 0001419051 2012-06-30 0001419051 2011-12-31 0001419051 2012-04-01 2012-06-30 0001419051 2011-04-01 2011-06-30 0001419051 2011-01-01 2011-06-30 0001419051 2010-12-31 0001419051 2011-06-30 0001419051 2011-04-01 2012-06-30 0001419051 fil:SharesMember 2011-12-31 0001419051 fil:WeightedAverageExercisePriceMember 2011-12-31 0001419051 fil:WeightedAverageRemainingContractualTermMember 2011-12-31 0001419051 fil:AggregateIntrinsicValueMember 2011-12-31 0001419051 fil:SharesMember 2012-01-01 2012-06-30 0001419051 fil:SharesMember 2012-06-30 0001419051 fil:WeightedAverageExercisePriceMember 2012-06-30 0001419051 fil:WeightedAverageRemainingContractualTermMember 2012-06-30 0001419051 fil:AggregateIntrinsicValueMember 2012-06-30 0001419051 2011-08-31 0001419051 fil:StockIncentivePlanMember 2011-12-31 0001419051 fil:StockIncentivePlanMember 2012-01-01 2012-06-30 0001419051 fil:StockIncentivePlanMember 2012-06-30 0001419051 2012-04-26 0001419051 2012-11-01 0001419051 2012-11-05 0001419051 2012-08-24 0001419051 2012-08-31 shares iso4217:USD iso4217:USD shares pure EX-101.CAL 6 tsoi-20120630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 tsoi-20120630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 tsoi-20120630_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Escrow Agreement Consists Of : Net domestic revenues. Options exercise price per share Outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Common stock with an estimated fair value Common stock with an estimated fair value Canceled Warrants Canceled Exercised Weighted-Average Remaining Contractual Term Shares Cost And Accumulated Depreciation of Fixed Assets Net loss {1} Net loss Consulting fees A fee charged for consulting services during the period. Net international revenues Common Stock, shares outstanding Total liabilities Total liabilities Entity Voluntary Filers No of shares issued to warrants No of shares issued to warrants Part of Deferred payments made Part of Deferred payments made Estimated minimum royalty payments Estimated minimum royalty payments Monthly payment from July, 2013 under the MDRA Monthly payment from July, 2013 under the MDRA Inception fee to be paid by the Company to Boyd Research, Inc Inception fee to be paid by the Company to Boyd Research, Inc Shareholdings by other stockholders unaffiliated to Boyd Shareholdings by other stockholders unaffiliated to Boyd Net international revenues. Revenues from external customers attributed to all foreign countries in total from which the entity derives revenues. Available. Available. Available. Granted. Granted. Option shares granted before December 31, 2011 Option shares granted before December 31, 2011 Statement, Equity Components [Axis] Expected volatility maximum The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Deferred License inception fee Cash Policy Restricted Cash {1} Restricted Cash Net cash provided by financing activities Net cash provided by financing activities Changes in operating assets and liabilities: Additional paid-in capital Common stock, $.001 par value; 700,000,000 shares authorized, 305,458,333 and 305,458,333 issued and outstanding at June 30, 2012 And December 31, 2011, respectively Accrued expenses and other current liabilities Current liabilities: Other non-current assets Statement [Line Items] Boyd's beneficial ownership percentage of Company common stock decreased from 78% to Boyd's beneficial ownership percentage of Company Stock options available under Incentive Plan STOCKHOLDERS EQUITY: Expected term (in years) minimum Expected term (in years) minimum Issued shares of common stock to James P. Boyd and Timothy G. Dixon Issued shares of common stock to James P. Boyd and Timothy G. Dixon Issued shares of common stock par value Issued shares of common stock par value Restricted Cash Consists Of: A summary of the stock options available {1} A summary of the stock options available A summary of the stock options available Share Based Expenses Policy Income Taxes Policy Net cash used by investing activities Net cash used by investing activities Salaries, wages, and related costs Licensing agreement, net Prepaid expenses and other current assets Accounts receivable, net Entity Central Index Key Amendment Flag Company's outstanding common shares will be reduced to Company's outstanding common shares will be reduced to Total payments made up to November, 2012 under the MDRA Total payments made up to November, 2012 under the MDRA Subsequent Events Transactions: Net Revenues Total Royalty accrued but unpaid Royalty accrued but unpaid Number exercisable The Following Values Were Used to Calculate The Intrinsic Values Intangible Assets Policy Inventory Policy ACCOUNTING POLICIES Subsequent Events Equipment Increase in License agreement and due to related party Increase in License agreement and due to related party Stock based compensation to consultants Depreciation Non-cash expenses: Weighted average shares outstanding The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS. Net loss Net loss Common Stock, shares issued Notes payable to related parties Current Fiscal Year End Date Weighted average exercise price (number exercisable) Weighted average exercise price (number exercisable) Exercise price equal to 100% of the grant-date common stock fair market value Exercise price equal to 100% of the grant-date common stock fair market value. Stock Based Compensation Consists Of The Following: Risk-free rate minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. Other non-current asset certificate of deposit The Following Table Provides Geographic Information The following table summarizes information regarding stock options outstanding {1} The following table summarizes information regarding stock options outstanding A summary of Compensatory Warrants Outstanding Organization and Presentation Basis Net other income LIABILITIES AND SHAREHOLDERS' DEFICIT Total assets Total assets Document Fiscal Period Focus Entity Filer Category Acquired certain production molds from a related party Acquired certain production molds from a related party Inception fee unamortized value Inception fee unamortized value Exercised. Exercised. Weighted average exercise price (options outstanding) Exercisable Exercisable Exercisable Compensatory Warrants Outstanding Presented STOCKHOLDERS EQUITY Restricted Cash Total other income (expense) Total other income (expense) Revenue: Statement [Table] Transfer of shares of Company common stock to Dixon under the MDRA Transfer of shares of Company common stock to Dixon under the MDRA Promissory note rescinded for purchase of certain production molds Promissory note rescinded for purchase of certain production molds License inception fee to a related party License inception fee to a related party Weighted average remaining contractual life (in years) Weighted average remaining contractual life (in years) Option-pricing model with dividend yield Option-pricing model with dividend yield Issued shares of preferred stock Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Recently Implemented Standards Entire Policy Disclosure for Recently Implemented Standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company's consolidated financial statements that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company's consolidated financial statements upon adoption. Equipment {1} Equipment Cash paid for income taxes Acquisition of fixed assets Cash flows from investing activities Other income (expense): Total shareholders' deficit Total shareholders' deficit Shareholders' deficit Related Party Transaction Expenses Payable: Related Party Transactions Agreement: Weighted-Average Exercise Price Production Molds Office Furniture and Equipment Equipment Consists Of the Following: The following table summarizes information regarding stock options outstanding License Agreements {1} License Agreements Increase in cash Increase in cash Repayments Other related party current liabilities Accounts payable Weighted average remaining contractual life (years) Weighted average remaining contractual life (years) Exercise Prices Exercise Prices Options Outstanding: Stock Based Compensation During The Period: Risk-free interest rate of Risk-free interest rate of percent Options vested and no options were exercised Options vested and no options were exercised Property and Equipment, net. Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. Related Party Transactions Cash paid for interest Supplemental Cash Flow Information: Increase (decrease) in accrued expenses and other current liabilities (Increase) decrease in prepaid expenses and other current assets Cash flows from operating activities Amortization and depreciation Gross profit Gross profit Current assets: ASSETS Document Fiscal Year Focus Royalty expenses payable to a related party Royalty expenses payable to a related party Issued options to purchase shares Issued options to purchase shares Aggregate Intrinsic Value COMMON STOCK: Issued shares of preferred stock par value PREFERRED STOCK: Shipping and Other Equipment The gross amount of long-lived, depreciable assets owned by the entity and used in the entity's principle business operations. The Following Table Provides Geographic Information {1} The Following Table Provides Geographic Information A summary of Compensatory Warrants Outstanding {1} A summary of Compensatory Warrants Outstanding Net cash provided by operating activities Net cash provided by operating activities (Increase) decrease in inventory Legal and professional fees Total revenues Total revenues Preferred Stock, par value Entity Well-known Seasoned Issuer Document Type Exercise price per shares Exercise price per shares Stock Incentive Plan Granted Expected dividends The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee. License Agreements Consists Of the Following: Geographic Information Organization and Presentation Basis {1} Organization and Presentation Basis Selling Cost of goods sold Common Stock, par value Deficit accumulated Total current assets Total current assets Shares of Company common stock pursuant to the Escrow Agreement placed by Boyd Shares of Company common stock pursuant to the Escrow Agreement placed by Boyd Deferred payments totaling payable under the MDRA Deferred payments totaling payable under the MDRA Canceled. Canceled. Stock Based Compensation Expense Represents the expense recognized during the period arising from equity-based compensation arrangements. Accumulated Depreciation Computer Hardware The Following Values Were Used to Calculate The Intrinsic Values {1} The Following Values Were Used to Calculate The Intrinsic Values Depreciation and Amortization Policy Geographic Information {1} Geographic Information Significant Accounting Policies Increase (decrease) in other related party liabilities Total operating expenses Total operating expenses Common Stock, shares authorized Property and equipment, net Document Period End Date Dixon's beneficial ownership percentage of Company common stock increased from 5.5% to Dixon's beneficial ownership percentage of Company Note bears interest perannum Note bears interest perannum Contractual life of years Contractual life of years Expected term (in years) maximum Expected term (in years) maximum Outstanding Compensatory Warrants: Voting rights Voting rights EX-101.PRE 9 tsoi-20120630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 10 tsoi-20120630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000230 - Statement - Equipment Consists Of the Following (Details) link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 000270 - Statement - Compensatory Warrants Outstanding Presented {Stockholders'Equity} (Details) link:presentationLink link:definitionLink link:calculationLink 000160 - Disclosure - Cost And Accumulated Depreciation of Fixed Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - Equity Transactions link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000280 - Statement - Stock Based Compensation Consists Of The Following (Details) link:presentationLink link:definitionLink link:calculationLink 000340 - Statement - Geographic Information During The Period (Details) link:presentationLink link:definitionLink link:calculationLink 000320 - Statement - Related Party Transactions Agreement (Details) link:presentationLink link:definitionLink link:calculationLink 000180 - Disclosure - A summary of Compensatory Warrants Outstanding (Tables) link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - License Agreements link:presentationLink link:definitionLink link:calculationLink 000250 - Statement - CAPITAL STOCK TRANSACTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 000260 - Statement - Outstanding Compensatory Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 000290 - Statement - Stock Based Compensation During The Period (Details) link:presentationLink link:definitionLink link:calculationLink 000360 - Statement - Escrow Agreement Consists Of (Details) link:presentationLink link:definitionLink link:calculationLink 000220 - Statement - Restricted Cash Consists Of (Details) link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - Equipment link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - Consolidated Balance Sheets Parentheticals link:presentationLink link:definitionLink link:calculationLink 000190 - Disclosure - The following table summarizes information regarding stock options outstanding (Tables) link:presentationLink link:definitionLink link:calculationLink 000210 - Disclosure - The Following Table Provides Geographic Information (Tables) link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - Restricted Cash link:presentationLink link:definitionLink link:calculationLink 000350 - Statement - Subsequent Events Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000200 - Disclosure - A summary of the stock options available (Tables) link:presentationLink link:definitionLink link:calculationLink 000330 - Statement - Related Party Transaction Expenses Payable (Details) link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 000310 - Statement - Stock options available under Incentive Plan {Stockholders'Equity} (Details) link:presentationLink link:definitionLink link:calculationLink 000240 - Statement - License Agreements Consists Of the Following (Details) link:presentationLink link:definitionLink link:calculationLink 000170 - Disclosure - The Following Values Were Used to Calculate The Intrinsic Values (Tables) link:presentationLink link:definitionLink link:calculationLink 000130 - Disclosure - Geographic Information link:presentationLink link:definitionLink link:calculationLink 000300 - Statement - Information regarding stock options outstanding (Details) link:presentationLink link:definitionLink link:calculationLink 000150 - Disclosure - ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 000140 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 000060 - Disclosure - Organization and Presentation Basis link:presentationLink link:definitionLink link:calculationLink XML 11 R33.htm IDEA: XBRL DOCUMENT

Related Party Transaction Expenses Payable (Details) (USD $)	3 Months Ended
	Jun. 30, 2012
Royalty expenses payable to a related party	$ 175,579

XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R25.htm IDEA: XBRL DOCUMENT

CAPITAL STOCK TRANSACTIONS (Details) (USD $)	Jun. 30, 2012
PREFERRED STOCK:
Issued shares of preferred stock	5,000,000
Issued shares of preferred stock par value	$ 0.001
COMMON STOCK:
Issued shares of common stock	700,000,000
Issued shares of common stock par value	$ 0.001
Voting rights	50.00%
Issued shares of common stock to James P. Boyd and Timothy G. Dixon	250,523,333

XML 14 R9.htm IDEA: XBRL DOCUMENT

Equipment

6 Months Ended

Jun. 30, 2012

Equipment

Equipment

Note 4 – Equipment

The cost and accumulated depreciation of fixed assets and equipment at June 30, 2012 and December 31, 2011 are summarized below:


		June 30, 2012		December 31, 2011
		(unaudited)		(audited)
Computer Hardware	$	7,374	$	4,612
Office Furniture and Equipment		3,639		3,639
Production Molds		180,000		-
Shipping and Other Equipment		1,575		1,575
Total		12,588		9,826
Accumulated Depreciation		( 4,285)		(2,187)
Property and Equipment, net	$	188,303	$	7,639

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C83$W-V,S-U\X8C8X7S0Q.#=?8F5D,%]A93%C M9&8W9C1A.&8B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=OF%T M:6]N7V%N9%]0#I%>&-E;%=O#I%>&-E;%=O#I%>&-E M;%=O#I% M>&-E;%=O#I%>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;&%T961?4&%R='E? M5')A;G-A8W1I;VYS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I% M>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-U8G-E<75E;G1?179E;G1S/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%?5]O9E]#;VUP96YS871O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%?5]O9E]T:&5?#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E)E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5Q M=6EP;65N=%]#;VYS:7-T#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DQI8V5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-!4$E404Q?4U1/0TM?5%)!3E-!0U1)3TY37T1E=#PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D]U='-T86YD:6YG7T-O;7!E;G-A M=&]R>5]787)R83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D-O;7!E;G-A=&]R>5]787)R86YT#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-T;V-K7T)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7T)A#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN9F]R;6%T:6]N7W)E M9V%R9&EN9U]S=&]C:U]O<#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7V]P=&EO;G-?879A:6QA8FQE7W5N9&5R7SPO>#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;&%T961?4&%R='E?5')A;G-A8W1I;VY?17AP93PO M>#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G1S7U1R86YS86-T:6]N M#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I!8W1I=F53:&5E M=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF M72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U M;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T M7V-A,3'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@ M("`\=&0@8VQA2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^4VUA;&QE3QS<&%N/CPO M'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!796QL+6MN M;W=N(%-E87-O;F5D($ES'0^3F\\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4@=&\@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!E;G-E("T@96UP;&]Y964@&5D(&%S6UE;G1S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]C83$W-V,S-U\X8C8X7S0Q.#=?8F5D,%]A M93%C9&8W9C1A.&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V$Q M-S=C,S=?.&(V.%\T,3@W7V)E9#!?864Q8V1F-V8T83AF+U=O'0O:'1M;#L@8VAAF%T:6]N(&%N9"!0F%T:6]N(&%N M9"!0F%T:6]N(&%N9"!06QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^5&AE(&-O;G-O;&ED871E9"!F:6YA;F-I86P@&-H86YG92!#;VUM:7-S:6]N M("@F(S$T-SM314,F(S$T.#LI+B`F;F)S<#M);B!T:&4@;W!I;FEO;B!O9B!T M:&4@;6%N86=E;65N="!O9B!4:&5R87!E=71I8R!3;VQU=&EO;G,@26YT97)N M871I;VYA;"P@26YC+B`H=&AE("8C,30W.T-O;7!A;GDF(S$T.#LI+"!T:&5S M92!I;G1E6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M65A6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB28C,30X.RD@=V%S(&]R9V%N:7IE9"!!=6=U2!!=71O($1E86QE60@*"8C,30W.T)O>60F(S$T M.#LI+"!";WED(%)E2!'+B!$:7AO;B`H)B,Q-#<[1&EX;VXF(S$T M.#LI(&%N9"!'97)R>2!"+B!"97)G+"!A;F0@;VX@075G=7-T)FYB2!A2!A;F0@8V5R=&%I;B!";WED(%!A2!T;R!A;B!% M>&-L=7-I=F4@3&EC96YS92!!9W)E96UE;G0@9&%T960@07!R:6PF;F)S<#LQ M+"`R,#$Q+"!A&-L M=7-I=F4@06=R965M96YT2X@)FYB2!T:&4@0V]M<&%N>28C,30V.W,@96YT:7)E(&%C=&EV92!B=7-I M;F5S60@4&%R=&EE28C,30V.W,@97AI2!S=6-H('!R;V1U8W1S(&]T:&5R('1H86X@=&AE M($-O;7!A;GDF(S$T-CMS(&-U2!E>&ES=&EN9R!O;F5S*2!A;F0@ M;&%B;W)A=&]R>2UM86YU9F%C='5R960@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^5&AE($YE=R!,:6-E;G-E($%G2!C87)R M:65S(&9O'!I2!A;B!E>&-L=7-I=F4@;&EC96YS92`H8G5T(&YO(&QI M8V5N2!F:65L9"DL(&-A M6%L='D@;VX@;F5T('-A;&5S.R!B=70@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB&-L=7-I=F4@;&EC96YS92!O;B!*86YU87)Y)FYB2!O;B`R,#$R(&YE="!S86QE M7,[($U!4D=)3CHP M:6X@,&EN(#!P="<^)FYB6EN9R!A(#,P)2!R M;WEA;'1Y(&]N(&%L;"!N970@&-L=7-I=F4@06=R965M96YT6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB29N8G-P.S$L(#(P,3,L('-E;&P@=&\@=&AE(%53 M(&UA2!I;B!T:&4@;6%N=69A8W1U29N8G-P.S$L(#(P,3,L(&]F('1H92!!35!3 M02!02!H860@<')E=FEO=7-L>2!S M;VQD('1O('1H92!54R!A;F0@;F]N+553(&UA2`Q+"`R,#$T+"!T:&4@0V]M<&%N>2!W:6QL(&YO M(&QO;F=E6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M&-L=7-I=F4@06=R965M96YT6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M)FYB3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]C83$W-V,S-U\X8C8X7S0Q.#=?8F5D,%]A93%C M9&8W9C1A.&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V$Q-S=C M,S=?.&(V.%\T,3@W7V)E9#!?864Q8V1F-V8T83AF+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^/'4^0V%S:#PO=3X\+W`^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^1F]R('1H92!3=&%T96UE;G1S(&]F($-A M6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/'4^26YV96YT;W)Y M/"]U/CPO<#X@/'`@2!R96-O2!R97-E6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^1&5PF%T:6]N M(&ES(&-O;7!U=&5D('5S:6YG('1H92!S=')A:6=H="!L:6YE(&UE=&AO9"!O M=F5R('1H92!T97)M(&]F('1H92!A9W)E96UE;G0N/"]P/B`\<"!S='EL93TS M1"=-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.SPO<#X@/'`@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^26YT86YG:6)L M92!A2!D;V5S(&YO="!O=VX@86YY(&EN M=&%N9VEB;&4@87-S971S+B!(;W=E=F5R+"!T:&4@0V]M<&%N>2!E;G1E2`H:2DF;F)S<#MT:&4@97AC;'5S M:79E('=O7-T96TF(S$T.#L@86YD("AI:2DF;F)S<#MT M:&4@97AC;'5S:79E('=O60L('1H92!M86IO M2!S:&%R96AO;&1E2X@5&AE($5X8VQUFEN9R!O=F5R(&$@=&5N('EE87(@<&5R:6]D('5S:6YG('1H92!S=')A M:6=H="!L:6YE(&UE=&AO9"!O9B!A;6]R=&EZ871I;VXN("9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.U-E92!.;W1E(#4@)B,Q-3`[($QI8V5N6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^5&AE($-O;7!A;GD@86-C;W5N=',@9F]R(&EN8V]M92!T87AE2!M971H;V0@;V8@ M05-#(#2!D:69F97)E M;F-E7,[ M($U!4D=)3CHP:6X@,&EN(#!P="<^)FYBF%T:6]N(&]F M(&%S'!I M2!A9&IU M2!I9B!T:&4@0V]M<&%N M>2!I6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/'4^4VAA2!S:&]U;&0@9&5T97)M:6YE(&EF(&$@<')E&ES=',N M($$@<')E&ES=',@:68Z("AA*29N8G-P.W1H92!O<'1I;VX@=&\@ M2=S('!A MF5D(&%S(&5Q=6ET>2X@4V5E M($YO=&4@-B`F(S$U,#L@17%U:71Y(%1R86YS86-T:6]N6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6UE;G0@ M=')A;G-A8W1I;VX@2!42!);7!L96UE;G1E9"!3=&%N9&%R M9',\+W4^/"]P/B`\<"!S='EL93TS1"=-05)'24XZ,&EN(#!I;B`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`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^3W1H97(@;F]N+6-U7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3,N-S5P=#L@ M4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52 M+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HX-RXW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52 M+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU4 M3U`Z,&EN)SX\+W1D/B`\=&0@=VED=&@],T0R,R!S='EL93TS1"="3U)$15(M M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY,BXR-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)SX\+W1D/CPO='(^(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED M.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!" M04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HQ-3,N-S5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU4 M3U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-RXR-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3,N M-S5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@ M0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=) M3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/BAU;F%U9&ET M960I/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(S('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-RXR-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/BAA M=61I=&5D*3PO<#X\+W1D/CPO='(^(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3,N-S5P=#L@ M4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52 M+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HY,BXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3,N-S5P=#L@4$%$1$E.1RU224=( M5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y M9#@[(%!!1$1)3D6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY,BXR-7!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`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`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-RXR-7!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B M;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3,N-S5P=#L@ M4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52 M+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-BXU<'0[(%!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E.60X.R!0041$24Y' M+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A;G-P87)E;G0[(%!! M1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-RXR-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^ M(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3,N M-S5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`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`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY,BXR-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^ M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)T)/4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC M96-E.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z M=')A;G-P87)E;G0[(%!!1$1)3D2!A;F0@17%U:7!M96YT+"!N970\+W`^ M/"]T9#X@/'1D('=I9'1H/3-$,C(@6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,BXR M-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HY,BXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^/&(^3F]T92`U("8C,34P.R!,:6-E;G-E($%G&-L=61I;F<@=&AE(%5N:71E9"!3 M=&%T97,@;6%R:V5T(&%S('1O('1H92!L86)O2!O M;B!N970@&-L=7-I=F4@06=R965M96YT2!O=VYE9"!B>2!";WED+"!T:&4@0V]M<&%N>28C,30V.W,@;6%J;W)I M='D@7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!42!H87,@;F]T(&ES6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^/'4^0V]M;6]N(%-T;V-K/"]U/CPO<#X@/'`@2!IF5D('1O M(&ES2!I&]N+"!T:&4@2!W87)R86YT(&=R86YT960@:7,@97-T:6UA=&5D(&]N('1H M92!D871E(&]F(&=R86YT('5S:6YG('1H92!";&%C:RU38VAO;&5S(&]P=&EO M;B!V86QU871I;VX@;6]D96P@=&AA="!U'!E8W1E9"!V;VQA=&EL M:71I97,@87)E(&)A6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^5&AE(')I2!W87)R86YT2!B;VYD(')A=&4@:6X@969F96-T(&%T M('1H92!T:6UE(&]F(&=R86YT(&9O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB2!W87)R86YT6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/B9N8G-P.SPO<#X@/&1I=B!A;&EG M;CTS1&-E;G1E6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-#(N-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)SX\+W1D/B`\=&0@=VED=&@],T0Q,C0@'!E8W1E9"!V;VQA=&EL:71Y/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R M-"!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494 M.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#(N-7!T.R!0041$24Y'+5))1TA4 M.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED M.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^17AP96-T960@9&EV:61E;F1S/"]P/CPO M=&0^(#QT9"!W:61T:#TS1#$R-"!S='EL93TS1"="3U)$15(M0D]45$]-.B-E M8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D'!E8W1E9"!T97)M("AI;B!Y96%R M6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HY,W!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/C(@+2`T/"]P/CPO=&0^/"]T6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^02!S=6UM87)Y(&]F M('1H92!C;VUP96YS871O6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1% M4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E.60X M.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A;G-P M87)E;G0[(%!!1$1)3D&5R8VES M92!06QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P M<'0G(&%L:6=N/3-$8V5N=&5R/E=E:6=H=&5D+4%V97)A9V4@4F5M86EN:6YG M($-O;G1R86-T=6%L(%1E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/D%G9W)E9V%T92!);G1R M:6YS:6,@5F%L=64\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#(S M-2!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494 M.B-E8V4Y9#@[(%!!1$1)3D&5R M8VES86)L92!A="!$96-E;6)E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C0U,"PP,#`\+W`^ M/"]T9#X@/'1D('=I9'1H/3-$-S`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`Z(V5C93ED.#L@0D]21$52+5)) M1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/C`\+W`^/"]T9#X@/'1D('=I9'1H/3-$-S`@6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^0V%N8V5L960\+W`^/"]T9#X@/'1D('=I9'1H/3-$-S`@ M6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C`\+W`^/"]T9#X@ M/'1D('=I9'1H/3-$-S`@6QE/3-$)TU!4D=) M3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#HC96-E.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]5 M3D0M0T],3U(Z=')A;G-P87)E;G0[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^17AE6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I M;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C0U,"PP,#`\+W`^/"]T9#X@/'1D('=I M9'1H/3-$-S`@6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,BXR-7!T(&1O M=6)L93L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HU,BXU<'0[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^4V5E($YO=&4@.2`F(S$U,#L@4W5B6QE/3-$5$585"U$14-/4D%424]. M.FYO;F4^)FYB6QE/3-$)U!!1T4M M0E)%04LM0D5&3U)%.F%L=V%Y&5R M8VES960N)FYB'!I MF5D(&]V97(@=&AE M(')E<75IF5D(&]N(&$@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB'!E8W1E9"!V;VQA=&EL:71Y(&]F(#$Y,24[(')I'!E8W1E9"!T;R!B92!O=71S=&%N9&EN9RX\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT+C5P M=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`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`Z,&EN)SX\+W1D/B`\ M=&0@=VED=&@],T0V('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@ M0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C M93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT M+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`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`Z,&EN)SX\+W1D/B`\=&0@=VED=&@] M,T0U('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HS+C6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)!0TM'4D]53D0Z M=VAI=&4[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y M9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)! M0TM'4D]53D0Z=VAI=&4[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5)) M1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ.3,N M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D%#2T=23U5.1#IW:&ET93L@0D]2 M1$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E. M1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/CQB/D]P=&EO;G,@3W5T6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE M/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L M:6=N/3-$8V5N=&5R/CQB/D]P=&EO;G,@17AE6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT+C5P=#L@4$%$1$E.1RU2 M24=(5#HP:6X[($)!0TM'4D]53D0Z=VAI=&4[($)/4D1%4BU43U`Z(V5C93ED M.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT+C5P=#L@ M4$%$1$E.1RU224=(5#HP:6X[($)!0TM'4D]53D0Z=VAI=&4[($)/4D1%4BU4 M3U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU-"XW-7!T.R!0 M041$24Y'+5))1TA4.C!I;CL@0D%#2T=23U5.1#IW:&ET93L@0D]21$52+51/ M4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z M,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB M/E=E:6=H=&5D/"]B/CPO<#X@/'`@6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F5X97)C:7-E M/"]B/CPO<#X@/'`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`Z,&EN M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N M=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/E=E M:6=H=&5D/"]B/CPO<#X@/'`@6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F5X97)C:7-E/"]B M/CPO<#X@/'`@6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)!0TM'4D]53D0Z M=VAI=&4[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y M9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)! M0TM'4D]53D0Z=VAI=&4[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5)) M1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)!0TM'4D]53D0Z=VAI M=&4[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[ M(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)!0TM' M4D]53D0Z=VAI=&4[($)/4D1%4BU43U`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`Z(V5C M93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT+C5P M=#L@4$%$1$E.1RU224=(5#HP:6X[($)!0TM'4D]53D0Z=VAI=&4[($)/4D1% M4BU43U`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`Z(V5C93ED.#L@0D]21$52 M+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT+C5P=#L@4$%$1$E.1RU2 M24=(5#HP:6X[($)!0TM'4D]53D0Z=VAI=&4[($)/4D1%4BU43U`Z(V5C93ED M.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT+C5P=#L@4$%$1$E. M1RU224=(5#HP:6X[($)!0TM'4D]53D0Z=VAI=&4[($)/4D1%4BU43U`Z(V5C M93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT+C5P M=#L@4$%$1$E.1RU224=(5#HP:6X[($)!0TM'4D]53D0Z=VAI=&4[($)/4D1% M4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HU+C(U<'0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HT."XW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D%#2T=2 M3U5.1#IW:&ET93L@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z M(V5C93ED.#L@4$%$1$E.1RU43U`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`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y M9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HT+C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)! M0TM'4D]53D0Z=VAI=&4[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5)) M1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU+C(U<'0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT."XW-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D%#2T=23U5.1#IW:&ET93L@0D]21$52+51/4#HC M96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^02!S=6UM87)Y(&]F('1H92!S=&]C:R!O M<'1I;VYS(&%V86EL86)L92!U;F1E6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HR-#@N,C5P=#L@4$%$1$E.1RU224=(5#HP M:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[ M(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ,RXU<'0[(%!!1$1)3D&5R8VES960\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3@@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HR-#@N,C5P=#L@4$%$1$E.1RU224=(5#HP:6X[ M($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,RXU M<'0[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M079A:6QA8FQE(&%T($IU;F4@,S`L(#(P,3(\+W`^/"]T9#X@/'1D('=I9'1H M/3-$,3@@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^070@ M2G5N92`S,"P@,C`Q,BP@=6YD97(@=&AE(#(P,3$@06=R965M96YT+"!T:&4@ M0V]M<&%N>2!W87,@;V)L:6=A=&5D(&9OF5D(&)A;&%N8V4@870@2G5N92`S,"P@,C`Q,B!W87,@)#(L-C(U M+#`P,"X@)FYB6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^56YD97(@=&AE(#(P,3$@06=R965M96YT M+"!T:&4@0V]M<&%N>2!I;F-U6%B;&4@=&\@82!R96QA=&5D('!A3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]C83$W-V,S-U\X8C8X7S0Q.#=?8F5D,%]A93%C9&8W9C1A M.&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V$Q-S=C,S=?.&(V M.%\T,3@W7V)E9#!?864Q8V1F-V8T83AF+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB"UM;VYT:',@96YD960@2G5N92`S,"P@,C`Q M,B!A;F0@2G5N92`S,"P@,C`Q,2X@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ,C8N-S5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/ M4D1%4BU43U`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`Z,&EN)SX\+W1D M/B`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`Z,&EN M)R!V86QI9VX],T1T;W`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`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`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HW,RXU<'0[(%!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/E-I>"!-;VYT:',\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS M1#$V.2!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU, M1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/DIU;F4@,S`L M(#(P,3(\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C$@6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/DIU M;F4@,S`L(#(P,3$\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C$@6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/DIU;F4@,S`L(#(P,3(\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C$@6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/DIU;F4@,S`L(#(P,3$\+W`^/"]T9#X\+W1R/B`\='(^(#QT M9"!W:61T:#TS1#$V.2!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-2XW-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^ M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HW,RXU<'0[ M(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HQ,C8N-S5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1% M4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D XML 16 R29.htm IDEA: XBRL DOCUMENT

Stock Based Compensation During The Period (Details) (USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2012
Stock Based Compensation Expense	$ 60,938	$ 140,265

XML 17 R28.htm IDEA: XBRL DOCUMENT

Stock Based Compensation Consists Of The Following (Details) (USD $)	Jun. 30, 2012	Aug. 31, 2011
Issued options to purchase shares		7,950,000
Common stock with an estimated fair value		$ 636,000
Options exercise price per share		$ 0.08
Options vested and no options were exercised	2,428,000
Option-pricing model with dividend yield	0.00%
Expected volatility of	191.00%
Risk-free interest rate of	2.23%
Contractual life of years	10
Exercise price equal to 100% of the grant-date common stock fair market value	$ 0.08

XML 18 R30.htm IDEA: XBRL DOCUMENT

Information regarding stock options outstanding (Details) (USD $)	Jun. 30, 2012
Exercise Prices	$ 0.08
Number Outstanding	6,900,000
Weighted average remaining contractual life (years)	9.17
Weighted average exercise price (options outstanding)	$ 0.08
Number exercisable	2,428,000
Weighted average remaining contractual life (in years)	9.17
Weighted average exercise price (number exercisable)	$ 0.08

XML 19 R31.htm IDEA: XBRL DOCUMENT

Stock options available under Incentive Plan (Details) (Stock Incentive Plan)	Stock Incentive Plan
Available at Dec. 31, 2011	10,000,000
Option shares granted before December 31, 2011	(7,950,000)
Granted.	0
Exercised.	0
Canceled.	1,050,000
Available. at Jun. 30, 2012	3,100,000

XML 20 R8.htm IDEA: XBRL DOCUMENT

Restricted Cash

6 Months Ended

Jun. 30, 2012

Restricted Cash

Restricted Cash

Note 3 – Restricted Cash

- Definition

The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9, 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 6.H.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13728-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section H

-Subsection 3

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

XML 21 R32.htm IDEA: XBRL DOCUMENT

Related Party Transactions Agreement (Details) (USD $)	Jun. 30, 2012	Apr. 26, 2012
License inception fee to a related party	$ 3,000,000
Inception fee unamortized value	2,625,000
Royalty accrued but unpaid	47,201
Acquired certain production molds from a related party		$ 180,000
Note bears interest perannum		10.00%

XML 22 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (USD $)	Jun. 30, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 85,851	$ 87,976
Accounts receivable, net	28,576	37,416
Inventories	43,498	48,198
Prepaid expenses and other current assets	12,164	490,037
Total current assets	170,088	663,627
Other non-current assets	17,390	12,350
Property and equipment, net	188,303	7,639
Licensing agreement, net	2,625,000	2,775,000
Total assets	3,000,781	3,458,616
Current liabilities:
Accounts payable	36,544	56,777
Accrued expenses and other current liabilities	32,728	39,155
Notes payable to related parties	3,180,000	3,004,090
Other related party current liabilities	47,201	56,211
Total liabilities	3,296,473	3,156,233
Shareholders' deficit
Preferred stock, $.001 par value; 5,000,000 shares authorized	0	0
Common stock, $.001 par value; 700,000,000 shares authorized, 305,458,333 and 305,458,333 issued and outstanding at June 30, 2012 And December 31, 2011, respectively	305,458	305,458
Additional paid-in capital	1,115,546	975,281
Deficit accumulated	(1,716,695)	(978,356)
Total shareholders' deficit	(295,691)	302,383
Total liabilities and shareholders' deficit	$ 3,000,781	$ 3,458,616

XML 23 R6.htm IDEA: XBRL DOCUMENT

Organization and Presentation Basis

6 Months Ended

Jun. 30, 2012

Organization and Presentation Basis

Organization and Presentation Basis

Note 1 – Organization and Presentation Basis

The Company had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.

Beginning January 1, 2014, the Company will no longer be able to use the in-licensed “NTI” trademark for its AMPSA Products.

See Note 9 – Subsequent Events, for additional information.

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS140-4/FIN46(R)-8

-Paragraph 8, C1, C7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

+ Details

XML 24 R35.htm IDEA: XBRL DOCUMENT

Subsequent Events Transactions (Details) (USD $)	Nov. 01, 2012	Aug. 31, 2012	Aug. 24, 2012	Apr. 26, 2012
Shares of Company common stock surrendered by Boyd			223,991,933
Salary to Boyd through employment with the Companyper annum			$ 100,000
Shareholdings by other stockholders unaffiliated to Boyd			100,000
Inception fee to be paid by the Company to Boyd Research, Inc			3,000,000
Promissory note rescinded for purchase of certain production molds				180,000
Deferred payments totaling payable under the MDRA				140,000
Monthly payment for five months from september, 2012 under the MDRA		10,000
Monthly payment from July, 2013 under the MDRA		5,000
Total payments made up to November, 2012 under the MDRA	$ 30,000
Transfer of shares of Company common stock to Dixon under the MDRA				5,000,000

XML 25 R22.htm IDEA: XBRL DOCUMENT

Restricted Cash Consists Of (Details) (USD $)	Jun. 30, 2012
Other non-current asset certificate of deposit	$ 10,000
Annual interest rate	6.00%

XML 26 R36.htm IDEA: XBRL DOCUMENT

Escrow Agreement Consists Of (Details) (USD $)	Nov. 05, 2012	Nov. 01, 2012
Shares of Company common stock pursuant to the Escrow Agreement placed by Boyd		223,991,933
Estimated minimum royalty payments		$ 301,000
Total Payments made under the agreement		177,000
Part of Deferred payments made		$ 50,000
Boyd's beneficial ownership percentage of Company common stock decreased from 78% to		11.00%
Dixon's beneficial ownership percentage of Company common stock increased from 5.5% to		26.50%
Company's outstanding common shares will be reduced to		81,466,400
No of shares issued to warrants	2,000,000
Exercise price per shares	$ 0.05

XML 27 R24.htm IDEA: XBRL DOCUMENT

License Agreements Consists Of the Following (Details) (USD $)	15 Months Ended
	Jun. 30, 2012
Deferred License inception fee	$ 3,000,000

XML 28 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 29 R7.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies

6 Months Ended

Jun. 30, 2012

Significant Accounting Policies

Significant Accounting Policies

Note 2 – Significant Accounting Policies

Estimates

Cash

Inventory

Depreciation and Amortization

Depreciation is calculated using the straight line method over the estimated useful lives of the assets. Amortization is computed using the straight line method over the term of the agreement.

Intangible Assets

Income Taxes

Going Concern

Share Based Expenses

Recently Implemented Standards

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References+ Details

XML 30 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets Parentheticals (USD $)	Jun. 30, 2012	Dec. 31, 2011
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	5,000,000	5,000,000
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	700,000,000	700,000,000
Common Stock, shares issued	305,458,333	305,458,333
Common Stock, shares outstanding	305,458,333	305,458,333

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References+ Details

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

XML 31 R17.htm IDEA: XBRL DOCUMENT

The Following Values Were Used to Calculate The Intrinsic Values (Tables)

6 Months Ended

Jun. 30, 2012

The Following Values Were Used to Calculate The Intrinsic Values

The Following Values Were Used to Calculate The Intrinsic Values

The following values were used to calculate the intrinsic values of the Company’s outstanding compensatory warrants as of their issuance dates:


Expected volatility	136.53% - 217.26%
Expected dividends	0
Expected term (in years)	2 - 4
Risk-free rate	1.29% - 1.86%

XML 32 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2012	Nov. 19, 2012
Document and Entity Information
Entity Registrant Name	THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Document Type	10-Q
Document Period End Date	Jun. 30, 2012
Amendment Flag	false
Entity Central Index Key	0001419051
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		305,458,333
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2

XML 33 R18.htm IDEA: XBRL DOCUMENT

A summary of Compensatory Warrants Outstanding (Tables)

6 Months Ended

Jun. 30, 2012

A summary of Compensatory Warrants Outstanding

A summary of Compensatory Warrants Outstanding

A summary of the compensatory warrants outstanding at June 30, 2012 and changes during the period then ended is presented below:


Warrants	Shares	Weighted- Average Exercise Price	Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value
Exercisable at December 31, 2011	450,000	$0.78	1.26	$34,653
Granted	0
Exercised	0
Canceled	0
Exercisable at June 30, 2012	450,000	$0.78	0.76	$34,653

XML 34 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
Consolidated Statements of Operations (USD $)	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net domestic revenues	$ 454,897	$ 456,618	$ 961,519	$ 457,108
Net international revenues	144,828	94,323	245,980	94,323
Total revenues	599,725	550,941	1,207,499	551,431
Cost of goods sold	13,753	17,269	27,616	17,343
Gross profit	585,972	533,672	1,179,884	534,089
Operating expenses:
Selling	28,179	44,169	50,828	47,366
General and administrative	31,327	31,694	70,322	31,719
Salaries, wages, and related costs	285,294	254,549	605,947	254,549
Royalties	175,579	160,231	354,315	160,231
Amortization and depreciation	76,049	76,893	152,098	76,893
Consulting fees	218,621	18,708	478,761	18,708
Legal and professional fees	135,725	32,136	221,774	39,136
Total operating expenses	950,774	618,380	1,934,045	628,602
Loss from operations	(364,802)	(84,708)	(754,161)	(94,513)
Other income (expense):
Net other income	7,100	35,652	18,832	35,652
Interest expense	(3,001)	(142)	(3,010)	(277)
Total other income (expense)	4,099	35,510	15,822	35,375
Net loss	$ (360,703)	$ (49,198)	$ (738,339)	$ (59,138)
Basic and diluted loss per common share	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average shares outstanding	305,458,333	296,549,542	305,458,333	168,949,899

XML 35 R12.htm IDEA: XBRL DOCUMENT

Related Party Transactions

6 Months Ended

Jun. 30, 2012

Related Party Transactions

Related Party Transactions

Note 7 – Related Party Transactions

- Definition

The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 3A

-Section 04

-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details

XML 36 R11.htm IDEA: XBRL DOCUMENT

Equity Transactions

6 Months Ended

Jun. 30, 2012

Equity Transactions

Equity Transactions

Note 6 – Equity Transactions

Preferred Stock

The Company is authorized to issue 5,000,000 shares of $.001 par value preferred stock. The Company has not issued any preferred stock.

Common Stock

In the first quarter of 2011 the Company issued 250,523,333 shares of common stock to James P. Boyd and Timothy G. Dixon, the shareholders of Splint Decisions Inc., to acquire Splint Decisions Inc.

Warrants

The following values were used to calculate the intrinsic values of the Company’s outstanding compensatory warrants as of their issuance dates:


Expected volatility	136.53% - 217.26%
Expected dividends	0
Expected term (in years)	2 - 4
Risk-free rate	1.29% - 1.86%

A summary of the compensatory warrants outstanding at June 30, 2012 and changes during the period then ended is presented below:


Warrants	Shares	Weighted- Average Exercise Price	Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value
Exercisable at December 31, 2011	450,000	$0.78	1.26	$34,653
Granted	0
Exercised	0
Canceled	0
Exercisable at June 30, 2012	450,000	$0.78	0.76	$34,653

See Note 9 – Subsequent Events, for additional information.

Stock Based Compensation

The following table summarizes information regarding stock options outstanding as of June 30, 2012:


		Options Outstanding						Options Exercisable
Exercise prices		Number Outstanding		Weighted average remaining contractual life (years)		Weighted average exercise price		Number exercisable		Weighted average remaining contractual life (years)		Weighted average exercise price

$	0.08		6,900,000		9.17	$	0.08		2,428,000		9.17	$	0.08

A summary of the stock options available under the 2009 Stock Incentive Plan at June 30, 2012 and changes during the period then ended is presented below:


Available at December 31, 2011		10,000,000
Option shares granted before December 31, 2011		(7,950,000)
Granted		-
Exercised		-
Canceled		1,050,000
Available at June 30, 2012		3,100,000

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph d

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 1

-Section B

-Paragraph 7, 11A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 23: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 37 R23.htm IDEA: XBRL DOCUMENT

Equipment Consists Of the Following (Details) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Computer Hardware	$ 7,374	$ 4,612
Office Furniture and Equipment	3,639	3,639
Production Molds	180,000
Shipping and Other Equipment	1,575	1,575
Total	12,588	9,826
Accumulated Depreciation	(4,285)	(2,187)
Property and Equipment, net.	$ 188,303	$ 7,639

- Definition

The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.

+ References+ Details

- Definition

Gross amount, at the balance sheet date, of long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References+ Details

XML 38 R19.htm IDEA: XBRL DOCUMENT

The following table summarizes information regarding stock options outstanding (Tables)

6 Months Ended

Jun. 30, 2012

The following table summarizes information regarding stock options outstanding

The following table summarizes information regarding stock options outstanding

The following table summarizes information regarding stock options outstanding as of June 30, 2012:


		Options Outstanding						Options Exercisable
Exercise prices		Number Outstanding		Weighted average remaining contractual life (years)		Weighted average exercise price		Number exercisable		Weighted average remaining contractual life (years)		Weighted average exercise price

$	0.08		6,900,000		9.17	$	0.08		2,428,000		9.17	$	0.08

XML 39 R15.htm IDEA: XBRL DOCUMENT

ACCOUNTING POLICIES (Policies)	6 Months Ended
ACCOUNTING POLICIES (Policies)	Jun. 30, 2012
ACCOUNTING POLICIES
Estimates	Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash Policy	Cash For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of June 30, 2012. Other assets include restricted cash of $10,000 that is used to secure a company credit card.
Inventory Policy	Inventory Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at June 30, 2012.
Depreciation and Amortization Policy	Depreciation and Amortization Depreciation is calculated using the straight line method over the estimated useful lives of the assets. Amortization is computed using the straight line method over the term of the agreement.
Intangible Assets Policy	Intangible Assets Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any intangible assets. However, the Company entered into the Exclusive Agreements on October 22, 2010 and April 1, 2011, which gave the Company respectively (i) the exclusive worldwide license to make and sell the “Total Splint System” and (ii) the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company that is solely owned by James P. Boyd, the majority shareholder of the Company. The Exclusive Agreements require a deferred $3,000,000 license inception fee, which the Company is amortizing over a ten year period using the straight line method of amortization. See Note 5 – License Agreements.
Income Taxes Policy	Income Taxes The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.
Going Concern	Going Concern The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Under the New License Agreement the Company’s rights to sell AMPSA Products to the US market (81% of total revenue for fiscal 2011) will expire at the end of 2012. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Share Based Expenses Policy	Share Based Expenses ASC 718 "Compensation - Stock Compensation," which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See Note 6 – Equity Transactions. The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 "Equity - Based Payments to Non-Employees," which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date. See Note 6 – Equity Transactions.
Recently Implemented Standards	Recently Implemented Standards In January 2010, the FASB issued guidance to amend the disclosure requirements related to recurring and nonrecurring fair value measurements. The guidance requires a roll forward of activities on purchases, sales, issuance, and settlements of the assets and liabilities measured using significant unobservable inputs (Level 3 fair value measurements). The guidance was effective for the Company with the reporting period beginning January 1, 2011. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

XML 40 R13.htm IDEA: XBRL DOCUMENT

Geographic Information

6 Months Ended

Jun. 30, 2012

Geographic Information

Geographic Information

Note 8 – Geographic Information

The following table provides information related to the Company’s revenues for the three and six-months ended June 30, 2012 and June 30, 2011.


Net Revenues		Three Months		Three Months		Six Months		Six Months
		June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net domestic revenues	$	454,897	$	456,618	$	941,519	$	457,108
Net international revenues		144,828		94,323		245,980		94,323
Total	$	599,725	$	550,941	$	1,207,499	$	551,431

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

+ Details

XML 41 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2012

Subsequent Events

Subsequent Events

Note 9 – Subsequent Events

On August 24, 2012, the Company entered into the MDRA, the New License Agreement, the Escrow Agreement and the Voting Agreement.

The New License Agreement essentially carries forward the Exclusive Agreements’ terms as to sales to the US market, except that under the New License Agreement the Company’s rights to sell AMPSA Products to the US market will expire at the end of 2012. Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory semi-custom AMPSA Products field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.

The Company has been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.

All parties to the MDRA granted general releases to each other.

Future Development of the Company’s Business.

Warrant issuance

XML 42 R16.htm IDEA: XBRL DOCUMENT

Cost And Accumulated Depreciation of Fixed Assets (Tables)

6 Months Ended

Jun. 30, 2012

Cost And Accumulated Depreciation of Fixed Assets

Cost And Accumulated Depreciation of Fixed Assets

The cost and accumulated depreciation of fixed assets and equipment at June 30, 2012 and December 31, 2011 are summarized below:


		June 30, 2012		December 31, 2011
		(unaudited)		(audited)
Computer Hardware	$	7,374	$	4,612
Office Furniture and Equipment		3,639		3,639
Production Molds		180,000		-
Shipping and Other Equipment		1,575		1,575
Total		12,588		9,826
Accumulated Depreciation		( 4,285)		(2,187)
Property and Equipment, net	$	188,303	$	7,639

- Definition

Tabular disclosure of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References+ Details

XML 43 R34.htm IDEA: XBRL DOCUMENT

Geographic Information During The Period (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net domestic revenues.	$ 454,897	$ 456,618	$ 941,519	$ 457,108
Net international revenues.	144,828	94,323	245,980	94,323
Net Revenues Total	$ 599,725	$ 550,941	$ 1,207,499	$ 551,431

XML 44 R21.htm IDEA: XBRL DOCUMENT

The Following Table Provides Geographic Information (Tables)

6 Months Ended

Jun. 30, 2012

The Following Table Provides Geographic Information

The Following Table Provides Geographic Information

The following table provides information related to the Company’s revenues for the three and six-months ended June 30, 2012 and June 30, 2011.


Net Revenues		Three Months		Three Months		Six Months		Six Months
		June 30, 2012		June 30, 2011		June 30, 2012		June 30, 2011
Net domestic revenues	$	454,897	$	456,618	$	941,519	$	457,108
Net international revenues		144,828		94,323		245,980		94,323
Total	$	599,725	$	550,941	$	1,207,499	$	551,431

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details

XML 45 R26.htm IDEA: XBRL DOCUMENT

Outstanding Compensatory Warrants (Details)	Jun. 30, 2012
Expected volatility minimum	136.53%
Expected volatility maximum	217.26%
Expected dividends	0
Expected term (in years) minimum	2
Expected term (in years) maximum	4
Risk-free rate minimum	1.29%
Risk-free rate maximum	1.86%

XML 46 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (USD $)	6 Months Ended
Consolidated Statements of Cash Flows (USD $)	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities
Net loss	$ (738,339)	$ (59,138)
Non-cash expenses:
Amortization	150,000	75,000
Depreciation	2,098	1,893
Stock based compensation to officers	0	42,000
Stock based compensation to consultants	0	1,012,000
Compensation expense - employee stock option plan	140,265	0
Changes in operating assets and liabilities:
(Increase) decrease in inventory	4,700	(63,305)
(Increase) decrease in accounts receivable	8,840	(20,043)
(Increase) decrease in prepaid expenses and other current assets	477,873	(1,017,678)
(Increase) decrease in other assets	(5,040)	(10,000)
Increase (decrease) in accounts payable	(20,233)	1,061
Increase (decrease) in accrued expenses and other current liabilities	(6,427)	61,444
Increase (decrease) in other related party liabilities	(13,100)	0
Net cash provided by operating activities	637	23,234
Cash flows from investing activities
Acquisition of fixed assets	(182,763)	(8,827)
Net cash used by investing activities	(182,763)	(8,827)
Cash flows from financing activities
Note payable to related party	180,000	0
Borrowing and other advances	0	69,562
Repayments	0	(21,750)
Net cash provided by financing activities	180,000	47,812
Increase in cash	4,061	62,219
Cash at beginning of period	87,976	2,366
Cash at end of period	85,851	62,219
Supplemental disclosure of non-cash investing and financing activities:
Increase in liabilities from acquisition	0	35,101
Increase in License agreement and due to related party	0	3,000,000
Supplemental Cash Flow Information:
Cash paid for interest	3,010	181
Cash paid for income taxes	$ 800	$ 0

XML 47 R10.htm IDEA: XBRL DOCUMENT

License Agreements

6 Months Ended

Jun. 30, 2012

License Agreements

License Agreements

Note 5 – License Agreements

See Note 9 – Subsequent Events, for additional information.

- Definition

The entire disclosure for all or part of the information related to intangible assets.

+ References+ Details

XML 48 R27.htm IDEA: XBRL DOCUMENT

Compensatory Warrants Outstanding Presented (Details)	Shares	Weighted-Average Exercise Price	Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value
Exercisable at Dec. 31, 2011	450,000	0.78	1.26	34,653
Granted	0
Exercised	0
Canceled	0
Exercisable at Jun. 30, 2012	450,000	0.78	0.76	34,653

- Definition

Number of share options (or share units) exercised during the current period.

+ References+ Details

XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 28 186 1 false 5 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.therapeutical.com/20120630/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - Consolidated Balance Sheets Sheet http://www.therapeutical.com/20120630/role/idr_ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 000030 - Statement - Consolidated Balance Sheets Parentheticals Sheet http://www.therapeutical.com/20120630/role/idr_ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets Parentheticals false false R4.htm 000040 - Statement - Consolidated Statements of Operations Sheet http://www.therapeutical.com/20120630/role/idr_ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R5.htm 000050 - Statement - Consolidated Statements of Cash Flows Sheet http://www.therapeutical.com/20120630/role/idr_ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R6.htm 000060 - Disclosure - Organization and Presentation Basis Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureOrganizationAndPresentationBasis Organization and Presentation Basis false false R7.htm 000070 - Disclosure - Significant Accounting Policies Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureSignificantAccountingPolicies Significant Accounting Policies false false R8.htm 000080 - Disclosure - Restricted Cash Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureRestrictedCash Restricted Cash false false R9.htm 000090 - Disclosure - Equipment Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureEquipment Equipment false false R10.htm 000100 - Disclosure - License Agreements Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureLicenseAgreements License Agreements false false R11.htm 000110 - Disclosure - Equity Transactions Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureEquityTransactions Equity Transactions false false R12.htm 000120 - Disclosure - Related Party Transactions Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureRelatedPartyTransactions Related Party Transactions false false R13.htm 000130 - Disclosure - Geographic Information Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureGeographicInformation Geographic Information false false R14.htm 000140 - Disclosure - Subsequent Events Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureSubsequentEvents Subsequent Events false false R15.htm 000150 - Disclosure - ACCOUNTING POLICIES (Policies) Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureACCOUNTINGPOLICIESPolicies ACCOUNTING POLICIES (Policies) false false R16.htm 000160 - Disclosure - Cost And Accumulated Depreciation of Fixed Assets (Tables) Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureCostAndAccumulatedDepreciationOfFixedAssetsTables Cost And Accumulated Depreciation of Fixed Assets (Tables) false false R17.htm 000170 - Disclosure - The Following Values Were Used to Calculate The Intrinsic Values (Tables) Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureTheFollowingValuesWereUsedToCalculateTheIntrinsicValuesTables The Following Values Were Used to Calculate The Intrinsic Values (Tables) false false R18.htm 000180 - Disclosure - A summary of Compensatory Warrants Outstanding (Tables) Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureASummaryOfCompensatoryWarrantsOutstandingTables A summary of Compensatory Warrants Outstanding (Tables) false false R19.htm 000190 - Disclosure - The following table summarizes information regarding stock options outstanding (Tables) Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureTheFollowingTableSummarizesInformationRegardingStockOptionsOutstandingTables The following table summarizes information regarding stock options outstanding (Tables) false false R20.htm 000200 - Disclosure - A summary of the stock options available (Tables) Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureASummaryOfTheStockOptionsAvailableTables A summary of the stock options available (Tables) false false R21.htm 000210 - Disclosure - The Following Table Provides Geographic Information (Tables) Sheet http://www.therapeutical.com/20120630/role/idr_DisclosureTheFollowingTableProvidesGeographicInformationTables The Following Table Provides Geographic Information (Tables) false false R22.htm 000220 - Statement - Restricted Cash Consists Of (Details) Sheet http://www.therapeutical.com/20120630/role/idr_RestrictedCashConsistsOfDetails Restricted Cash Consists Of (Details) false false R23.htm 000230 - Statement - Equipment Consists Of the Following (Details) Sheet http://www.therapeutical.com/20120630/role/idr_EquipmentConsistsOfTheFollowingDetails Equipment Consists Of the Following (Details) false false R24.htm 000240 - Statement - License Agreements Consists Of the Following (Details) Sheet http://www.therapeutical.com/20120630/role/idr_LicenseAgreementsConsistsOfTheFollowingDetails License Agreements Consists Of the Following (Details) false false R25.htm 000250 - Statement - CAPITAL STOCK TRANSACTIONS (Details) Sheet http://www.therapeutical.com/20120630/role/idr_CAPITALSTOCKTRANSACTIONSDetails CAPITAL STOCK TRANSACTIONS (Details) false false R26.htm 000260 - Statement - Outstanding Compensatory Warrants (Details) Sheet http://www.therapeutical.com/20120630/role/idr_OutstandingCompensatoryWarrantsDetails Outstanding Compensatory Warrants (Details) false false R27.htm 000270 - Statement - Compensatory Warrants Outstanding Presented {Stockholders'Equity} (Details) Sheet http://www.therapeutical.com/20120630/role/idr_CompensatoryWarrantsOutstandingPresentedStockholdersEquityDetails Compensatory Warrants Outstanding Presented (Details) false false R28.htm 000280 - Statement - Stock Based Compensation Consists Of The Following (Details) Sheet http://www.therapeutical.com/20120630/role/idr_StockBasedCompensationConsistsOfTheFollowingDetails Stock Based Compensation Consists Of The Following (Details) false false R29.htm 000290 - Statement - Stock Based Compensation During The Period (Details) Sheet http://www.therapeutical.com/20120630/role/idr_StockBasedCompensationDuringThePeriodDetails Stock Based Compensation During The Period (Details) false false R30.htm 000300 - Statement - Information regarding stock options outstanding (Details) Sheet http://www.therapeutical.com/20120630/role/idr_InformationRegardingStockOptionsOutstandingDetails Information regarding stock options outstanding (Details) false false R31.htm 000310 - Statement - Stock options available under Incentive Plan {Stockholders'Equity} (Details) Sheet http://www.therapeutical.com/20120630/role/idr_StockOptionsAvailableUnderIncentivePlanStockholdersEquityDetails Stock options available under Incentive Plan (Details) false false R32.htm 000320 - Statement - Related Party Transactions Agreement (Details) Sheet http://www.therapeutical.com/20120630/role/idr_RelatedPartyTransactionsAgreementDetails Related Party Transactions Agreement (Details) false false R33.htm 000330 - Statement - Related Party Transaction Expenses Payable (Details) Sheet http://www.therapeutical.com/20120630/role/idr_RelatedPartyTransactionExpensesPayableDetails Related Party Transaction Expenses Payable (Details) false false R34.htm 000340 - Statement - Geographic Information During The Period (Details) Sheet http://www.therapeutical.com/20120630/role/idr_GeographicInformationDuringThePeriodDetails Geographic Information During The Period (Details) false false R35.htm 000350 - Statement - Subsequent Events Transactions (Details) Sheet http://www.therapeutical.com/20120630/role/idr_SubsequentEventsTransactionsDetails Subsequent Events Transactions (Details) false false R36.htm 000360 - Statement - Escrow Agreement Consists Of (Details) Sheet http://www.therapeutical.com/20120630/role/idr_EscrowAgreementConsistsOfDetails Escrow Agreement Consists Of (Details) false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 000030 - Statement - Consolidated Balance Sheets Parentheticals Process Flow-Through: 000040 - Statement - Consolidated Statements of Operations Process Flow-Through: 000050 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 000220 - Statement - Restricted Cash Consists Of (Details) Process Flow-Through: 000230 - Statement - Equipment Consists Of the Following (Details) Process Flow-Through: 000240 - Statement - License Agreements Consists Of the Following (Details) Process Flow-Through: 000250 - Statement - CAPITAL STOCK TRANSACTIONS (Details) Process Flow-Through: 000260 - Statement - Outstanding Compensatory Warrants (Details) Process Flow-Through: 000280 - Statement - Stock Based Compensation Consists Of The Following (Details) Process Flow-Through: 000290 - Statement - Stock Based Compensation During The Period (Details) Process Flow-Through: 000300 - Statement - Information regarding stock options outstanding (Details) Process Flow-Through: 000320 - Statement - Related Party Transactions Agreement (Details) Process Flow-Through: 000330 - Statement - Related Party Transaction Expenses Payable (Details) Process Flow-Through: 000340 - Statement - Geographic Information During The Period (Details) Process Flow-Through: 000350 - Statement - Subsequent Events Transactions (Details) Process Flow-Through: 000360 - Statement - Escrow Agreement Consists Of (Details) tsoi-20120630.xml tsoi-20120630.xsd tsoi-20120630_cal.xml tsoi-20120630_def.xml tsoi-20120630_lab.xml tsoi-20120630_pre.xml true true ZIP 50 0001078782-12-002971-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001078782-12-002971-xbrl.zip M4$L#!!0````(`%9P=4%&G`IBGF(``!>J!``1`!P`='-O:2TR,#$R,#8S,"YX M;6Q55`D``U0EK5!4):U0=7@+``$$)0X```0Y`0``Y%UM<^,VDOY\5W7_`5MW M&V>K+)OOI&:2;&G\,NMDQG8L3W+Y=$61D,0-12H`:5O[ZZ\;)"60HDA1HL>I MV@]3'I%@/_V&1C<`@M_]_641DB?*>!!'WY^H9\H)H9$7^T$T^_XDX/'`<?!N&Z^?/S M\UDRI\Q=TC0)/#<\\^(%/J,IEJ[D3Y1:"X"8S:"1HI\'$4_E%H_ MZT5;]?Q_/W\:>W.Z<`=;3X5!]'O=<^IP.#P7=XNF6RW+_.#MBB-)%?6,_8>?):DG/H05E@;=^ M(([V>":.!I7GL)%?<8V<*>L\NWD"KO0?WZ'6WG%AFPY`H]J\B_])-F@DB1P/%&NA*F6R)PIK^"&[Y M>/LZ=&>-=*=NR&E&LO30FM15E`3)ZH'.`IXP-TINW44SIX__N'H8W5]]>;RY M(..[3_#W[G9,;FX?KQYN1_AC].D4?EZ<9:AU]"O@%\`3<\.;R*_BT)5A'BQB*-Q$GN_ MC^*RC)=F^K>Q3+[R9(7NKS0,?XKBYVA,71Y' MU+_A/`5][$]_!X6M<+#QHFNXTBP!!H1R**@\O8-Z%C#:Z?]<2UUZ6M#/1XYW M%RZ?CR(?_US]D09/;@B/\%%RX3*V`H/]XH8IW3CZE_%EVVU&VF[*%M'(:.C&T-F@R;0.`]D6R'#4O2#N&5VZ@7_ULJ01IV#O.TPL M1YS3A.?!J;-X$-@M8X.]!T2O+-4H8P@)G7TX1T>JPU841[)%'SC;,EJ6;FGV M/BB2L+=QY!TLE3Y4-G"U1(^$W192U72S$^@]BY>4):O[$#(P,#1&LB5&_4.Z MK>HXNJ++;K2;>#]<;&O`MO3A`1Q8.B=&69D)" MNF&DF7Y?K&RK0[/M@QG)KG:670<\VU&K/:TKZ9HQ"-)>JS0*U1#.!Z9[=X6C MTJ$A2;=,P]@>[LI4CP7>EM"T;-ON"LM2ZG\*W$D0!DE`#X["NF9K3@F[GG`/ M\#6F':JFV17\,J6/\0,-H?;P[UUVC/"GP!G\WY3X8J+,[E'J=X27U'&#M MH6784JR6B!T$4F-3%<32]X"`;&-*03Q?E*^'%0Q**7FIDCL*;ENR#F!277Z8 M8%FU+U4=%8*'H]58K`O6R/?!E'$$I2&DBC?1A;L,$C?LGC2HT/4-.:K7$SX: M?%O>H6UJI8%J#^0'FK@!%/)7+HN@R.,0JM)%*KKJ)9T&7M`]^`Q46[6LH13_ MVD'ZY&E;,8.A[>BF=3!#PF7F<>A3QC'E2E;=E:(-36LH&6>;YC&0=4B2E*B27N%Q?W MBO5GBCQ8[X?V6@S6C`X]LY?-YX[29!ZSX%_4;YXUKE<9U@"E,J`9HD=N:I*= M(WB11J37=JL]H%Z%M5:'.H*Q/ES)5I2J`1L0^N*DIM#OD0\Q*W^0-J3%F!;J M?7"P*V4['G_O5:G#U5!=D>J#E\,4LHN3L1M2_D"?:)32CW'LM\RW_%9?2IJ& M,Y2*^#JBQZ&JM:B6I3JOAUI9)-K*I"W55(>O":]F\&HMO&':JM)%^GQU+O#I M9<"],.8IHW?11QK/F+N])LY%S).[J8CJ8ZA`NP=;W39+R4&)W,%0=>91; M%V:CW51;-_94Z4<6Y2N6_UAM/4KU1XZ MCM$?6G/OT@W%&;:#C6D80F:<+_YWMI+F@%12*E:B=BA0;RJ3X(D>:D9=U>7=$BWD>V.ESM`Z MV-GXVJRTN(*MZ)KV]7EJ=!9=M>4:K`M/4#"Y+)O;_=6='9#G:(ZIR4:J$CP< MK4<['< M?Y!U5-TLE?95@H>CU29!FJI;_8.U59.::MO&:\`V9S+#_86]6U+,:]99<7=# M#DVE).06Q2/PZDQIJ8XN3^OUA]<63H=0`AKFZR`W&M32'!A'.P/?1%Z\H)^@ M3NULU(%N&4XMY(;H4:!UEATXABVO0_2+V6+=@6U"1:R^'GJCA0=#PU3U#N"X M-3V[USU+4I7J)O>,TD$(M='6M$RM+XBV7NDX>H]8S8%U/[EN@""C/#ET\F"@ MEW8L5,@=#%7;Y51#ZQNIK:/I<+=_S.;NI]0ZUH*/*<_TZZ M/:#7=T%3UO+KP;?6((X\T_.:?+1T7=TV._-!D^/&4,667^@ID3L0J+83&\/2 MVWC'X[2.E;JCRR\*]8'8W(%-R&GW$K'88UMLYOK@\L"#"O,R"'&E6J8Q-#$9^(J\M,U.OHF"6FH4=7=`C?Q_ICP1AQW$K*^IR_+>U)T0/3#2/&UI'L"'/+EYQ.S1SLG; MP\!:9OUVS4'USU[R>K)6=H3N' M]2U[T5<]Z6/1FYT&CWM2.O*`&XGOEG@=7RL_OL`P%,V2,OMZ^L>RT)Q2=$*' MO!4WUM%+FOV]B8K3,XY:RC-LI515-X#TQ$[ST&'I,'SWP]#V<2F'J\EQC$8U M;6/URUS+-(6BR%O!>F`O/XOD,G]'J/9,DF. M60C1,G\-_5BM#TREV8FWP?KEKDVA2G,HZLQ>Y22'(S2G*:5WZENA>F2L922U MU%[9JAP`<83*+$.S6UBK@/7+7?/*F&K()XWTP-U!IU*TZ5#5U>8NL>>9%;VQ MNV\^&3.>EUKY"7!TY&N:.3]D0:,[CR=Z1A'=33;DL^@VAOT-7AM'F<<1PY,!W*Z MPQB8G/*^_'1+J_N#O@:O7;1Z(*?0WJ/4Y_C:T'@>L^21LL4EG1SAFJ4WWG=0 M[X&'YM%F:%I:5SX>('?,7/-NVK\N=E+O@8>66D6USS(V>H`?D2M5TI1NV"^#K,M.Z8T>3-_S]QV M.0BW+AVPCCH'MX?#>>NVU>VCL3JV..F/"J12@%<+'X'8H)IM0[]C, MC?+E--QY'H>!7[P?<`_Z`5<0/^^F^8#HAN+P'I%T;%YA?P3&/H2Q]WN3=G[X M)DS>_V4PH+.7P>";6?(>?R\)3U8A_?Z;/](X>?]Y]/#QYO:=$D1$_%LFV?6B M]03_Q?/_?JJF\)[(4Q(U$K-.<'\!)_CX^:0@=+[$_Y&.'"!B M-.'+PTD\SL7W&G(]4Y],"[4"B4*O)(B\,(5DA,S!1X'$W'VB9$)I1)8X*\K@ MS@1B`#\EST$RC].$N*D?)*=DF3*>0NE%DI@D`,72$%(EU`BC,SS\#O3!23P5 M-\?42UF63&&+JQ=O[D8SBE],6`1B[SKY-E>R8;\?7UT4/YSW?SLC&V7<1()< MO`PB?":GOG`C=R;DP2N/FT_;D'$7@0=-XK=0V MF;N@6999#))#U'M$/Q3=!1(M\XQPJ#>]ZD"*0:1@_<\$&-D[F$+K%31Z\ M#!;0#>>M,Q%3D&I*^HR M`C_%I0BTD280!\A2I'=G;]W%-F3:.QNJ#,2GV]T.%9.;%BZ"J1@5LQRB]UV# MZQ#\=$YF+S\6.L3PY\*C'F7B;Q!-T<6$K=?DX7JBL]; M9";(+`QY-%U,*".Z*JRL[A4)UH'@ZD+NS]=HUI3A@H',_RD\.85+.<$6KO%I M"DTS!\?KA:,VL9WI4E84/C&*HA1PLB^J$."[T/U/^&.*'^C".+B6Y8V]KZ]` M1YY1>=G0!LH8I3,(31L6+5298D.6X--,LQ%^[NB:!:!/B#;DP@T#<*XH<*'[,?"1W+G7FAO3 M99+YF9;YF5(:V`3='6-;#@KY0P*9+%,?]:^$XL[?#+*9;'/UFN MQS(AX=^Y]F@6'_""I%I&\9-[D$M0-BMI53@&*6[#$T=>RRG@,@#*@H_*B>8 M*E2$NT7(,T0G?"YF?F93I.:%+J0]4S'P0VHEFP#.JJ%#,XJ;LEM141)AU,6X33Z['*E!DK], M(3X\4)YW5K*N$JLQ[//EPZ@4P#`J_PB!@9/[,_(A7OERQ\/?I;Q.-``<&""\ M>1XP4-F/GR^!21C0*%_'SGA&Q0`E(/#!TTJW%,3RQ3*9)T$P6,3)?$4^GH%X M+^4\5URH/O"1,LCX/H`,X(E97-I;K5"6Q57=YN6VI,FU'/LJH"3L+7W>IEG2 MK1N1*^ZQ^+D6$T'$KXLY>/\,@G20A)((D$EF#T-*OVWV*N$*,';57V(1(.NP M*\2J+>7`_)9]ZP.%`$6%96NU73$Z)NEY#BA[8A9XEF(.!STAPK(K3#DFVMM. MD66MHR6DY!L)-JD21*U%EDB!,][&3V*,VVI85;"XMMM6.VH7&"5\41]`E*X= MB7L5^CZZ>>8A?XSE(HDS"4#B6N5L@0Y05R&.]F+O%Q,M9&$>O,H#N-9 M:>P<0U),=[H"V`6H048!`_<.`^)]AHF(*.HFP&\$3Y&YRXN:ZKMW3*;3$ MBDY4E)#"X;V1J!S!`SX'_C)&'X`Q;PE<@4/@.(OAC;F0@(7$IT\!#KQ29!U] MOA^/R#V+_=1+RC$9-+`Y5WF2R5!GD[=.[>N[/IB,+2"G*URCEG/)EO^(GS%S M.:T&$YFD<#5>\K0(6N9NQ:54WD7M>V(KU#Y.5=BXY(W@I5LVIU#E[_*EEWP* M!0H`*!+0W\O&)=].TD04Q,BXR#>7Q:U8=,P$2H==Y/.O?H$OKX%B<-9L*`[= M"6;X,5L-)):1WT4P\,0QF15F9-7_.?U'[KZ>R\0N8!AMGEVVVZ$V"A/NQT5A M$HNNNBX`OHS!K.QW"O$.8A140=F4UL9W=KASO5ERMT(0](V*Q:N0$'JA$7U9 MBJB3$:61G]>16KG(@I$$TVZ0_U34`17:NX3:+4)-]RD%ZB(\YWZZ_EU,4@"( MCS-ZX6#C;U"WT="'P<#+U^,@K]&5OQ(FSEA:X7`4@=R"V?<$"0O'+TAGJN#8 MK)CWV*@@GP#1WC3`X<1/INH\1JR[W[:M\2O7:TOP'DQ1C+$P&$%LS$!<`;-M M-1SXH>^[;%4="W79K[XT^WDY8UM`Z(``NMHV*MIE8]D]=+.(>;*E(/"'T[:> M!]F-J.`$XHY>N&%DRPI9EYO0@OG!%.@V>]3]Z./5X,/#U>BGP8>KZ[N'JW=N M^.RNP'^_0C`L5#]W_7QUPZWO5CB+O[_27;X4V89 MZXK\!2*CZ#MY`"WGU6CMRK`-?D9G011E8^;.7G*:#^_5F"UF6\OJS'IE4C$7 ME`-/09QR&+`X'L2[1>E;45+BLQ66A"R8Y9>[GQ`&`W$`TEI!%N)Q7',Y]FDV.BG(XFZ;9:9OS5Z%!/Y M:VV^;05>N%&N.I)IS&CUI$EFGI1G]7L0#?*1Q)?G4!YOI!E&J&-\BGH3*0%. M2!Y2+Z,<;9T7QR M8+R"@G)1F@C?*@WK/)J+J@$2)YQKP)5&T1L7E.%\.9:'6;?'Y"#$==0D2YQW M5R)%5H$^OEE'+],D6`W/=HVXM7K,E8!9WK8802;%IH[AV2G(;]I]QE!?BJT3 M0WGKQ#B=MY"4GYM-)A%HC2(DM%Z MG>4>(#R(7%]_UXE64MV&-[)ACA3<_4EVG&#K%/]S!=D2F)%R02H]BB\<4[.M M*.N%Y!T;6=`TZ#_X03\QG'XY&Y^167;0,_0,U\.Z%-=@-AI+T0C]E16#*'A+J MR?98@,\EJ=B\DFW.R$*<'TQQD3X?!&(NJ>E-H\_:#7%W:P\>>)T7ZM*>'UR) MPWTQU[@OYE2,#W.(TN!D80!>A(LO^`9%UECX(J@%=T#E1!9XZ"6" M'A#X'U4Y510E\VX88E)>9,>>2$2)5RS+`Z]!\O_M?6MSVT:RZ.<]5><_X-0Z M-W(5J!!\T\FFBK9DKW9CRU>2D[N?3D'`D$0,`EP\)'%__>WNF<&#!"B2(@E( MFGQP*!*81T^_NZ<;W1359N(D9RZOG2_VWB(-)*0 M$Y\M"13MB8"3-!CH<,9<+\Z;"#PH'(IGQL+F3!6$F4\ZD<9.TH%X,[3.`QN+_J&0!]7I,@%CS[X3=+KD:OL%`3X2G[E+?`">F+)'E*M/@E'#< M\383HI,U&5[J@?4XK@O0L+R)@U8.O]J]%S)+QA2<29`;2N<93Q($:&`2INLR M+HGF_/8?BD3R?%+&'"6;($V404$*V(*,D`F M8VHEC^FF;'U"1X7UV*)8A?:FC9*:I+6$/<9OY]Q`9XFS>\EH-#F3(D\9\AT3 MN(['$R:YTO!N'SY/A/,(+!U=?]#ZG2;-X-"L-$QV13K_BMM_](ST08!R[B#)?!Q=:T9S MJ"^/DK$B/%%ZPPRHZ2Q]OQ(WSR1A!"1#S,[-ID<%;`5@])2(`>ZG% M);+W)CS!4T;M1!(ZOHC2BOP:%AEHO&FB<`06+8G;3?QQF?A7:LBE`<#4@$O" M$6L,2QC0"3+B@E9Z:X*E=ZK)0C=%BWL$$C-FAA0#Y]R!>2;9#?A60/8Q]WAS M:P'3!3BO-!$'@+)!5='9D-VNV10:$+"OC&M%GAZ%DPX=7;D6WXF=R2!,93( MHLAEH!9_RU(.Y[B,&^>`89L<-[(UD6Q,ZTPVYH19-*!\^^QF!-/DH6<`"K^- M8H&Y!``?40*GT'$QUL`S6##5B5\%)K22R3M%RW1`_R$1,\/,,-?YSBC]!J@( M=91VS`X%UJI`)74Y$"0RQH!OABF=F,&@I"3VB/%M]C&J9& MJG!-<=E!'&K"-7.8C-Z'Y)LC9.!@9/[B;5 M4WBEB!+$K1/4A-]ND=R!!_IH]KN\/I-&_?;Q8QG=^?.L!Y:#!5NU*ARHR:;BNR!@HC/&H-EW2)7?;+!D]6U[)=" M;4FECE:HMK3:.EV*LD"BLC!+=#S?3'HIZ5J`B9Z4L8B(4N9]XY;V*^M6:"8F M.7'Y@>3D+QB&2CD>D#`37XJ\?9][>/6L?XQ^T9>?G,=@*F`]`Z!1<6N._X#V M9^)\X-212T:B9#6Y/(P&H\M/W`S@=P680\80JOWH.PRR))TW9,,I=\HRGB'( M$&%->:=,\V]=9\+70>2)XI+K]H@9>4CE+DZ@6YV<@H'(IA/"U*Y07E!&+M9M=AO= M%5-+`*HA.*>L087S?H%YSQ,NLCD_DX&9<[QHA!A]@5L)P4`*O^-E0XM'`6"G M,2V??B9+:-AK&(/'[#BQXHL,?217BR\2H/$PP`VJC\D>>#(DW2HCIP":I*AL M_1E[X@H50D_TV-4U:F"-3UVS@&+L?#FG&1A\YK:"O)?]"*<1<9+\><([/,V, MO^8+0PDO0B=7H@C4Z)]+U..`(?6X"V&MH)0N8#,3N8-0[`!IB(&I9/]1;<(%%:L`@NI31W$$^D]_,('@II\$(*_3%"9 M1J"B;HXW07CP-8W9"G^<=,Z)!'@_>\N?IT:E7V3P9)82B!#FR81),-K4`A]( M0*9HHUQ*"U/!&4O=`X0+A8_TY":B+GRO*$*3J&4:L5BQ?)=,^S"3LCZ;_8-?B^?H4!$+*D%1U1+(K<;/G?:^R%O MY&-(-3,4959P9DCQ;:,ODUM%9)Z2%^CNF8L,&O,">761#ZM)#/FZ-B9/>$#Q M:"Y=&Z2I6DW!@8I0;V,\6BYK65S6M$H$["SK"[2B>J`>\G[*C.`5'*QX)L+[ M=C;R3WD;#X0'B?!C29':Y=0(^GFUT`ERM3">84B:+@\RU[]_M_^]V\Z=9H+I MZ(E!+`HUIR_20SS`8($Z/L<$2F\B'FZ*Z`W^$@*#7?DE'2%(/^*5;#N:BB=; MS:X8);N7]Y=79^=7C?>7-S>7G]_]%:`SM`<_:^+KW\X_WJ1??AV=G5U\^20? MAKW#@Z,/__QT=?GMRUGCP^5OEU?O2!=&KRH6BI!OT#CT_!\79S=_?V=TVZ?] M[CSSQ-7%I[^+1\3<-Y=?5];#GUI9$#X*K^81_:?(+@5%JSZ0Z)U6!P?#Z-<& M$(-^I1C1K@T@C/YIJT*4J!$DAJUC08)_#!0730"$ME\JK")_OB1GGB81%7^N M&,*OA//G87SK1Y$_6POFF_/_=],8_7;QZG=@ M/R>Q)PKCOE6"]]D)WF-3P$L4P"=K\5\)WL.)A0_\4EB@_=T,['OT+"L!O"^2 MH$R[#2F"GDT'?J/LXEJ<0U]O]SM**-?A*+8@B1J=0TVE]1/.H:/W2AQ$2DX? M3DY?CL>.Q;2/<>`Y21&N?`ARZ6`U*)!^0_[3U7GNH1'*],+Y&8'YY$K<< MXY7$/9S$%1<&,6OKL^_:H3*,Z\5RE)`](,LQ!I0KJ\1LO7"^1F!^>6*VH43L MD47L]=29S^7M))Z[GYBT2MS6B_6H6/`QQ*[>[7>5T*T7YJL8<*68KP3PX00P M55M4@K96[$;9M8=D,RV].Q@H"5LOE*\1F%^>9!WJ@U9/2=8C2]91Y@9PKO:W MDK:U8CW*K#T""SK1.GIKT%79S35#?F79'@/Y6[HQZ*O,Y@KBMU3!))\II6-7 M326#:T`7^TUQYGR*,P_-]N-;ERE!O4/8=Z"WFVTEI^MP&/M->*Z"0%Z>,.]O MDHK%/V)AI.0OV[G#SVE5KFWJ:^4*%.9DU]7S7GRRT$^RF2C/:LLM- MOD:_J%%O)G7KTVY#C;DL:9]M.S1VF$OU.>.0O=5%5;OE[N)I9_&3,+[]DYI& M8K50F?"6WQ:@$V^-&O).M%MT_W%5+"KM#T3EI[F[9E>9"O=#=A9OCMN"H^05PS&557)!+-% MC#,<+P=R^JJ@P'$]."0^'7.32=(U@9D&W%^?*2='6L!OJ!ZLUDTX"!6JIO+` M;TZ;30-[G(F"OO-D840/^8X#LH.V*"^+7RT_7POHPGIGP!6/"-H^!^PCP+7X MN@1D,_TCL8$%?XMJY@*A`T'?^521EXLU7538]1I8SS(,4>?A]4[I#1^8^1W2 MR!RK^N)0V?%_SXZ4E.H5;G-DI#`.,4@X3#\070<$Z>,^J,8Z]1[J-G^0;#Z[ M&=X?6!-,_.CZ4+[=*J= M.0^^IZ>EWS,@$WT5SY@EV@[PMH)88M;BY90+GZ@%^?QA!JBP[:O[7;Y./C.I M38)H[8"M'._Y=(F6""26-F`5Q:)E^VMZ)M.H\#W:6HUKP#=4L41]ZK3UULRW MFAZ*64[>4-9)"V;!K[V*B+1D;J.J6^.51V^EIUW:Q"@ M0HF/;5&03;G.F&5XPLJY4B.U7#<'ZM)^$U#I^(5VZZ/";E('8]FZ3?1$`"3( MG#JN!Q]>[J]M\S;MT5+KWFQ/7='9IW((IRA&]!#RMMZRUW;2J9C6#,PA<$"U MMN2S>4:9U6'].*)*[KP+5=$1F/)U)TC:!7#`K2]GO*^R(_4M?6P,Y2@U\*QU M6E56_&UU:@.)8;MFM5U?"9KL+RBT*CP76WA97SXF;@?I??%AH]T[[;9_T!I: M"]WXO1^>&"Q59+$K68#@*"@Y/!:2DGSB\#WVX>=J2 MHH5#T4(+9$-Q'2Y%#P>CAZN13Z^%Z&D>A7 MM%CODLEZ#`I[(5E3TYNP4+/C0/K:TH;WV"?7YIXZT?KV13=':M)^K@! MWA[[8`Z'OY4=RS7%EM6AU.I0_F"8"\'LAC:Z8X$YP:PR%EA.R+2O@6-M;H)M M(`&/?EP'DH35'Y8\JRLV,QWJ$/XA$XB^8<%,D5FM3FXTF01L@A'MBR2:_3M& MLY_H8'HM)ME>[RT*#D>6LAFM=CO>)^T\?WVW,IKI=+%-/3_E[CLHI8CAFCY1_K<7?I>J^5[PHF_SKZ=-YX?W4^^F?C M_?G'RZOS=Z9[;R["C6XN+K^\\WR/E4(%WT[@ M_'AEI2>NE^J?:>^I],X'>0T,@+3A[.OFN/2T43R)PRC)'M.+:FR)NCM8W&8> M!]84EH*%/\TD+=`?:WU]V%TNG%92YR9708G7V_0R%7_RA:;>]-H]&A:+M.&5 MM_'8L;`Z%UYO8[.YZR\8"T_3$Z)2=W+%5%6-:I2*M.`YI@73N,W3YJ"XSMJ( M%K]46;.E=UH#6DAN[#M&-3-Q,9Z?_$3U@.2<=G9QUVGU4*R^Y'BBQ!5,&++@ M#A;'3R!(<=X;2>//41:J\=_`+S"Y60*)L%2YEBK M+&+BAG9:XVJI(I?G8BU0>,1U<&@6S!P/#R4+GBP.PB;"2,]4\IKP(EFX3'XI M,0J&N&#L#Z3:^I#]L#[=XD.&-)5SLINA5-`\8: M?%IQVW+UDN8;H]/46[UN\E;H/*QY)XM..U/^OBIAY6@5UAZF2$<`2:A:%/;: MI@)<`XD5'^#UWPA99+T-;2'+]C9_^)G@OE2E!G\RA@;\F-9#CF595I.TU:+,Y;D?P$B6*"6S9PRRH MM8/HF-03L_/UU_B(8C"LYHJ@HK6%"29UFCVJ6X<_V2!R\**OQ>P,M<(IX#(K MKZG&7B@(Z'B$._B[XJ9D6'>:EIL45 MZ#![21J'Q^)U5'IP>4%FD%VUK]VR['WLR@&Z5`=17"@'MA9F-2T-)7A`",'Q M2>XR=[5\52"^Q!OB]>DCV:WR=GBO/L[!SN!@#4,V`41]X%#AY7`%!7QD4!LH M]*J[(%\?QM"MM'Z&(@D%!:4TY)%A6!\X&$IIJ)HJ%!04;U`&A:(*!07%&]8C M0XVP85@A.M2G+^CA6E`J,UMQ!F51*'FIH*!X@[(H]@*(^L"A?2PP;)[FWI=* ME>5C3%#&%5L'@%DIE736@"6!\[O[J1.Q)P.JZIL=AV#1.S!A!58%U@W`VNH. M"MF#<8B+OF7P-H;M&D-\;VT#7='1^5(DEURFR25T2DL=G15!*#[S8L#:Z@QK MP&<&O3HK(@=C-)E+>SLPFD-HU[OHSY6?SU%NI2IU_=A4@WXCP+K8=BZ[#Q?(5OOUAC<+\PAPIX4 M#CE$CO(N6MJ>2R*+A2[>3Y@5>:/0F,%UA<#UNJ4$9464<^#42D(*@7A!:*U,GYJ M>2Q*#BOUYOF`51D_QX6WBFP>-;)Y3#1^KIK?F\UY\#&Q=VV-Q,H!NA_U`IL! M*@FH%(LZ@+6ZL+$R(P^@UQV35:]MK%4Y9/>#V#U]V*16U8JQ*'Y=![!6YW=2 M2O5A$/L0O0M*`;NN.T'ED-T/;@]/C;YB*XI;OT"P*AZL'!MU9KW*L5$]CU!@ M58IR/4Y@WXA]5,Q>T^"OJ5Q?T5F!5W%AY+I3G0F5S'2N;BW^D0H/R+]NYV].46PXQTL)X-C.#A>:/ MM6C*X$7?^J[YHD>4>6,EF9ZMF9-36_"0LV.`\>;T`AS%CB^C1\]C<&XMN:$VCQ@(198 ML;5;YOKW[[2=]U0*%H#RVH(N'/=INQ9SW;EI8WL,\;!L28:_A'/36OEE@T2] M=MLX`"GMV,L>V%R%;8J-^K2S-];TF3PX'`:=VL"AUZY9D^+70BYY.13Y\YV% MT"CAU\"+SV!2K*BKM0WBQ\;&`O]5$.?^H+Z+"^SEDWU%FJU!Z6NE?E[%?0Y' M![RSJ!9.83>A-H&-<75N[`=,<2/%C5XA-SKIZ\,N<:.WBAT=F1`^<0:D^(SB M,R^>SS04=SDR^LL&T8J_*/ZB^(OB+_M&_P^F9S%7L9?GQ5YN7=/ZKAGS2`M] MU[$5F]G2>:,WN\IW4[GG.!?%4PSH^3$@GDVJV7X,)ZJ8T'9,J*T;FSF0RP/Y MO_P4AXV):<[?4:!\ZKLV"\+S?\=.M/CB1^S,"2W7#^.`W;"'Z+T+S_SZW__U MEU_D6U?,-2-F?S6#:'V!:%)`O>$_#]E;PQQ4;_^W',P,HMFG\+_ROUV[^ M^"NNZ7\:#39Y:#3D&K?`4%=V9H0E:WV-,/:O1K?YLR86J-$*M>P2"0R/-V$Y M=%[#$A/3,>[C%C6N3#3X$`PYS``(O`L>#;,3$> M;09,-M3&@3\K(DSVP!.1!$V_,09$ESC`S`E#/UAH'L!MF6#P.R!-,P@UH_D# M#!2Q@(414J-F>EX\HQPG7"(`+PZ`O6LV3"RSJ>AU(.[I4O8,LB#YQ/Q)8,ZGCJ5=I'L_GMPA+>/BR]GY%U!S3KNH MZ*P;%=%H[+NN?T^W@)S@)'R>"\V'BG]W,(3P`*Q/!:CL,0 M"H;.PQI.0X]DO\FSCY>7:6</4SZXZ=L;D"V0[NZ7KO4;TKZ7`512P5PK8_&*QH@!%`54#6\D`10&*`HXC M`Y3]==C(ENW/6!@Y5I*GIOA0'>XS;%YF4WF'#G<*G6Y''PPW[]2D2$*1Q(LG MB9[>,S:O0ZM(0I'$"R>)HHLA19^&'4/O&D-%.G4X-$4Z=3B%3K>O&R55S97E M=UC+C^[%>::XD:;,/^6&>J5,R.B`E==2*JW"_->&^9MKKGJ[U58$H@A$$W$< MJSLK#CDJ^K,5A*/*HVXFDNJVAMYI]O3-4P;M: M'(PBE;J=2+=KZ)WVHRF<_.,CU7*/?&'WVF^BQNY22=;ST`K\^_3; MI-KF[SX>9_I#3V9N+2J)ACB-5DZ9%6JZT/AX8^;+=EESQ_G(#( M\FQ9]ALV.9"5%;6 MM1FV*018>9KQPQ*0LX##MM4-@$48P>PX3/;,X@#\"7N@V='@7[@R.I,A!CX>,?<HV'6DN^ZI"7`X+-I)$-" ML0PZ1-P,?8L`N5NJ[5LENWC/&V(^POJ2DL=>6NTX=S;WP$]%?6.![>_&HN.\%G%6':4+$P#:$/NO.T#YBS+4Q]]A4BP@#)/<8BUR>$N; M`G$#0B#^,5OBV,STXC$\&0>B0*WI$MF//G^]'FE?>=WFD%A;'$W]@-%%LLMU#<(,CLRXZ4XP4^#N3JI`S%1)X%;&$)3'/**XH2'HD8 M1:QB+I%)5.HG&!<`5==0K/F<-4Q`IGE"-J[N96IR,-XRYM&QE9W(+7,=6%:H M.1&]A"HSG`(;\XKQ6,S=9AP44A+#DUC'W?'*R.P6*XPGI<:1\2(XF$FT-8\C M*3.*WDUF%CPA@B%TKGWE=:]$E2KD09536^&J4IRR-V)X?_?O465843.S0U*; MXC"':QX\*5`IS/2-,.=S^);7[T8RB:30X;J:*-[-K*GGN_YD(8DD3V+^*F-$ MC:6,X3X(F6Y-32<(@=,L\\\3Q##$5!*(L35-J6%)%A8,3WT./%2;DHE\X.AO M:5VN>>N#8N<'BT9FR;C>F=.P0.4'_2._F+H(V'+\R#Z4H'-)F7>.5C@)XL;2B2]/"9H5/,0> MYB2:^:!@;B#Z\283&05@SBQG##@,^^=]!);&+MM4^18*R,>D;@L"CK)YBL#3 MY&]9P1XFL6$J``PG\`6P#S;UF7;&=1[MMZ$LCKNK,XY+K-RJ%2$X/D9#>` MS

@#42A0@.FC>U\$R7Y#9@ M$YLXGL>%9BDMZ$*^+S-M_&L)G)SVHMQQV:3U.GX!9UHU43[AY>*].0R1>U M'KXP--KYR2@%ZHF?G=@Q+=(7J5P!15-Q8`M2"`Y\"$0ZWCA"BI1:=`,4&O-X) MM8ESAZ@:S\$D2HRWC/:#CTNVV^?)2=HUZ.`@T*X78!#-Y(^#G]&V"4S0'UQ0 M)^Y@).!.18<7DJX,.@$\$8YCT@/]V0R=2F"X_8?9'-=1[J&/SH^XNEBN?TN! MB<=)-C>QU_R8F:9M!<*D$(X""*C`K&[#X;M(M7?$(YBA1*2BW/./5S"?;F$^%&1@<4M2F<.6B!AC'8J8O-(23@G6-/H<]]V!9HB213)(IQ MUCMUYG/\`WDU1@7(5Q'$W'W"QF/&'82E^F&=@C4E5)GO0J?-XP``&)('\['> M])2KS2]H5KT@Q2+R'I.`%V^`R9A7Z:7'"'&.87_XZ6K(F5KHC&F0G< MX4V;0P%>X.XD`>E*T86B4[!"#'=D8X>Z=N8\`/W93HB$!6?I`DYQ0&GPS"T% M+J/$HTQ(D9`I3@N_8&+ M!/V0Y>)41:^_Y3C#7\K,VMTP+(;3TYKKXH`;H6!*/9X)&9,;`C8V81X+Z*(P MQO_X0\RT1!2Q4DRC0T!BF+NF)=S,FX?M48:+PT,]XQ8HCJ+.C.P0.S>"9L?HKQHJ^07,62U'F<).6L[2X/T*8!!+$?Z<2[A?,<.T29"#^] M0&=-#$!?K!'8&`Z.AJ@923^UT!A6F"`P)4-R)1Q5+DF&'>E`RC:Y2*4%7Q\E@(:S<2QG3H.D;9SQER4_R9(.E;I,5G=^3[8!&-CHHK\WT_;` M`9N9CB>80BHZ\"=^'F^Z(I2(Z1^4P<2588*`%'?P]ZI47,'"8,9+`= MGBM@!##.V+SC63D(,`&X!@PS]Y&$,]%M\8IH1"SMS-N0M$GA?%O)HVC0,H0] MD.".'0=F%AWX$JN5T2%!-(S=)1&]G'G$N04:QT`5(`C0G$"AC`4=S0DKE7)D M[]C,"I`W)/4-4>.Y-8T$F$6A2H!29U;T;O#].Z3J;<\XHDE4H3^]MSBIQPA0%`<0;49ZNW3F, M>YHGC&9.,@G?^QB#!3"./+;#@S+$/B#^CB`(.77OJ*V9,V M*57H7@8,)EW!9D%B-\-)1S&Z:"1++LV4TW-\7NK:E7K;T"*)9S,\\R3C"K`! MX_(A3MD`1+1.5X9:%:`;J2Z,$Q4$RB*@0$7(P.8?RUVA0F`F30B#`N[;"6U*@DE M7*-)["0D#,OGYPT/HME(7IV_ M,UW0RL/RNPHRQ]XI.%+GT03\)\[W,2;7W1F[8ZX_SR;?%1S,>Y&1F2ZM4MR] MEJ[ZQWS/J7>?0B@I:P:)@"G?@^:ZA.RE,9.T5,QY-/-IOS?%(UB8[\Z0(TAM MAP1$[$7"">GZ8;CY"HJS:!+NF1W,O'57_-J(H-(Y[Q=Y,-ES^719K:\[E8>)(R2L%PD:S+LS%FYI]@*T8+ MKMH*EV$X)0]"HFU%I%83\Q4!FG!P*JROF"OSX`/^`N957E6Q2GQ.7 M>U?(+9)4^$*4^/!&80C,863?.:$?2(?R21KW_C`:I7'NMZ<:_)T-7(CXGR/7 M%23KLM)UH4BGH#BQ4U-<>2$?O_,@@Q(GXIZ/]AGT92YHV\(U[5"R&%>:\K&H M,.;KH%6!\L'/$QUN"<3:ZF+D(6':Q+W?][UO(+L?GP@`,#WSG+\8/R62TZ/A)F(]H.P\86MC2 M-31.=#2P[B.A+G/="2S0&7(:PLAOI]>GTBN/3@0+N1CJ9Q9)000S'`>,-$>A M(K@W>@8]3;^[QQ.X0ZD M/"SVJP^2='&LVZJ$IKB"/2#M1^$(N4Y/!/D##*Y]=/U[X6"9.N2P=QW8LBUX MG?#H(_H"F&(2FW30*-<%2X/!750%B&WDS/];SDZ=1L"89*Q<`$L$O6YOXOATF[@8B M=ELR!$QU##@+"2-$$*ZMTN$G<@D,4C^P0_',6"C3:1K7S.<*&TA3=-#28S,& MI&TG2$2I9G0;("0\]&\Q%AQQ2E!` M?";=`77!)A!'Q)4@'C61OEZ@03!OX*F[U&CBE)SS:F1V0%,"NL3;3(B>N63X M@KM6Z7%O>I)+Y!V!BN:`ND]*9?@1"")BO\&F;/[:<>A<+H*KMOM0;3)C"OXJ MZ![5$B!@AR>\83:,B[XO%,%S#D%*9T-7..5:)0EVPB[%2UV@08-=1BC*[W6% M>6:0.#;]>WY_W%E>S:F6NVE66O.@T&\*J'1I17XN%-MJ$2=HJ) MO.B9\JYPSA/P`"@GSMOT39X/*)=P[P>N?8^V@\R\E3I<[E;:I@FX^-*)\^3I MREQ%NDR'QO^?9*ZVB2#O-X^2'TF-"-]N=:>(GS9?E1\\M_70-&AQ50^EFJZ&LQ"Z* ME>='F>`2RP0FSF[,ATHT(IQ;@\GW9O\ECB9NN/&$`8?/$^$\`KU'UQ^T?J>I MI7YM&B:[(IU_I:7.9)GK;O/@S?7'T;5F-(?Z\BBCU&K$Z7/;7!X3B?_CQ1>M M,\B,DK"2+W-J)K(=F!LXA";AI@O:`?1(DI#(M]GUH9@%ZGN/;3#`=+ M%Y6FWQ)_1PZ5+"[SF#0W%QF$%X#54^H#L)?:J`$C57/B47Z(#`J/N<\?7T0Q M1WX+BTQ:,"5NXTCX\XJ6Q"U-_O@MB^Z9R`\K-'W3.Y2IR9ODBZ\QQ6%`)\C( M&5HI>J>!E9Z);1" MAT!R(0Z02Y&G0W(V-+HQK`WB(%AH63#AU-F1;_F9W)'HIGH&$>9:GVK?LI3# M6;4(IF,&Z@;'C?PP$VI.-^:$633`H&AN,X+;TH0(%!X%PBP&`/@(2P[$0LO& MBUSH1\41H`([K?&=4`02HB.J^R!M;2_?'T(E/UUNR M0TD/HL!@5,"X,[*$4Q?SWAR#_HUL?B"R@MI=QV#2GRC9XH./K&^,*W'9%.A$QIQE@DF5F*QG0=9B)S_-^:(_I'6"9!A(* M7Q<>=\)/'A$YG^(=B0I%R_W>)2/1XHG@PMC"15T7&*P)=T"Y&,MO^,I1N+J&Q&&A1= MLD2O`3(J9[RLE<6>/+?DY@=%T7-G6$ANZR@I[V/$JYA>2`=ZQ97:#WY8B9?Q MFCS^[RGR>2X`NLU\*G2@5:5JA3M1JZTB[H07B M&B5,2K>\5(AT&E/*G8F.IK&XP4J1D`:/]";9O";6I^#"B5=M8WAS@*,224KQ MI8BC^-SAKF=]C[)\5O[))$8#9"X"G2(4,\_X5CB!Y>I(9"^&).E5+I8@(RA@ M"HI#)AH:(^B7#;)<(6]>B_!F4B4'<=XD\)&82P*QG,)1%G.+`S$C#ZEL'AM% M.L%R,0;T5^)#B5+\,P?2VTN+)D;&692AHPI:H:DIIYE3<>KS5%C`X'#&Q"AR2_*7-C M5M@:W6:WT5VQXP2@&H)S?DUORP%4O<9YPD4VYV=)[A]@ZP0Q^@*W$H+U%7[7 M/OJ!Q2,LL-.8ED\_DYDU[#6,P6-&HECQ188^>,`0V/]%`C0>8KE!W339`Z]C M0P4/12E$F/W# MO((FH'>2M$-6F`EV$ZKK1*<$:BII*77O@"'UN`MA"J&@+V`S$[F#)*H/-,30 MO_%S(>,H8#T<#3D?SB]J$]::$F^FM)E4DLP`^%'BKP(#``/-A,7(Z9PHR8[` MM2[]C'F>.,%RVM8NW"`3)MM,G2$5:.RX[ZZ81=?J+W`]N%QF7TM!78$*))>C M9=:C)0O:BW,]FSTN+%MREPAN-4'M7F3DFC,F&$$F("]\CM(!*2JA^8B7<1!( MO0^L&.E+7@A,5*6261Z6\_)OD>:$OV$>8PVCMTHXH M/3>Y(2\]/BL9R\N)!=D;P\6WZ@T^D6D++81VB44VY,RYRI!FFBT.&H3)?1@E M!A:R=6QR1:=:9-Q4*H-%U#V5)JE230(D+@CB4^7I+&8P)O/E]$E.Z/HC#F91($.7<2_L'OQ;/T?_?[1^C;>HNA@^B+O.$"L!>_WSK$\@C<1#S>%WQQ_"0%? M5GY)1RAMA]9J=L4H=6@CT3Y8'XE$%JYIJ-&J#R1ZA^K>L`$<#*-?&T`,^I5B M1+LV@##ZU#ZD*I2H$22&K6-!@G_`4JCJ]LZO1,15AOLK)E;AR2B16RN!H$1N'43N ML=O*OT31BVVG8ALS7]XJP?OL!.^Q*>`E"N"3M?BO!._AQ,('?B$HT/YN!O8] M>I:5`*Y!1]G->_PJN_B0Y]#7V_V.$LIU.(HM2*)&YU!3:?V$<^CHO1('D9+3 MAY/3O&*9]C$./"?I*),$N)7,KI75H$3R`?E/6^^UATHDUPOC:P3FER=QRS%> M2=S#2=RO:;.F*]BP)5BOA+`AQ/`5"!/"=I: ML1MEUQZ2S;3T[F"@)&R]4+Y&8'YYDG6H#UH])5F/+%E'F1O`N;K/2MK6BO4H ML_8(+.A$Z^BM05=E-]<,^95E>PSD;^G&H*\RFRN(WU(UD'RFE(Z=SY4,K@%= M[#?%F?,ISCPTVX]O7:8$]0YAWX'>;K:5G*[#8>PWX;D*`GEYPKR_22H6_XB% MD9*_;.<./V_0+:>XM-6U-65V[+++,=47IB*9HD;F".O+4>'?2UY&]W=977V4 M]K*[P=4J[AC7I>IR(>]/)IN&)5V/J'P8-F=UO-"QY+/E_5_].*)" M9[QJM*B0B(U21`]'V>Z,%_N7U?2HKEFXOCS6OJZQU;>4EC%LUH=3=UI55I!J M=6H#B6&[9K6"7@F:[,_(.)=U$N]\;&*+5:2WD-HO'Q.W@_2^^+#1!F.I_8/6 MT%JH%O9^>*+QK?8S!-5?Q555$D5Q=F\B@H.3P741//$X:WHPLW= MX(H6#D4++9`-Q?>Z%3T/ZTB; M>#7VZZ9XU`.2[9.0'7K$*^TOCN;U&(EZW`OIOBCV3V0]&(6UOGFKO5"SXT#V M*4U;Z6&3'&RJ1)WRJ._-BR[^W:Y1P*O?J[+"<;\^M&P4'`H5^V`.A[^5'0LIB>I0ZG4H M?S",IC*[H8WN6&!.F';^@)TD0Z9]#1QKEX MHK=TA,TY8]/5;E@P4V16JY,;328!FV"$_2*)KJ.U74Q?^]4I7H))MM>\7,'A MR%(&FW^S4O.O5M^MC&8ZW>T*GJC3..1IO&F>]C>_I?<*[.'*3L(X+;D\IHCB MZ$31[NB];G%RKA+B!Q7BG]#$9[8BA%H0@I+2M;I&IL3OX4&L\'B_0%;R\AA& MKY*82F*^B'-0$O/9@5CAL9*8STAB?L"[:NY^!:8*I=1+<+[B\SB^`'VU\=_C M"U*%UTJ@U@[Z2W'7W=K;;XS\QZVK4","J''\59U,/6.QE9Q+7:3SWA33T_Y> MX[**6(X9H^4?M[]+M=V%IZWN3QW]SE2^4@R_2L1O43G_8:'F>&,_F/&:J9C- M%M"MJ1`WK?E\U_G[5%3[)2?F7^*UJ/H4!^]6>26J5Q^-N#,X6!6X30!1'SA4 M>"-*00$?&=0&"KWJ;H75AS%T*[TTJDA"04$I#7ED&-8'#H92&JJF"@4%Q1N4 M0:&H0D%!\8;UR%`C;!A6B`[U*?9^N+KBRLQ6G$%9%$I>*B@HWJ`LBKT`HCYP M.%S;JIUSN_I2J;)\C`G*N.(A^DZ54DEG#5@2.+^[GSH1>S*@JDYG/`2+WH$) M*[`JL&X`UE9W4,@>C$/<;BF#MS%LUQCB>^O=`R/?X@>14J-=ILDE=$JWR7DI M@E!\YF6!M=49UH#/#'IU5D0.QF@RF>H[,)I#:->[Z,^5G\]1KF(H=?W85))4 M")UCA=!0B>*ZR`P%UH.`=5`]A^FM"Z]4#N^]$:ZE:4/ M4?Z0UZ[A*;`J?XB2,,]?PCQ7?XC*H5(Y5"_C%)1T56"M3H@&*/TV9.+T[--< M$M7SD6>3*77*K)YU,CF,='XN6I^;S;G MPTV#O\H!NQ_4;NF=UF`K MUX;*J%$9-<\&J(H-*W_%L^##Y*]0>EY=T%N!57%CY;E0G@N5S76L;"[^D0H- MRK]LYPX___)3'#8FICE_=VU-F1V[[')\/34#]MX,F?W!G\V9%YK8OFED1$,T@QIY-OTYFL\#9CGT^Q5B3#BZ M-P.[>#8-"VO!'U=L_+EFIQ[ICV MU34]S8RT?\0>T]I-'9XR6IKIV9HU-;T)"S4[#AQO0B/,6>#X-G[T-`;CVIH3 M:@"/$.N^V-HM<_W[=UIZNGM`$!H"#G]MG1E.DK1=B[GNW+2Q:X=X6'9*PU_" MN6FM_+)!_F"[;1R`PG?KE=L"[EMA]V3C$+;I;I`PUK2_/#@+'QL9ZR*L@SOU!?1?/W,LG^XH4 M;H.RZDK=SXK['(X.N(ZKA:@%A]H$-L;5N;$?,,6-%#=ZA=SHI*\/N\2-WBIV M=&1"^,09D.(SBL^\>#[34-SER.@O^U8K_J+XB^(OBK_L&_T_F)[%7,5>GA=[ MN75-Z[MFS",M]%W'5FQF2^>-WNPJWTWEGN-<%$\QH.?'@'B2JV;[,9RH8D+; M,:&V;FSF0-Y'?L&3DP/*4A'89`:'=L7F?A`YWN3"&_O!C(9\OQ`_[BO!@,!^ M\>7L_`N<^VD73WX=XM],F3;V7=>_IX0`8CKSP+]S;!9J3KI.+6"NB1[DR*>T M`02;Z2V(;OYJ='H_A_#$'?-B>`U>HF>B:<`8Y1V$SD-C!MN:AB+'8#4U(?N- M<:J5Y@V\A-0#XR#IM3MRYU9O3?+1P4/NK?KH!D:W2D`,ZR.P^U7F8"B$4`BA M$$(AA$((A1`%<-C<[?!:E*S]&<%?6*1="25^8S/X=5!CI9Z&5T'GE?63O2$K M]3-9IPKK:W6?3"&^0GR%^`KQ]XSXU\Z#0GN%]@KME6557Z7_-7*<^ME5QTXA M>8%L9[?\A=>(_K44N(H"]DH!F]^T4A2@**!J8"L9H"A`4H&* M)!1)O'"2R%@7:S\-.X;>-8:*=.IP:(ITZG`*G6Y?-TJJSRK+[["6GX.FN$?7 MF$Q7F7_*#?5:F9#1`2NOI51:A?FO#?,WUUSU=JNM"$01B"*0GUN=KCX<;-XY M3%&#HH:J@7T,<;%&2"A3[G"FW(T?F:YB1G6@C[WZE*JHDO/B.%9W.-3[K:XB MCSH?/GXXZ]M8]"$_](% M;S'9019IK"ZQV>PTAWM8XAF`/G2B"Q;PU/F_8V>.]+_; MUI=)N'SHW`J^!OZUA%JSL8I(M8/_J^%K)Z%L-!J[?3*D:6%<]B MXB9`T$D]6/CL,FI,Z]FC&;+N_]#WI2-O#;A&IS7HIDO>USJ.O[G5PVBTC$'_ MP%O[S;&8%[(/?ABMPY4SPP`QDE39+1`R>2+*#DOSC1WWW4A9\\7$WJV9X*#=K/-9RT9\TESKNZR3UQ_D_DNPC!F-M6C#B_'7P,V M9J`@\-K3Z:3\]TWVVI7(^MC@&ZT`=*??33?.H/*WT/X*4AN?WA"CF\;CBY'S ME"P*E(69*,^]"TSZS68Y5#)C/S[[X>!1,$FRG-]]-`IX]?%=F(H@N.PPCV_U MQO^'.0-=^KV_L`%Y;YR9'TT7G\ZZ>20- M`@^Q@ZT6D/`$V5-L3RO*#ODT?`/>4Q$SP)GKPPX*5K,Q0X"%'8XAX,+VRA)2 M?4Q@ZXT/0LF:`NWQ%]:OZ`+,YT&[P`@:=I>5[I+Q4Z)(]<`_G&@Z\L[#"(:$ M$_AH.BNJ][(E5K:07KN7K&.#&9+5+-'N5\1!J>QO8`&4+0<$^8`O9MT$RZOX MG86P2-"(O_CBFS\`'S=D;"4Z6JLS6%Z&C)!N/IO!=Q8] MV30>R`-XT@I2GQ7^N-+E"X_7"]?QD7\5KJ_7'+;%`M<._.3IEYI^K1QCI]GJ M=;=92`Z>X;X/*,6<+_'LE@7;2;)5,`\SKIJ5$9.Y_A"2><0E\Y64S$O(O2.I M#,$VYRO89IY5L;YR-*,`\'?"T`OX?I$^\M5%NYP[-H>3*X[M M)[PI&7M))^(3"+/V/1O[`3MC%L,EMI&S&]M9?(\OJY%3M#=<1+)H\'&OU4W-R#4CISJZOP"[ M?#&RK`!LSO=Q],V;FXZ]]#%IN>M]T:7+:AY*F!3 M.NKR@0B]5.9G;8Z=Q0JYT>]V^\/<^:R?(:]]F"X+1;NK]0'>XMD[WL3.&':-K#/<_J<$G-0HG[73[1O.1G1+.L>@B6]9# M]BW;'HDZG4%+Z!AE@SYMUJ(#'7;:TO@_Q*2/G&RKTQT.FH>G#26>!`K#`](3' MW.(M7/LJ];7:PZ$QE(D03U]&JEQ+5[:(/PNA*,SU=11;MM9VTTB4CD=&3U9! M]W3EMY]-FY%5#%M(%K_#0HQ^/UG(XQ.DV5P@]B_'9R+5*/O.#FO(J/OEXR93 MX\E&SN68[J7]QX+PJDS!^4(M7RP88O.'(RT@*&;`96X_N#&?T0S*UPH M:&9"-=O3(I)-41;.]@."UIX.V.WNNJO$[;FO963C3OCL=<:-)=XCZOS#<=WW M[(J!ELWL[.JWH?N!T>GU.IDXU!8S9C3XRS%_@@?4;OP_3'3218_&Z'!1W55F ME+7PR@MSNY\>66^ M=(VF:P:+&Q^_O)D&?CR9GL_FKD_L`0-8P*3$>',6C/*65Z$E6+30K!]@AQGS M$)V"Q0BX%[Y?4!(N;1"_`WH"^WH,SSG(\_D,NP$VM]ZMYRQT*L!/["O8W^\7 MZ?[XXUL)L$O',"4,_6*!M#$]8#N"+_=$/9-P;\*K0 M=G^B8V#WB5,6OR342-IB9@LWJ:6L_7QV-=IEL9UTL5O,E*R.&MBY4NF`?7UT M[ACO:H=,_1H.C)RF-=*6[SEJV;'CG'[&[@,?;3UQDMVR-)5.L MT=+F-_X7_VX'Z)5HCFOTM353I0O$ZZ5C#).4<^(;GS2!XJ66L:@BM,QES>\X M\_*])8LQ[HO+NJ#.V.T37#++M[G6S;*?Y:PUOK99B1A6<^R57>+O?_D%/=_< M10=_8)9'A)($ M=EF_4?7J`?2M!GHJME_]ORJ#_C*5=`Y()=PM5ODNC0UV:>R^RR6.6H?M/LKZ MGK#=_8P]QU+"?Z3.JL9COP:PA6U=]^3"\)P#[P';P`&J$6.?<]U(5'#PXL M-74V\"%^^:EPY%\!;&+JHTB=1^_F/#<8K\L@JCOD2R\>//-#*,HVPTM[M3N/ MLOL6SPW^([F/"[D/2IVI%;R+[SP]-TCOE:4?TUS-W0![U5#?E_'YZ+VVYP;E MXXK2?<->"=/*3T2)T^-!7%Y#K-Z.'3Q!`2M(D'YNR")S$/@6\&Y(K=4N!?`Z MJ6/J-`[.)GEHL&(V25YVK":RTPXH%%OY#@Q.#[ONH%N/'71WQ2),+*E\!R!L M6YV==U"]NM#:3EW`M_SIKM\Z8&<8!^Y4;L[_\)/^FU_&5_+L8_\Z_Z(1^ MIV7TW\$OC[^=27WCH]A4KD#L#9_[$L]`4X]\P6)@``%0`<`'1S;VDM,C`Q,C`V,S!?8V%L+GAM;%54"0`#5"6M M4%0EK5!U>`L``00E#@``!#D!``#56E%SVC@0?DYG^A]\],%/QAB:7L.$ZW!I MR&2&2QCH3>^M(^P%-"=+G"0'N%]_DK%3&RR3W)2Q^N+$TFIWO_UVI96'ZT_; MF#A/P`5F=.`&[8[K``U9A.ERX&+!O(\?+Z^\P/WTV]LWU[]XGO,`[(8@G@C' M<_`($W!F"9:0ZW#>M[N]('`;37L[ MYZ3-^-+O=CH]/Q=LO7US<9$*][<"EQ9L>KEXX/_UQW@6KB!&'J9"(AIF"P7N MBW1\S$(D-;#3)AVCA'[S]>*W_"A*2I,5;O)5.PE4`CB')C MVM4?"$L[D7E!6%BT[!*=K8R[191ND;D%$O.4C41X2X36VG#@`Y$B']'Q"+Q. MD*7GNVSXVU`(93S73-`Q\IQ<^G4+K&7GGJDU2SU+&%IC^JFMES*,O;R M<("E.O#O+0G\&*,Y)EAB,)U]18FFLB,,64*EF*`=4H?!B32I%FXZ7RH"74H: M`T2[3SOE-4\@*F`[R8U!WGYZ3$#M/OX^)_"%38'H-GN"^&F*:A98SE$=5+M/ MOPXG'Q:/J MRE)S/^3&;M#(@,BZ1VPI2J!%0Z''%".::0B<:N*ARL@ M-XF0+`8NAE)R/$]4&7QA(\85(GJCNSAN[J;/:]/F##ESM.UNP[*MD2YOMVN@ MPI@>QW)-]8VPYA#B??K0:!@S=03_F[Z:&L>:%4WGI3'\I?ZQ#O*Y=K+C`W^! M27K")D0[/(*C7*D0L#J^58#LKM8[H`H/T4D0Q9AB(36Z)\C0&0K@U"JK27HQ M=+MO4A/.%B!$ZEQ%Z1C%?@INCL&=Z]MB]:XT93M$*KX4EN>L#N4!C.KX75J2 MS*JG1KJY4<7X%2V-R7PD9C4#9G#59'RPA0P@Y#LD$Q5EH9^#B`-@U33\:@D- MSY#N::AN!6,F3K;2!K=K_X#/[X"?']F2SFZ0V9TNV[)1W?5%)RN3LTQ1, M0A+.4(0"D+8UO_X`%&F1(@""$B]-'[[D8C>`[OZ`1G>C`?[CGR]+[^@),TZH M_^7X_-W9\1'V'>H2?_[EF'!Z\O'CAT\GY\?__.\__^D?_W5RGY\?'9V\7__+/]X1!P?B;%\_N7G11"L M/I^>/C\_OWMY9-X[RN:GOYR=O3]-"'_^\Y]^^BDB_OS"2:;!\_N$_/ST?^YN M)\X"+]$)\7F`?"=NR,EG'OW\ECHHD((5#WFDI9#_.TG(3N2/3LY_.7E__NZ% MNRE&9\3+#!,L,$,K'`;$0=X[ARY%;^>_G/WM_5FJD>RVI#YR36*-G'_Z].DT M^FV:6G3G!J_DZ=X_G&Y^N4--#.R\:ED@^],&6L0<1CT\QK.C^)_?QC?Y\8@? MG+ID>1K3G"+/^_DH8O9SL%[A+S]SLEQY./G9@N&9EH^$<0G%!PG"7V1OIP?S MM!",,"=\Q"?BI]B7D[E"'E6]'\[S:U\G+IZAT`LJY#C?=Z7\TB4B52HXUW4% MW$8=G2SQ\A&S*EG-])OB,V%RET.S/3F-F"4N^VU(G5!H(4C^'OCNE1^08'WC MSRA;1K:P6(Z`4W*2=!XQ;-UW2A8Q:8A/Y$]OQ7\S@^*7`/LN=I-A)?_UR!JQ M.0!0TZ@87>' M*,WJ=C8.6)9I84J3[F*KFN6YT.PFK6>,+HVJ2X:E6HZ/0BY&IRO))_*.CRAS M,=OXO*WJ_3)D3!HP&_7OTK:*@GK:Y!'("0@.B$O$%V(#D7]=_0C)$_($OWP0 M7"+&UB(4^A5YH<[JV+4%`)1FGJ7QLM0#./P&CD-#P>D8.UAP+:S_/=8N)"5M M-_#1R*G&XY?V\+CQGX0DE*WU,&1(NJ']K%1JI;]O3^DCAE>(N%('V.S_'4'#2N\?VM-[:G+<4]\QZE]-"P`' M$P`:`<'M%R-&5Y@%ZY&(-*-(7C@?*^G?Z_Q7$O]X5ORA-T; M/T#^G`C'(YY56GP*&@%'J$ADH%N(<>^`KO-$!'#;Q"U!C\03RL)<+-9)0)W? M%]037'&Y<(-U0>1NW;P#*15[58#;8U*LVV5<#`U:1:KL=-3@!S\KDT2[([26 MH6Z!?ZPFAH)4B>!^5UR(N+`0NWGI]-!HZ+N%CDYH<*;NG@8XF49C[,E#G!%B M$<\>XIS,"';-D)7IH4,@EE(,.#]\&.(IW6';B**A08=`,XD-S@]/B5;L5H!! MX1`_`J#]*^VB0W7*#X&HO'/>;NYZAL6:WLAH.FY34;8<.)5!12DH.`_ODBZ7 MU"_$(D?6(2#R(H(S8P/7)1MN1HBX-_XE6I%`LJ;VLC74'<)$*S`X>S7&@1`= MNU>(^<2?TT%@T[!)B-&L"Y:'D1K;V"+F&C$K-SJ=4] M4ZI=PJE8!6K4_K:#6K5B(L_3"6>3)]ZMUXQY/GOW05!'Y="?'>H'^"6X\B*Z M+\<*F.ZTS1I>$6X*EA8X:EQ]1>].]Q#J>W=8ZJM];5G-+0>PU;[9$$0` M_L`BYMS(#QYA-EF(26`5?FD;=^`HRU8-X(*S+.,1EWP0!@O*R!_8M<(MUZAS M>.7%!A>^I2+,DHO,IF4'$+-2`+C0+L6UY=HRM>@63+:KJL7H+>A/30Q M=1=A200%%\3E.'T(`WE36%XBM\4EW:2+X&1$[@.V!@.V5\[YP^QA)=K*X2J) MU30]MQ2F:;CI([2W%Z%-D(?Y&#]A/\1?*74-9;9*T@X84+6(X&*MS97R[\3% M0\(=C_*0X0?_*Z9SL787Q!DPC!(QKH4:KL2J9X+WRY`'=(D9'P0!(X^A6+]3 M>DT9)G/_4E9Y,7V!0+UC=F!NU*QT<(%B+(IN/KS^N@/0;44!&-?QX&$6V9H) M]?0!0Y:J`SK/"08N9OO**.X?^/+X&6?2R@YZ^ M`U`8A+4+PYKTZ[#G;3G5>719HE8A*)Q)&9=N1SIPSMQ7[`MQO('O#MRE4*04 M)2!/V(Q'4:ON`%0H/SC/2$0)B&T.QK^CN=9#RI%U!Y.\A!4Z3OD4QXQXOXWI M&GF*`N7L[^"K<$<6<%[/$*\8=DB4IY%K;DE90/Z(_JN9QZ86\/&PDKM"9TD] MNV7*+/0DK]=8.<5W".#K5245.-=&.L.8\X@?A>*U9/#5KY=0#<+?`3G^M@Y_ MAV!0R*C&X2,`'&Y\AR[QK0@6BY!(478IZ$H+"&\YR".6#8?RD0W+8-C``;WRQ*"@8O$">.F%Q#XLGS M/=T1:D&K#@!3*+AF+SFK+I3^CLE\(<8:/(D5.L=%M5U630!KWDYDC=IW]_"^ MN*ORXB[Y*O&U1Y\KK^W:=@R@M&O+3%_9]?8JN\1V*P$>,?I$Q`RZ6'_C\H7! MUWAZX`3D:7,7T!RF[M$18--[B'K`Q52;N@"#DY@B:!63_2?C;EXT$1<<%@/W M?T,>1*95OB$D=CF'1(^F;YW>*:UF1=8RU!N8'_5``"Z$CV)?^TF74JJ(8W.NT[)Q]T"SU0JX1*B:7UWLI2;N'EPZ MJ<'5'46W$A\BAN0'!@JJ3=7$'81'(S6XZFPAD;R_@H=X\W?*58K?.ROP&$MT MT#T8RV@'7!%4GOGDDU'ZVU[F-JT"6'ZFFI',*`.K:8S)FZAQ+J`I?LL%?!P>OX+6!=1EW@UK6& M^6OB(]^IP':;.NJN[3:J!]S^++AW,':Y?`XKY3^NA_C1\`%M?1.(:]9BPN[4 MI1E4`LXBI]F=+"@+II@M+>'+TK\Q[':4`9C;`Z>G?`'`&98"S MF?82'[P?O@5HRZ@+7,)82 MCB`Z$'.4L;68CL;O%EJU[2R&.26`2_LGEYQ>JT.2.,IW%?9D^PIL08!R<+<= M@?PPU55X9*"^-YI8CQL_=50A7;DH4<*)HEK0NEFK"%4U;9/;IG:*JC!4*<;+ MB4[TYPQ',U'>-]XYDMC])-\>';Q9#&V4!RY^F82KU>;6+_(2Y=SX,\J6FQ?< M"KZ<;=FZ`Y;56A'@3N*2!T[D5W.U9ZHIDG;!*#??5`^Y;.0$E\+9%+E.T0OF MDD/]1QL4A-V%)"^SG8GK7TC8^X6$U&<1V!SY\'1O7Y>FQ]N"JW7;6BQ>WPC2IP-PZHP`+DNVQ% MH7DV&I^9P7K*D,^%-T(.^,J;L<_6YNH.'PU;T6V06JV&M3VW9%DUW#2J[>VW MK%)N]N&J5G?;BI[5K#3KE86/'/$A9VZ>JK&#.=Z;,?WVN6B4:T.+B\?OMU/ M;^Z_CAYN;RYOKB;5.;J&OEO1M(&?1G4NO_`EOZ3@..$RC.Q7^L&'A]DU><'N MYK).%+]6`$7Y(5M!J#R;C0(W7>!KZGGT.3F+X]\QP_+@7#Z:XSD1RX+H1GZ; MT.?$V1!5!>)AP[<"Z&$L-VL))^%RB=CZ8?;Z(`1EZ^^("; M$/$D0]6OVH*16EZN!=RUNT[CJC.N#"MJ6X\VH$8=S:<-H!@-F\IGS@F7):" M#G$@9M/>$!5UVR`&1:STCS;;LGK;F4>;14A!.0GX)HZ0A2/&Z\M:\@[40.A% MK;T*:>#[(?*2(_ZQX%91::0@`JQ5G5C]`7G-^]#KR<_60*>WS`.W(\O>&]R5 M+#GJ-Z>WMSG%[TR(D"MZES(4=F9"9\$S8CCZ2KVV5+J@&6"S:B\ZN!*QZY`) M1OH.X&,0%EP5[!UR%D(6MDY?W#W7J9*QT\/F:\M-E(#Q,`IH=]&BCY/WCI-S!7VU MQ,LE1VDP;B[)61\_O[WX.9X"LI!$QVR&!+`M58MD%P/W1G3_[Y4.1C?3P>UD M^G#Y[^EX<#\97$YO'NXG!UK-HFZ;_%9I`2N]781D%S5>Y/CJ^FH\OAI&*&IN M]1H(`=L]DWCU7Y[G/(P_X22\AA&+W\:/2BE45^5-Y*WHN'ARO%YU-XK:JJ9' MB*D>?+%NUF'-;T6O,*FJ1N#RX>Y.F/T"`Z*B`FX]E(+5KLXLJI=TN:2^G=U( MT[8V=0VS03UO,Q(V;"Y28UO;"E6;3FJ[01/Q*Y4W@<=DOLB%4[E?0]9E5H[: MCT2TT$WIO]`2\]$%7;L#WYV2)0T6ZZ]#\J)^0VFO?B`#L:=F[,Y8^JAW[Z@W M5;^M*O0_,/BU[+W!&-B2HSX4AA\*R^^6R0K>7ZF'`OGJVOI.3)UEN%085#TM M<)?6(&3MKI=B;/1BK^"8MGL*3H2LW$YIO0\>MU<3YW03TA M"]\\"'3H&>+!`S=YRG@PLWWP9X:R,3Q7<9IREPO2/VZ M5=_-.'&VEPK2TM2>Q_F.Y?D'=@=/8O>>XZL789`)QR-&'*Q5J44C^(JVD;SV M+,\.$V,L.8WRSWYT5!(B3P:;MD@4M.\<*$7ZJ#UY-)C/&9X+4YE]C$J+AYD> MOOX+Y*T]D10Y_C>^(Q@D3UA>Q=#;=1TI?"WKI01W'ZF#Y=[Q0?(VK-1QG*,# MG-DQ"`?.08ZF]U<9W&-W&#(9V$>?G-OP'OWYB/CF1G>4#2"Y0H>#NNH"C'NI M"-R5ZHTAB\HW%%*DGAI+O"O=MVOVZ*@K*)=43^TNS242&X^70R+S*\"ZS8K0 MUP#5G->.9NG%KBFJY0[A/D,UF+O>A[T^6PW)O3359<:&>$I'(7,6`N6-D=;6 M7^KH@5O.`F%K3S>EBCN_DV`Q\*]X0);RBOXU(MJ:;9M6P!5O)7CMZ:8==R/* M=0F?)()?H7WH0S*TZ@4"!X+47+>4K*!]FAI*P#!EP!:M% M:ZQN*?W76>R>L)PRV9B3&C\CZE,Z(D!*Y7G7AJO7ZL MT@*D-N"K'_(`AYZ?G47Q4I0`&PK64]Z1=(?N$/L=!SIO\-`>@2-UL,+4D'[J M)+P8=:#_W&*E!*[H'=[TMA6]+,ZZ;^L)>A@"XM=P5I_;L\'THV=57 M;JAI@&M1(12$LD(9!>I"W%+-@:N_G"HJS`M76,R4\U@&\NK,/!+\8KTE&:&U M_-'@6>PH^9W$5/!J*I%J8'3`3I?Q$63F:/>$:R]D8[SBSE.BQ,DHM\^I'!SQC&@>B M]H,"RXTOOL>^OQ>0=``8W'W44?N!@VD7V$R@?;?0*5*&W:E%GZ@Y M+,6]^YG@R.IEKBU4?IO]X'&;3H4?PFN?TNGOLAM-17^7O;_+#AR:_BY[?Y>] MO\O>MJ+[N^SP0>GOLO=WV?N[[/]O[K)KUF`2)ZK6V^OO@"=K4D+4OJ=OXNN- M(Q'?E[[`,\KP$#N1$._/)=K:DXOBEL"5;:V`VO?W>'2%JI/?`%?EJP`-O#FL MO^#3F3L\35[326YTJQ;R]G?`%982HO:+-:\V6*6QU"^!JRPMAMV)6)_4WSNI M/\;1Q[!'B`7KJ;"%7`0A4?(Z^3;N@L!X[#0N'LA\$W?X6(RI7440+7KU;`^E-@SH^0,.Q>8B:LOC]BU`VC_>". M>BZ_%G(469.R/0"'HK1":H\$[FF`+V0)3G(#>"0V>=]7?IU!3PM<[08A[2*' MW@NNV@N.+X'Q$5I+*>IQA36#M.\/:QCKG6+X3G&\F^X@6.P7V[4#;D@MA>\O M=M9L5+]B.A=$"^*DKC96>R.^S!`-&M0R;/7F%)(YK8AEY&$^QD_8#_$]WKU" MHZ,";%:U@M5__1,'D3_LH\T8\>"JNPE:4L"*-8L([VWGS6XRQBN9__#GF3OK M$=>ZN5[<$#!*9<2WRU?T;L7^UQ#"1XY_A+*T\TD6=*8S^(?>-+#HNLG+!!;L M].X#)/?!5,#[,)-54\A?I][IFH2,R7G"L'NQOJ!K54*W3&O`-K2T(FIW+80S M@]AZ2N5PTP6CX7QQ)2P%C:YIRX<[K";*#)-^[3"W28]E%,[4<@T>21 M=Z;$QLLOU@_2@J;O47WST4S0$1GB;WC7+:9RG4`':P^UU'ZFDCV6O,`C1,2Z MWDZ;#2-CS+'0Q4)0%YP6VO4!'*D]E%+[RTO,>RP)KCY5^BM!=G[_VFUT'YA`+^VTP@5C(2Y\]['+V4,0>/$1"0U38C1VL1QYR M]DHJ6G<*W/16H;;:4Y"O'_RZ$^I;ALNX="79XA7`%;4`CDJAP+6G$?,^5+SQ MOLX!*R\RUPBXXFW$KCTM*"NOY.:3#=,E-ZILDIX8N*Y-8M:>T9.6:W*!?:$6 MAR#OX=G'C"_(:H29O(^/YEAE$X?885B^<"E#O;]_G%(%(%7U#!R]RA18?^)/ MQ@WE6;WQ4ZQ^^*#$NK*N@8-=G0IKSR?&7$Q2CT;''$6>SG?B>1/W7VW3)H/CG\H]'88_%3_X/4$L#!!0````(`%9P=4&3JL2+:#L` M`(BX`@`5`!P`='-O:2TR,#$R,#8S,%]L86(N>&UL550)``-4):U05"6M4'5X M"P`!!"4.```$.0$``.5]>W/DN)'GW[L1^QUPWO5-3T2KN^7>67O&]FY4Z]&6 MW=W22M73YW!L."@2I<(.BZPA69)J+NZ['Q(`J\@B08!,D(6^B[!G-!*0F4C\ M$L0C'W_XC^=53!YIEK,T^>,WIZ_>?$-H$J812Q[^^`W+TY/?_>Z[[T].O_F/ M?_^G?_S#_S@Y(9]H>A8'V28G)X1=LIB2NPTK:$F#_.NKW[P]/27DY`1ZQ"SY MZ0?XQWV04\)Y)?D??[4LBO4/KU\_/3V]>K[/XE=I]O#Z-V_>O'U=-OS5/_WC M/_R#:/S#<\YJ'9[>ELU/7_^OCQ_NPB5=!2M68/Q3;-?WCKW*V6L?T5^IWRXPNVLG%6?8:^K].Z$-0T`C4 M^CVH]?3?0*W_K'[](;BG\:$M/Q\>Z65[/L:+=GI]50RWM",I=%%,DS8@]X3 M2WU7!%F!D+O2?S+)YWR=H8-DKO2<3MJT".)ATNY[2FGE4@J_^,!_J@E-GPN: M1#0JQ08Z'78LV(B5`@B7E-.P2O.;&-;.-/NFJHEOBCQE)^4Z)L;)E[V_7^1A MEC[-'C)*5S0ISM(D9WF17R]F]WF1!6%1$A'2__$;NSZOJ$!QYIX&D!_^\'HO MV.%09EE(TBRBF?KD5D<69&'Y"_ZC03[5XG68\G5Y79R4HHKNBRQ=V6J[%"'M MH\/7??%3_0XM@OQ>#&23GSP$P1J^CZ>O:5SDY6\`::RIAG) M@4<7+(XQCB@--[`PB"UVVW@V!>P7X2A!\B(-?R*IX$R"IR"+<@(_Q7']3VM. M(2>\$TEA`\UMXN<-RVA$6+)(LU4@&]&L"%@"=(NTI,82PGN0<,/IK=@OO$O& MA:'>&).MYJLKL#V6AYO76;I:IHB%L3G)1F'PB3/BV".T9$46G!=Y!&:NC,_QN$PVZ&1\4YM)#QU5K:4W M)A%&`\?@F$9MEE'^"0?_`P8HC"M:SB`\0#833K\$&5^N^<[91MC)\7@PX!KH M6J=[PKTPP/TJSS811#"[Z@'"X\ZMI7$?,$8 M7AV-K3AR,H>OC%\H>UCR)7?V2+/@@=[2E=RI\=.C.#-N@GA.L]5'NKJG6"7#$\61[%B2"D\"3'V!YF`]5==(Q)P.!Z+$NA9GM3^C8-3& M"(,22<\G`+2-L#J_>EUBCB5Y,4NB64$X7U)A3*J<2;H@@C>1S'V"%T)G]>T_=#E%]P;I^J(?; M-]WT8Y;3)-_$!?_H7E)ZB+J6!LA%L(T9;GTK*9(%[?XX3B.HZ3P[`SE)R#^, M#W#-DF8DW`\AI]DC"VE.(K$W%_>6:[%!]^JVLET[]257#YKI5M.+I&#%]@N+ MZ#G+0V[QFXQ>)^]I^I`%ZR4+9QD-RG>)2SZZBV>^;"1!?":NBOD*,BN*C-UO MQ*/K99KQW6IREF[XWI0U3&4:GN@U?Q*58#\C+!%,P8+XJ:=\_?+%`B95Y>$' M8$)X36>GE?M9>6*H/!!IS*RS"]I*;`1R\+@@&+R4;W@Y2?<\?(.ZC3X.D6H_ M0],![0,+[EG,"OWR76V!AE$+.PQJA.,/B?=$76ZS!\I:[)R1L`(?`]HVW09QL2U9M:#=U`/I`&TE#L[]N70C M6DD>))-,=J!QA7V'@S$9`&Y0T_MU6RFF[M7=`W7#S>%CFA3+N"0+=Q1_WL1; MWNSMYX3K9[ZD'\]O9RU68=D191S]A,/8B.)4@H?`U!%@]I(`.[(!?N("&#BZ MLA?WXS.9C;MQ3FU"_715M:0A2!UN4%=B%%S[EY3.TW?T)F#1NRUGU+X M'QUC]$=Q$1NDP88C&0+MB!LY6EQ5GR/5VUKK?9RN*>XVSB#`.(^MG?X& M4XMOLI.2IMQ<4O7DJ2*^P$B"W:.GB`N+8W"\@*=/$I9OGR),3+Q7"")/2Q8N MQ4>1RKMKCC+VR)MY%XMIH^3:S9X52H<;S.PQ8)Q73$];3*3R1Y11-)E@S&!' MS1GJA\FWKN5\\%A0HY.3E9Q36TESK%6[T$%SN"6\A_ORUE"P\B\H&S@@CS$` M1PE-R"]1L M>SH(@+<6#Q\+7SZY/4AF_"`+W$C)CKP]%==+IVXCXYT.T!@D[VR@QPEFMU96 M,ZZ])UJGC*GD!PR8M(N?-WQ3"!<%:0*7X[-GIO,HZN[C(%+20B34$;QD\))( M%F3/@_P-N/R7+^#KI9-F9*3U/"'>`I_7-.2@_C&-N=W'G,_'X!D>6]I>`;5M M<>]_)A%P$;22.'G<42EOO"U"Z1M]TG=3I>T+7\B!?SI((_@7K M^F,0PY)^D\8LW,[I<_&.\_Y)@Q>[OGAG\SXBXM)]Y$LBZ?H&IUXZ:'B:]Y^G M8P-P'[PQ#(1M_4<"8H>H&##>\L\K_U;"%U+@TG'4Z"ACZ0PJ/1C0UV%A'0JQ MLS(C$*>SM$^T`.%NLO211?SPSOZZ.C3/H>"=SCZODA"" M$^$J1_S[*KGFIZ``@H3/@C7CTZK)US&``-H^^PN+VIDM(2.E>(-,2S8D$!DI M1,K+2@B5-]F#AVOJ$+I#YW4ZZ,ZBB,G74G`2NDJ46!J]+\O;-=R__];O?O7S[]JU8Y*K_K4*I1+K? M2K+@H"!_WB24-Q6O'K\1F8T:;R$O"6<%UU/LD<;^'74U$]$1/STP0ZFCM2\, M,SX7E3C8LTV6\;V_;O73ML>O?R914"N@)"XN;I.<5G--AY*+SY',1M4TUD6[ M:3I*;+Z2Q+`=[.C@,G)?(PQJW6SBR;MMG5D#'9'RG?,Q':2$FZA,[/:)C[AS MV6IOBP92IP@H/PBQ,B5I6T"O^H_&%?]_0 MW;-^@[F3MWSR-Z!+!&%_G^\;8]>^V6LT/_RA'ES([][1A"Y8R(+X^BFA6;YD MZYO=V^_U0L6)5#9JY0DV@IBOW_YNGK8\Z[NBC'("<#P\#"9!E/\9K-/\]SFY MWTE$TE*DZG-[NMC%*(75^@51*9ATWO[M[WY-BM25P\$1=&5R3QBF,U_L?`2E M5ET31C$P1+17):GZSL=8Q(%"`%H"A]0;/KEW\^NSO_SI^L/YQ>W=Q7]^OIK_ MM2-[,9XF+A;,U9!PW[)]=2!^6"O%4`'%.T$(2$*JHA`IBS<[;J<:K05-N44) MWNL-W@I,G+UA"ML#AVS)9A&OO-]PH MC+DN$*,YEMN:7B-M?FLF="'"\<75I4IYN*A\8>;IGX,5S6_@^S1+HCE;I<5R M^_Z;.24#>?^* M"#&B/K0-CD/ZXNI@\5!^CSUJX/MX>1C#JFT!;"<_<9QQC/11I/,/6-,A_JQ,IQV'`XWDKT'''BB6!5[-G9!F8BM0"[]&"N5GKTZ M8=CJHHJ4[.+;#B9XFN3#VVL$GB<1_SM;[DB^W4'4J MGT%Y6.46M9W#V8!51DVO.\HZ=@KU23JXDQ-[O9@O:>L-3ULYY:*HFDBCLLRDCY&DT M53^MM'B>]9^]2?W(TQ6=!\]V6-0V=^$CWBD(ZN`M:!-.W%N4F8;?XN9M,1%' MCQ>Z2AXA\GMXO%`;@;'BA3J$=1(OM,EE#`TK^4P;*X0A0GU*$G MRS@A(V@G/-T'<0`9^?@V_4OPH+6^1C/\V5G#&+5K4#1?DB<@^5+72Y:P@GY@CP#C@NN>P?99^A!2G;>GH1,:2G9"88`E MDRN(U>HAHRI!3T(+W^!DIXE#SI.SE(M>I@);(&],DC%M;\(RC-0OBJR2BSW^AVX.)U;=S4%M0PQKE M>27S,RO*1)`FG+8O&#$.OEE'57>;?T=AH945:ITH M"1*@Z-/,MPZU.N,=:AW^R*#'007C#=KD]C+2X*=^@!FF MP.HC#`;CPTU3U$2NEAG\O)ZGG])'$<(.K0U5T/KU1QGF(%$Q=BGK1=<*2Y+- M&GP>2ZXJ['^8;=3]N*(V)S-?4Y_WD#2WT?@.\^" M)(?;7WB*[0B_L>F&B[#I(1CJ>G+'ATA&I,K)*P>V/BJI1<'TGJP)K[KI`^#] MEJ[3#"[?KY)%FJW4PZLHRZ*[_#9WQ%^'6PN'?6K:U>\1BX`OH.NOA\85><]9 M0KC>REJM*JG'NTWQ.8'[JI:U2]<2YVC;S1[E7ZN*[`8J/0AN_3!K8DI^-L=#*=)='YALY3%1AT$V3%X9YT``%<)HQ!PB*C$*?\AH0^$(5GIZKX&SLRP9HXW7F#+#^;@GSZ`Q2'>U=!H(9!_[1K37!>98 M]XU.OM(B0OA>!&.&%=J`/8Z`?!/S4Y8_WVX[A=A=\1T+4>=T'RVOP5&M"1H] M;0PQF*G2\PT8;6,]A(->NQ-G5(?4W$&^E/&RFS1V0>T? M;07"`*?D00+)9)=V;,_&U?;0Y7!LZF27(TKDDUVZV(TM(YN$%;FNFD^Q#/BF M,:,R`E=4G)+W\O!'_FUGH=Q2LG@#FKNXN?.J7K:MGJN;QWY`GC067MK\AS3O M"'>OM'$1T=YDB?4DBCDMQW'IPX0TAIZ;)#U2='ESM"T!Y#H8'*6,FK0AF>10 M@UQ=:Y=%U=K$0,8H@"_^G:RMIE94N9#Z!AN#%CH*F^EG8\*E+RUH?A-LP>FA MS`]=TD8_OX&;'QP09_=736."& M3N=8D7F*V27+^08)4I9?)-$Y%^L`)9U-4?%Z)@%0ZYP*&9?$"5`G%U#5D=/W M!5PV.JC&]-G-@K,35,V?2[IR51RYS,M)0+(25KX$E>)`W/ MPF]'.GFY&ZSI&.9ZT$<^2MDIKN-)Z>OGDCDCJ^SX*D M`)NO['8N`Y9]#+*?:*%+&8^EB"R0XF0XJ)?8.FPI"`&;#B[&K\ODH`\@RDD$ M;HVUA.T++@Y9"7G<)J6?4"_FNBP.]>/598HC)==+O3@T)F3]K\8KSCZ9>M51 MU53RJR\9?)6O@8+CW_9DHM4JYVIJ?5+S?O;F$AZKMD;U+M2$(\+)6/[394;I M+;<0?:6NME:X,#(]6U0(&2=[LN!T20:KHN.*7$BA;6[8E<0DVPV$)07EE#BN]2!*7J'S:A/\/[N33IS+1@U??@0YMUN+/3-"; M]%T\S;E&+>M,:YN[>"_O%`1C0IIJTR2D6<$6+`04\OU')$7P!5"VFFEY:;>8 M(S?!4*+*@,K&FK^G*=^^K9 M%R3B%:>+;1HZ[?Y4ZW%:@N=8=77&*Y8#J%_L4%$U,MZ&>P7>!+:3S3)Z$.0 MB:?U>@6-ZJ/[Q"5U1JZ3XU8YOJP6;I3;MT3.5'5O=CS3;/LER.`D7G6!L"I_ M8TO#416@H3](BTAB6XX M-LI3&;<4UA6);MT5A<:^`J*V^Q5>P@>KRHT(=CXAKZ]JJH`;-GD3>]Q*AQO- MEJC:PHT7;9T=UB=+I@9G@J8OJ.D8;JM?;)MZI\/`!Q;%J?G5Q1V:?SLG=GV:W%W^Z_G!^<7LG MDYN2\XO+J[.KN6^@ZZNE0T0.F\$,]*+:Q,-&-4?\3GG:TQ0!RR1?=-4L914`% M,2GBI;^4)$\$?5]08:6$JK^4Y42,6Q7ADL4T.PL*^L`/'"UH:6OEH")"*UN4 M#X6LAR#HDI*P3]#H&'>S%$*'OA%W$2'_3F8T.J-9$;#D)DNCC4@(^Y%_1O-+ M+NG,$-[>EP+N'F*8N*A;",52//!PGF2]8TI6P)7`?))@G`#W$0=L>FYU/_#) MKV&&*:]V"8-!-RKI!!67LI>4?DZ"%23-_85&.F>YSN;8A!)&09#I(R1]LJ"4 M;/8NG4XBDW;$.AU' M1A?/UE>R6\QC^3FV9E76S/:QLX;,X/+]0:0X>;?=-U'%&F9/01:I;+&5^_DN MCVS=V^Y$W$?*:S*:FD8-AVAY!O4F-.!(^K;+PS(R+BMXP59/C32Z MFU^?_46]7%S\Y^>K^5\['IL=$$57ZW,S*&1T?+=C!-D)0JJ2$"F*+UAUJ]## MXG8N88*():"<'@LYK[,@7W8@6],0%U'0R1P55+"C3("T3XCJ'G3-C=Y"Y5-F M8DA2_L4)9*FD2@8JS89$W]Y!E@6#*/@'QZI;!'FA\HDY"45V.@B+-\G^(SE. M9@B#-IIY(*S@-9U]E&72#.X>C69H:]`QQJV?@J8WH7NFL1ZBHUO+$Y[>BJ`0 MA]!Y2[('32/\N:V5*2[H4U$D?Q,T_\LW7+0/N7&6Z%`T(EX(2E8NH$"3.JLL M5.WB2O3R/#UGSVEBJAX\D!(N8@@G/NI3JUA7LQ)*MVK.OAX?7Z1$B#!6<>'Q ME6`,)1U5&9.'4^$46HNGH]2FVQ<(1Q%!&CA\$QL[WW$G"V9.LY$\6:4;62@*`N^Y=WY6=3Z,'DZF/ MJX^I31VOTZJUN[*0X0:O"@=4'Y?GJQ)P&6Z.TMAG3[P9B5/*(11,B4QYTI>\'5^"XS'RGCG<+R]4]ZAQWWDI'>6 MNNO(>M<+V8A(25E).&/\N_GP,8UH_(45RW,&&0B2Z*^,QFV>3#:]>*<2*18D2WP1;7(S[Z(1'BV MB@S7Y>'RAK>D649EZ%:+K70VQWFV6@B"\FR5E1[VMPOKDH6\6'#FVNIH',8K M$_'`L:]LD:0)9T/Y0@N9)BJ#DP-^`8>K^HA)I7W.6<9;$A3B0J7,QR73-HK4 M[MFW9:T,OF<4-%5@'WS"PG@#B6YV&\E#YB+UUQ,4`)$<%UXY9]J@JN8=;&VGF.=SOM$NXNW5:AV+FV6@S^8N)>CR0[4N%'=@R=I?8;9U!&S^6D8-Q8)`=RSO(P3KF=4G%W MTSUR:6I+OB?FYDR3` M7YQ["XL.W,Y9>7Q;L&=QUO(Q:4A_Q306MX'3.&E=15@*5'[6Z-WV,]^>7B57 MR2/-80NJ[KQA(IJ7599I&W4O!WOE&>+0&PG.M7,551=/.`+Q>!)#O!4.$ MQ3T9R')*2*5%\BHN/?M#\26OF-@4"_B M*/#+R8[?UP`\O78L,&>:P7%*XGZD\'[=@C.+3J,5OZT+Y<(#\$2Q(;LJD8*1 M3YBR5XAM<=>V:9IN;_8Q")M?T/DMS7?;CC@[HO9E9&&2$11D?\-&G M^`#[T1_NR&SG8CHX76ZRA,$S,Y?HDCW#3WD7FO3MT6`RBH*Z0UDL(/?4CH?P M3?+V&561M>^*R#?83S\U+=+4X;.%M<=B>JJDE!QPR M=0YK%-[MRFI5:LO=ED6UQ/&VF>^L3^U"'`.W-0V=#!9U0?C_9&&S\73=61[1 M(;*F](K@@CPP.)J+YUM[YR.;G@[\)JS%=+8GL5HE(<@6?T<<@!MW+0A-720A^\/2A:$)H0&A(9^;+6#I?IOH,Z!AV-D0IAP8W'))3YJQ:*R<=2*Z19L6<9JMS M>J]/7J5K[R"+E4$4W/5N2=PWI!F'W5&F='\K%[`_0!$ M'1W0*#(+@_4*(*KX/(GW9=]\PYA9*8<@LYVB":O6A6&Z@?53OH=U(TS3 M&%_5KE,(G&.HI,Q!M?4Q77/WR!LEY2ST/WK*"63"B>G231PGV<11,DT<-\_$ M5YMD`IMBPFF"B=H#7YN!'31P4AJGS@QU)UU[?G46C#I<4-M*.18"3WY?WCKH MMIHY;5C`YCBQO,D>ZU9ZW!MF1;V:--^KIY)^=[XN[V_;(2&NB1M58,XW&=PR M+ZD\=G>@I%]_%'`&B8IRW!0/#X(CJ;(DDB>!UPS)U2N(#=)3%76(.45XUK'\ MI\N,TJNDH!P(Q2T_0UTO6A"G:8CSF>MDCKI!X91/%IPT88HVR2#8/ETX2^>` MEMWT)=6/@:SY9\HCYP:S/FKN?!9(0G]L?^2$^48SB3ZEZC=?.+.NZHB6'5U\ MA"V%<_%!?A2LA$],DNY>UQ*:![F*/]$`4I.O>8B])0KNS2$TLOC&EF'HD55'9^^18 M2QJ+S#5!0JBLX0ZY`S;R#0M2V(E336ZSEN&HA'(C M259D=TG=&0";5`LK`` M$L"`)XO(&D:XCJ*7Y'[#8MB\86-4_"75M% MG-,#RH7(V1.S%9.CXNJ0?H@5VG5""^6\)WF&?(NWX=^_"GVA\W11/'&%>96D MQX#C@W38YF7`31S(WB-`%R=LT\-9S$>'..-$>OB$$$M%Z((ZC!,SJ:.4V)1" M4A+-)XR7A>^B<*X*8M#L99P^5=S^ M3,&SEKWQD;3]Q$3=SE18B6*%!)B1"C=O;F4&:J<1;#MD%B=->%5SSKE*9F&8 M;6CT8?_$KUW)++JZ2(IE+:`3M[,7D>+T+6QV`\F,T#(P=[_E^PJ<(?HHKR7' M5L_I/29J;S(*GZUSE?=6113SC:1P8Y%>H-8XMB(V`K+[#`*#]1 M%IJR3.ME/<\3.EM6KFFXL<15Z8N6MWE+Y M!D<+733<+&WG9CJ`B4A8;@@+IEL4JRW0`&IAAP&,(`?WH0NW2;H&BMD9`V$K MZS&PW#+>0^QJ83"A3[#892CO4L.GO+TMWB.X2P34![FVN_3N!J!SW`UW8+/N MIP:-%5I'Y]^NEH-!8,$>@X22-)&T"1`G@KHOZ+!00`D1ZPE`/'FE MVR`NM@<)ULP57NWZX9Z_^HB&>@23C/;7&BKL9,12K\['9O3VEJ699;&M%N/I;N^@:)Y!%-0UN*I@I)R@P.&BK-`M*ZBY M+9OG8"0FTT"-:&J#L-)*L^Z;%=:&&\#LX0$RNQ3@=)FQ)&?ACT&\T2F7@?Y]LHK MMUJCSFO!87;`G=`S+ES2:!/3Z\4=?0!!;JFH])P\5'RCWFW5'TU9YH92PWO. MX8:!L>MY-;$H$;D%B7K3SZQ(`PE[')M0`X.=9Q5J5I%=,Z.?8SII0^G0A'/K$U-0[3." MRW6+2"-X5C/%Q9O'MUX*,3M(:R=IPD+<6;K@QW7^F0KB2ZH%6*,9OJBVAC$& M1A_H0Q"+JXIUA3I94/]6,MWP&P6R.Q4_919@#M6-%A^[/SO(\5MGA#KLB^*F MF:+H\J,]1$J+.JPVHAXG`W%]N,V$PVW3/^4JIMYKQ+;[)LBNL[L"'!K$<]T- MS<0F7;NV675VL.+U$1*79Z-\OA*L7OKW?C5,)\W%L?_,C>4\>"$NQ+_0./Y+ MDCXE=_P+GR9\:PE/BX>/_>;V*$="*U$P^)(,"'`X^0E8D)('D4Q\@9FU-JJ^ MA3UF9FQ/U#DGVX*=VI^=^)Q6&3EQ-`6"/J&@;:!M#J5-E3K*@ENN1L9LN/N& M[K+B-IBCK+],-KL&TI`6S[&/&UYTZWRY?89PU,RY#35H,^AJ\(-,F\H/K_#D M^TAON"*U'FS:IOADJ!T"H-[YA7_/CC@!ZCZ!P#3V1BY3H_8G?*<">=[#(P&- M9$95F4Y5PE/\\_[PWESW,C6$%/XM"C$`7(BB8.D+#EVHH_%^@IY0S'=9YL4[ M9W`'G$3MG^3#-LBOL88E[D.L\OM%)55W7V"$N#8>230OV"JHRB[3[+X(RC2[ M4*@AE85@Q:=9?JJ_!4?T>RIS;;V@#06(OR_3F!M&7G;?)/R_XJTHKZD\/!\A M]>"RFB&19BN1[I`D::(2FTJV::9\X$GP%&018=)7M$S)*-,F0L+'U3I.M]2O M)(+:>:SO'CJA/MS.5*W$?:G$WL6.^U)`V>A`<5$7ULW:F%]'%>2!NJK"#C6W MPT&Y=W`RIY0SMT+VX9$F0A"R(Q3VE@+U]56#G;-`;Y+$&C@%]52;Q%E@5!"I<,.<% MB(^IAD[O+0M=^+(:C*W+PP/(N,8TX2&;QISF@PKIU1V?ZXWP!^-6IJA[&$G1 M-S2V#[1QF.U0[X0ELM.\N%Z\AU3R=_P$I('"82M\H>MVMJ@80DYRGQ:?FZ9W M5R&:03?J.WTIDK%;*);7GV[A-3P<(LA8/ARI@X_V3>`]M-.'6<[:F]!\J M`I;0Z"+(H/AD/MO7E3BG"Q9J4\E9='3@`2'ZY8I33[2UBR%O)`4`1(Y"[<>TK=F%YAIM/1]"'> MKO18/A>0YN5Q]E3L)/.=G-$P?$O8+>*;( M\NFB^*=P<")!QG+XE:BA`84HB^V)<'42Y2EW*A'1]0_RN<$K\[!2KKG$^I$O MRVOW$_L*"_SGF+:46BA+;()395&MLZF[4'!%'G\7X7B@J*P:E6*RYQZ7Z7"M ML\9]PBCHF/`](5@SV''](DT:2NK>J1JZHN2#[C'!U`W_DF`I&/(90181_E.0 M14#9-_3:*J'Q>M!K>HZ;[DCM_&?@DEE-M0)O'?(5/\\W*Y7>=VCJ(P234=(@ MX0>-NH.NI0T3CTHY^4(S2B"%!MP3G05Q*%8U`FT/\@`[=[HYGH9Z9%?KKR;? M5I-QU&R33LF5^4V:3*/]0WV3QBS/=OZ=YP2P&ZDJ./21LP4)XZMNS(B4O M7Z!CJ8E:[0;;&3EF:K?S#9VGE>([7,IN3Y5>)$9(_&86&(-&335Y&6E7*\?T M=96/-VO-G"S.=IXG#'LIDR:6]:0TF&VVPP>>Z%CCO:SV>3#+JF!.0T4P@EMX M6_63_B@!'CH--"(TNF%S%/=IZ04RVQ3+-(.+,MU-9T%KFU4 M87T!T)B_7=KTF1.G-2 M/(*ZC!Z,P]3FB[&/H=::D^,H=C9\2?F4%O0=#;+\*BDHAQLL7$&2;%8M:X2^ M+Q!7[PN>WF-%M=)8+TQ^"9K5J7Z8[&3K+=Z87`0/JBEK3M!4LD M&KXE*\G#=1(\W"C,J6B'C^98Z>3T&FG+*V="UW"P5RJ/54N3E97).I[K;'NB MS*"G>*BD1Y5B=*U5VKS*'M=3,550#9JXX0C[,84+Z%OVL"S:]@*U/Z.PTL8( M`PA)CV2"H*L5<:B0IC706MBI@=HVX"H:]?,_''*R&'T9;MHH<2&\!%N@:-4- M!=$^@J$>@66&U7P7H+S>E3-1L[G#6_=TD(^\C*FJ/+1B0.?^HYE`.,DW<^V^/,9Y.[[B60?EB M7X.5TII7O3\@)PR\BP5QM2!8!K[V[(P/FNLE)#XDMB7^$Q*,+Q8LI/[<0$?[\LTJWJJZQ"I;8\'H4D45"AFA9YW^#(-O`$INTF8 M#D5E%K0RZQYDV@UG273.XDVA]1HR]4(CRE(L#*X$2>'4$4FBA']WUU6T.WV9SXUC2@H5!O-\,Z&[(AM-QL\L=(CK*&:G* MP[O/[6"5M.X-AT_GE/'E^9);$?P+]K#\)`Q9,&;%69!E4,>E[0ZD7U\'D>8] M1,0E\LF78CT-X0>ZY^7R+.9\-#+7R5T19(7N-"8'5I![^L`26$7%18CH]Q4, M[2*)3`.#HD960SI.DH`>:FEF"NAM8X@$24$<9-MY"BGTYLLLW3PL+T2M)=CO M?6'%T MYTZ<.KF,/')C8LMQ-#!YFJ7A6JPE7\+BWG&E)5GKCS.5;J]]"R_INKNOPV00 M=(2X8\E1)(60/+UZLQVB)&/A)JOI1/@'R.00JCPNI(CH<@G0-\9Y`1B%0#W\ M2^JD0KX3-M-+;EJOOU!X/J41"1YI!JZ^M%Z<^05?DN[Y"DWW8GSKDV&8M53S M7[!$V7#0W[+\I\N,TMN@H'K7K[96*)AWL,7@&\B>+#A=61_4L8L74FB;2J^$Q6O>*/#1+6M0R^)%A&*\59K'D7P=R3VDBRD%!5=X'63P:-OJB5UGU]P5+PG@3<2IU MFH+,$R3BDB5\7Y*,KKD:EN+M#6Y8,KH*N-FQ1!P."@BCV&3;;U_!EBRG)9VL MS/E*0IDPCW=0%8/OMZ+G@F6K,JZE)AHPD=$M+\7/JV`+Q8R#.!9EAI-X2P(B M,IN`KN41K MQ1Y$\G9EQC1T&B^:UUE63&'/OJ"HW["M8W>/F@7S`^-B1'P]M'=.ZNR"QI2- M0*A3TR3I\^\6'R'Z_$W@;JL">1*H3+?^:B/HK42WLH&YZ2T62= MO-BY&!CJ=GZS7L;-_>"KE7; M]L[D#C3'<"++(647:)#%]!,MKA)^)J$?^#9BGL+@^%;CD450(`J2`U\ENY1' M^U$9[&H45@Y=U]PK`.7UMI<+SHU9*1FDG9&.2ORW\+.PQ+42#LYU^[Q:'MOA MF&K7^]R-!;PISVS5F`3+'%^&3@[.;#9"X7(PE5$G7TNR+SN=-`]T]C,U?.O] M,4V*9;Q56S( M(LWXUN>1DI7@+W/BY*4$+PG(,%(]ORG48+H='5D=4Y^)L"JMGIC0)O`]' M6DO7W6X[^$PH/Z8QUU+,BNU'^13;=A.F;>LD#XI6!"=I4!YWU,O'9M<94%#R MVSR2P[%^)9)[K\2#%"U?ORH9X/@A[&G)PB4)Y#Y5N8>P7&0Z#M53X"+>0&J= M@I:5%P/E@.O5$Y=1L6UY5`S@1'S2DF03Q&5BK=MFGE!-(]Q'3LL4];435.LN M%LX6:I3$QA6[I^23+][:T==6<0-*ICO3?\[I]>)"K2NZ=]>#1N@S>SM3U"I? M$O,%"]U#/3QZ=REXPGBXS7U.?]YPZ[MX%!=6IJP.VO;X^#:3*+CGA9(XD=2= MYVQP(7UGCH;&$'S#O5$%C:@[.S!-:`W[DC_-&CE&T[#KC+>37D*BC*:[`I)S M$W(^L&Y[^CKJ.PW33L/4!H!S4L^PD-)(7E,MTZR`Q(CG]+ZCP(.FO0M_L&Y1 M4"D`TBR3U4^%OZ.HW11$CP&??._P9E1$BW.8S:0U$R^I:4QVA6MW];2\G^UQ]OR??O7SSY@W\_VM[2>V,]C;.T5@E;"Z$_[]" M]*[DYUT1%)O#)!FGP>%VJ[V-`[RTL'0`$DF5"++^`:-ES$TT:/4\\D)R6/:MDDM:OYQT M=7*QJ%@(Y6)IJ17U4V%#%5;^(1`19+IKL>@X7F20TSN6LS0O M"*<.5Q";U4;6\3V'0+J0!66TVR5[YK^5.U?7MRYNA]EYX])[K+[87G]=64=. M.8]S*4\_5\F'?1UH.)//0LXS9RT9.ZV[X<)_>PB&B@1.]D?<2BELZ1D6['DY M"PIV/"[3<^AEP#(BSAJE*T!UE"P)-^(DIB)NQ8`S\'Y+P5=N!0&S(LZV[*P: MT)],D9Y'P5DX3K_P'^LQ&+5JV-_Z/>9&E M[G#SFV#;XG!GWV^$*RR-:$XL^D5Y??4M&'>@.($OJ$\.7;UU8[[`ZIRWB;.G MRCPM\"'KSDBN:>PF#ZI6"-Q>K))E7!6))R+4!=@V]LQ(SJGW(;!JYX:;;5HZ76 MQ,$&K,D0M_N2]#QTX6H;:G/7I5/NN$]`M_2!P7J5%)^"U>%\:9LY>.9I9^S@ M86=/F`!E7\!@&GGSY:9+Y\/OB<_5-2-<1@LVE>3#'9F1K+JA[HG["(:!2!)I[E3LE*Q+%I-H;>8X%\*>L>LT".EBO`P(_:0VV4>[]&7:`Y]@VZ6) M[FP%A\B9[IKGE@KOJYL@J^=8M4^AW(<"^I)H@+@8RU'LB.`W:JGWD0;6Z8:G M'YTO5H70SN%]VF"8#O^0?&`A/`#LC@U=B:;U;5&?%*,(J+=+29SLJ?N"&ZNA M5Y=D2_4?)Q*V"EW+8-A&%Z?QL#J!4+OWM*"E`Y=,/"L7IS4P\057?931%1;; M/3W3H>P3+=KRS[9DCC8\0`\@A$;D<.%1OF&0]G@1IT_*]:$M^[AOPH8M:7;]V-$RW*KZG")9$LP@R8<(:S5=LVNUL:^J%7@LMQ<*`7K$0 M%Z-!C8DOZ.FIC,,5K]<*5($5#\XHM4`*KJ`PI5A=LO_WI:A4>/`!.(HO>O3E^_>74$ M(A\%,%J\?P4).O[IIQ_?'9^^^M=___4OO_S7\?'1'4#GH8<3WIZ='1\3$K$<+HCY_9CP>/@"/:5D3>?[^,X_7/)R=?OWY] M_?2`P]<(+TY^>//F[4E!^/U?__+==RGQST\$5@I\?5N0GY[\[^W-O;\$*^\8 M1B3V(C\O2.#/)/W\!OE>S`13-WDDI&#_'1=DQ^RCX],?CM^>OGXB08G1.0PK MS<1+@+TU2&+H>^%K'ZUH;:<_O/G'VS>E0JQ:0WTTBN0:.7WW[MU)^FV9FE87 MQ,_DY=I_/,F^K%%#"3O/6J;(?I=!BU$(IF!^Q'Y_G%YK:N"$D9_``'^^0'ZR M`E%<_!Y%P644PWAS'WYH$>3P(` MF89.V1^,_=/C-Z?YJ/H;_>ASUOP4+"!K-8KOO!6H,2PD*S-81G6$J\QZV"^J MI'^FD+X2]OZ-@O"Q&-#5L@Q?'34P$?JG_M%:I(\A-"_"I%7=Y[Y-$[B M4!&2K_:?]JMVEF;`YW3`+A`6SQ95*B=57Q.4K_QW>[9.F?&<@C7",1V*]U2/ M"1';)3ZYDW"(1!>$9F_V"\QO*$RH%G'6:\2(U.F8>NOP7=%/>"-$1.D8'D*!!4CL M+;2N,I:%_7I8E&F=1J,BM`"/Y_C[EY.&D#?T@^X2[N$.#K]^\,!$94KVR5D`EZ&MEQ#0U81V"(]]'-$@C4^`#RC6U MR'=`.)BXM*X@))"TIZ7$]HA<1X]4$H0W8B`J)*[HORI73\N'[=4^P6#MP>#R M:0TB`NA0'C,7MB*=``V=DJZ`I*6%GM8C._((=#P!9_#0TCQ;ACRB4LP!)0MN M,KF%7*8LQBCVPI1R*,Q*'>L.1;X4.SZM%1C*P!.(:-V,,\%H#7"\F=`0/$V: M4`=FS>($\0PD+6(],'*!K9N:KF`$8W`#'T%P3549+2!U7O)^)41(4"'%`$\T-]!Y@"&,("!WJZ5:%)0JI/(0-^WBCR"!H%WKD?28&!L3+MD@($[<\/%3'WQ-NP@%OAH?.)[<'*(,E0%]A&9'!" M;7A#.C$X`GK7\!&);9W!NT,Q*#K2%(1LE6SBX93GT",$SB$(Y*"9U.`4C$:J ML`4;#+!K?/G2Z*I'0R+<-C%HY!90><CB"T8+0*"-9):F;B&4>CH%.0Z2C".D>O*:*V?^`6.CQ!OZ%$;\L$KUL8JY4@/CZY(^+#[8.> MI$I<@K1P][NB:]7;L4>ZQM2`IG.&O8C0[DAU4.7J`A(_1"2A2M*)O(SJ&7K? M=\;(@?&H%J/$L[V1BG?`=I2#4!.#T@KA7-"PO; M@E2CDXD#>[$B+$D$YAI MJ<"Z3$'CO@SE^)*5<`THW9$U8#*@P6UZ/EH;G)S:36`*47NZ[*A#4,27[6@5 M<1,>C:MUGB]!VFLL_BP/&<_':UHV#3.Z",,%-0\6@0OX&2KK_`BB1!E;-\B& MCM#<"9U%&GZ)C%\B8Q,$O!"0O"]]0"B0[-KGDMJ"@G2ZX@MI'1:7V2TX,`#; MS--JYU<)S1.+Q/+54]R@4 M!WA5*B?P:HAF793]`2-")AC-A3LCRA1.*+TBT@&MJN=A3K3(SX2KP@TQO1,P M2L3MZ=[A'?Q*$(9;3D4>995H8!"4O:GB4M;DL\Z9_``B*DXXBH)1L()1^A1$ M#!^!'!%5*9<@4FK`.L^,QBD>SG;'?/(60@^M0>82*DT9.UP(X;]=,T4;+^2< ME:A^YX(2:])8YSM=`*HY'V9ZH^-NQ>XY_C/]5]"7925<0$1+\@X7+?@]G.6! MDY#Q>@6XW;Q&X()F>7)9Y^8PIQH0DO+#4;V0S`4`Q#+V]'9"AX&`;@#@%!`< M*<7/*;@;S%U'/EJ!&QJRJE`L4;H5P)5%%`\F]R!D:Y:9;.SF(LV@7%[(#6`5 M@O?TZDDG2*EA&1H#O6XEP,/"T/PZB@'58BP/Q>M4SH'0$-.Z>/L.1:AJDN60 MB.F=`TT*JGH0;;T,AN M=+\*T=?.]S-N*[9B.^.6'3>W![[LJ/N&=M31R9GUUPE&CY`.B+/-1\*NB7V. M_4=^#!^S0]#RP+A%1;8@J/)>C!5D'IP M`DS`H`[G*/B_A,3I/,.N?_-1Y,/T]8VM@SU#W8SG7IHZB+[5#PC6I1O2*)W= MMD\EJ<3<.AE2:;FA[^[N<1`UTGIR!5HW46QUK#M3 MSN=7%)+RB5T$3"2W=3NVTC.\XY0A]N*,8K\NG]A)@`1R6W>^G$K$SA^!"Y#] M+CE-^:63"N_1H`(7@331CW7;QYK,%R\1BD_LRU4=:J[,!PUU.@=;XK1PV,W^(M M"3/<.44/#&6>(`VE..` M/VS\'I%1%0>&L?D;1@.>V=!?.MIY?7QHG+M9)3-1V&'MX>2)S2)#TL5^"EE% M+N^GD"K(NK"+^AGY^N'(_Y)`#(3O8(OV6^A78*O?$X`A M"NII)$%/,:K""=_)3"D'WQM&=&1@O*�/J8KE99A_%OJ*&S^S+7:<^BO.'X ML.'_?'I`'8`*T]VSE%D7N(R"P3L`.T[YO-6J2")$`6^3]3I,&?;"0CG7T1SA50:+XH5: MS=).V%=M55AWIU9QW]'$@Z*+2BHD0\-AUN=X-SMEDEJ7B\SVCL^\)T`8A^(7 M;3B$+H/2E%IAZ'J_N*3TH`I>>%%^]H\:Y4FI27;13>L;3`Q:V.M5)@9\=>-" MJ)H1S"%&18WO,%H@9!?:,LOF'P!ITWLQ`MJ1- M;ZBS\("61`.?BONNJ8U#,`E3Z@)CZ-.XDKEJN]N` M6GT##?H:%QT]P5&I5#+`!816I=7K1$(>VP)./N#L5` M?ZCKEQ]X1I=CU+C72$\EAS#NR^NZW8Y^84"?KH*T$M'#)X;E9D#58G! M=K/S]:1O%4QJLUT*LNK7=0#>'8!X^`+2@Y$OHEQ91=[<-_&H',@Q\9KJQ M"MRZ)39!3C^4EP`6S%&>@C6[?C9:&/@'&B4'M`!:Z%0?+=?0Q"&,^_OD@8`O M"6WF\K&;:+]1XU!+[V?7=A\GXYOK\^O*^NX5V2=T##6D)1QTML3<:D*VPBXD'&MX? M"1C/+TD,Z00G/,A8(QIRP5RI[?)(K@MGW69*P2DYUD,W[98_ZV6=P4I3%=;M M+B\NT=WHH28D=P8HL<#6G>`6+L7I8:5=W!GL]!5BX>6BU=66*QC!&-S`1Q!D MS&NN.#7+.8.>A@ILO$@TVSBO:QX%Y`Z!)!+8N@M!;R`=_@$L9SA5^$B+.(.1 M7'#K+O,LOW*29YG/$='V$S5+.X.>MCHZ/,0F6M?QJ53AYGJ5GRM*7]:-`@\' M"G!,2UL/CK$ZQ.^J[SLAPCH/]85&OI^LDK0[E1_R8@6FYTMP14*0_2UN""% M?`(8L&NTV!.?H9^JD!+12`##B$`_(^K*+.W6_$`F:C>FNS%7+7F0F*Y=:QQJ MM?25^@&EE^$(XSBS0X0DJ^RS%!7E$E.WC0QH'COJ M-Y75JXX1.`2S.KI/5BL/;\;SY]@!X7+E`O_!*2T=VD*%M3\4Y*R6GJP?9UR8X%/N;,,W;N8[5G2]#@[:,!2>]NI MC;7/KO;32TR,[B$;VNVL1?5/1BF`G?N0"I:&MQS5/#7MV52_L85?T0<)>J[D`,9TV6ALO5;5[M4XJ9OJXEFK;BO8%59PB M@YV%SZ]@G$F>,:\167/IE%CSU;/M51&MVRLOON%:A,.6<.B+A[G=AZO]DG#6 M(7!!C3^!U*M-U^O9_?+2Q\*%Y+:@T>A(943$PO;^8,$HBA(O+.X!GU)N>5%M MD\AJO8H$&_H6[>>M)%LS6?:?=ISV-6O?Z^ROR5/'5]GQ&].YX$Y1XAK$7PC^S)%E"#?P]FL=?J?P?,"(B/)3%;$%'ZBFHA;<. MKZL$1S!F>7SV*-`3^XO(@!+3.X&01%SKSI/>>E3<".!->9NK#!M)`2?`D0G< MX8E2P=4<2[A>9X]CC9GO],P`QR$1TUJM9X68UAWT%.[UE@T"12&K`=(5W+JS MG8)=_?3O$*3:C8+1BJ6+L^=.A/(),.VL>B?0[TZ9'9XSY1O-HNURL\UWP&24 M5B,B%5%Q.+3W=$7CAN)>TA:&K>PU?6'(6T_7=1NG,TQK&#J6=B.MT1*7E_3& M2WK#Z**$M)>EI\P%NJ^0V*)UJ<-1%4JA\][GM?/1Y'HVNKF?C<]_G4U'=_>C M\]GU^.Y^QXE,5>U>9RX5,VY:_!=+Z(0E%+CRT\NKR^GT\B+ME!+W14!HBU;% MCKQ`P/Y?G290Z(Y-BTU.Z492C7RGY@`Z6O(,\OQ$O%79074\\G!Z: M-=3Y&*UKM"J[B>H]4JWW6N[,EE MVB'O_A#W"'[?K+EYL,%?$*122>6UF,W%"UUHUC\ZCWJ+9VY MY)V#WS'XU:Q]KS&P)D_=C!A%8Q(_1;?DT(&P&UE:0QQ>LK/?=$[B\FD-V-F% MWU!(M1'">',+([A*5KQ-HD):6W0KC"HD8@ZA8N])7\4YK8LJ+L3LW!0)"1_7&$`V.$7<2?F45FO5ZYHO6]&JK0J[*\\*K<4*N^A M^]N`I+BO;9(UG.>?*V\E[[J4NW/#^UWLW9G=KF[2UN2#I5?^/;ZYN)S>7_[/ MQ^O9[]*+M7>N=.APS8W(N3OTW`RJLQ'!M(`BMKUK]`25\36WC"W&7AUJ\T7N M/23,W8/4`,&?$5[ZV19FRWK$]^E"6JW]4E9`C)*[6+BA2P`T,5$4=YA>%2:Z3V\ M'RT6&"RH`-5;SH7(R.E=0D(AN75'LUYRW4.?#LU7.+<>H`B`!ITM^N=&NQ+Q M.KM);`TP1.Q!*AR7[A-S",+/IXZ"2!F7C*16,%Y&P;`@LJC]`PO'0'"18!:* M9=TKE3W]^5"_,E1H*UM4Y49':*4DZUX13L7(-IAPI"C=`ULXNH$,:;.*W,'9 M4$&]+V><>Y$/P@86E:^LUFY5",7"1.]IWQ3&QBW(O1P^;=/47E.[;1CL*$EC MT+(D?=NJFJ%C#C<2MKL@Y&:*]MN.!3O?D)Y/E3,T2;"_I!TIFT:%^WA%]+;H M6#BW*<3M7=VE3<*?8+P<19Y7)A>\^Q%@\^`L(2OU%PA_)/V'N3HKC%H*`K^EX)&N6 MX4\]@%L4@)`-P6([W>\0A&(8Y*4N\[L)J;0L=SR0ZW"IGU*N8+M[=- M6.6KG;E:%1!:KU>1@(K=6%UX*<^+J+3-V_2$"U-6EY0UDN>$G.-;CW\!XA%ON&N-5J/UTE>"-BS(6PDXZS-A56O2.%,E*C]T*L3E%)4"DY?=F^+W M&>9M1H0W%.6+9L/6< MI3I$F1RCXM8#8*8,^S9_<5__'K&36(M4\+/-EF3B;=A'Z:O?S2E+=BQ"M@=T M#ZU;W8OV#L6>UH"*Q4#>4_3"=<\*L=6PJ02U[CD3?O_*]B.,DGB),'OBZR.- M67`IQ&`/<%27=:>L/^;SSKPD>JX,HZ'>?>M6]YF]0]'[RICF])??0]'>&R@J ML!K>-@KI?85--A=D7:?4<=0`*?3HP9"QE1J&Z\BG M3<)'P,Q"Y[=1[-SN_E=^=N&VPRRR!ALF5U'L7N?022`W4G"=8>=FIN[E(HJ] M7421GB8J]RGQI10B4EN4K'5!A5!>>T=#PWOXIO+6':8*GRTIIW=OO[-%=T*G ML22&1>>U=U"Y[6>MZ\S:<[Y:EO'*`OC\1/`9F",,+H"?6KNWI\SF"--?ZI+6 MPZ6M@MX/`^2M<>APAWUQ:IDWG+??6:^R MDAB]IPF?;3E/9Z4OK5=:61!QZJZ#.:GWS-(4I(]Q3ZC_L9E1C'P?)S1J2^*/T=J#O(A`1&F]AH4B]G_]I_\E@=03/`>8>A;1 M!*,@22>>6Q0&Y(K*H;(IIC58#X:Q2GJ/@N]0#,[8@GQQ`'9"7^@$O@G>5G4LC$VS#GH)^81-"(#8&)@+5>HY-:F^8ABJB"H5UCI^,4 M!2HOP`11`NY`?5R+ MJ&S1/7>"$XK6_Z%)$*>18N1E;>2-\_;Q"TFM5JU<2/N>QP`+)LH4K%F&,%I4 MK@=(N1;U=W5!JW$R48`BH]?_EOWD@8`O"=L>^<@V19;7FG;=E:]1]7XWWFLP MU-&V64E+LNWS.L6&=A;<<-Y,$'AQVKX1ITWVV.)XSG:&>]&F=&7>?8(Q,SL8 M!&>;,[3A+3*9E+9%_T+OPD@5_0/CA1[>S!!K;K;$*%DL+^GD@]+#Y.RV6AJ& MY9RN`1X)5D#:U&(_4&U4T_O2;-I]V)$UZNR0L\V83#MHJC>MV)?Y-ML M\^M0R`S%7LA>Z,H6`-+SF[2?W5Y,1QS83$I;CY.1*GK?\'V+HG@9;G)F:&>Y M@H\@_3#=WW%/[4%Z*(055*#4NBKK(6NOI-YOC:BQ1KGY3Q)N*-E;,[1$!5W# M1JB`WN]Q3\=Q,:AOO0!\7,_0'7K4'3YFY:W'Q5`=BAO9.X"'94'F[/X=<:0W M0Q?P"44JH%K69#]D;54D"(??["V5>TFH%KX^'Q#8/G.W8QY76>]>D[A*;CHZ M:2AJ1I*^59<9.F?H1NY66_Y1=1\USK3I/0\UOE<[4K MM04M>3IJ1\7U?XMT\0SB+8S@*EGEN^8*;XIK?^4EK,=%*7+O&=RFPYK[.,^] M0,MI;Q2R7O4Z@O>>D64;/YDC4\V-,&YX:3PQL?7:E@G:>S*5V:_[,Q"!.?2A M%XZ_1@"3)5Q/`&;W/GD+P+.,%\#'@%V"RJ+K?_XT0QQ(NJK9>OPZ4V'_.5<6 MJ)FS>AV56/WQ1R[:G55M/=S=*;'W5&[.Q7WI?O&D_6WJ$BM9(].CY#GSQV;3S7I9,06Z]YF:#[?5"S>-M:^1;+ MEM!Z[8H$;/VJ9?X-^_%`C1;]Y/\!4$L#!!0````(`%9P=4&GI&_%^0\``&.D M```1`!P`='-O:2TR,#$R,#8S,"YX$*48>*>M[I' MQRV`7(O8V)V=MS`C[??OWWYH=UL___3G/YW]I=T&]XA<.I#Z#+0!OL$.`F,? M>RBB`7XX.CGM=@%HMP4&L^9H`0%GXK*/-L+GK;GG+3]V.B^/U#EBR#J:D:<. M?]`Y.>YVV\?=]FFW%8)/L1.#/S\_'WES1.$2^1ZVH'-DD87`.3E^=\IEAIY' M\:/OH1M"%U=H"GW'.V_Y[C/P(&8HI\Z=8`X]=YD'72L';7MH@(?#;3O`P`O59>P;A,H:=0O8H8<,'"N.Y M_D(MB^W1CK=:H@Z'0!1;,0)Q#7"(VX[P^/3Z[@RZ+O&@QR>>^)?_OUQB=TKD M/]^=B2'Z&(W3"$V!'-^/@M3Y&X872P>]";^;4S0]?^,Q@MN1;7]?4G3$A8M` M*'$X6N'XBL<=CL+X)),2W:X91R0@M7)41OT4O>+8&$B( M;?K[]3;KTY@[H@SZ_'-,$T1$P6`*N/0@I@N^#RG_[:R3I9EDY3-D#]R? MY.>LPX>8(4@15MJGS'`RIE8@A5]%YMJJ":\PLQS"?(K&>.;R-=."KM>S+.*[ M'A^Z(7&PQ6?0VH:F"!HC'O\HC+@F)"RZI@76Q$!$K;%;UFZ79+%$+H,>H:LO MD%(^<&S@>R(5$#G>,!@&9(\]8GV=$\?F:9QP%6^5\\K7D](Y[(]9ATVR`Q$_ MD&`(8H[@WTF>?X5+POX>Y1_D+(@^PKQ$?!PE*TP?0& MOR"[QQCRV`0^.FH_KTY$,Q^Z[W*^+^@#S@`D.(`D"T"F0#(!`1?P?<"G,;TB M++B,QTP;2G\-G8XOLP.>"4B94GY?"JL+XC_D'7M-;_V`">NM238F*_;6(+1- M>$!DT,H82PNE\[=NSM\"`B!)H;&*SI$NH",*[/$<\>"C]I\TB,YM3K1N$](! M`:'&+%FSR'S@@E-C.$04$SMGXRI(&MN>YE:W-6&0H`P"TM*H`?'& MHL46'2&9W`TA32]@O1E%F-_<4" MTM5@6E)%%I<754GHDIWWN62G!UA`7J2AY:5G4UF4V_P66WP04>PI2JOF@71V M.\[9+<1?^V.3#.5SU-ZP/^G=CB>#RW],1KW[<>]RTA_O M!L2`I`:2Y)J066RK1)!1A;FU=ED+H,-.>*`;5$MIFL$!M[:2H(YE%L\>3] M$K*YQEQE@#I?4]0+$3$@J#7&>ETS6HSAC4.>#7K1:U!=3RV?HQ2WHJ4!)M2=(A/T5P1W@1&.41OP!DYDJ"20`I.FVO&XV#2EYPC9BRDYWA5EC0D>7 M)>4W%M,[&Y($B+@4]<^;*5`^!=*YK,JX&0A=T,^W2#/9;6.)7.GO/S+TS>>J M7C^)-#*Y89"O^`V`=:5B+I==$P0!Q?2&15-_%'L0L7RY1Q3^[;GVM>MA;Y4( M0`EO,H'6>580$$/LY$>^VH&`5#+T-?8RV5;B:THR@>D]\;DN5@R3_:027-WB MEM^02&TDB>/%Z;0&1L2;%:WJ]N_UBVA>(EZYK,3(F>X!%Z#I8FNNX"G<"`81 M=1"2;^*L6::BWJY7YRP%L+J2Y$21O13MY3>&4NYA9*/A@VLCVN>5/E^AGM"0 M%_T&9\9?34GGIEWU7D<^U/J"(8@Y`L&R.3.^T=3([=<;GJFKB*=;Q/09T!EW\AQ2D MY]K#Q`!<0)Y!JNQ3BJ-K_N5?:TR2DRW`)$$@*?[_6/"LD[BA@_^3NK[C#"^6 MA'H@N#3FEECRB>9*$_%?.[K7I"V^:G=/VJ?=HQ=FMX"KO,NEX%*43E4!LO>8 M"/8?!/ON.R/VN7M07B$!<>]?*T3B8I7*@B1NC!$"O"UBK;QBQH2;1%1>.M-! MCL>B;]KK:VB*1-#>7&,L2O;>(O'!@+GVSJ.`>7A)$7"Q(UL7YRV/^N+*'G&Y MS\>E/*#1K3;'S MNV[SHA?BM`#C2PE_Z(MO/U'B+R,VF#,(-#QOF9$R4>\Q.$G"=4./V#-7>D%< MGBO2U5KM2,T164%'W&P2"9OXHD2Y+=EC#GE$S@OV!>'9W$-V[XFO5C,TEF") M%#N2MQQN/VIDIE6D1OX^C^[:Y-FY%VBD1:E5F62C>;U"LS*%2M%J52J;3);: M1X.P!46V[^*BT^<[8C[=H+6?9[\]2-'[KD419*C/,RCXB!TL`M,-)8N>]T`H7,8&N9:D5K3%F>7'&=,2=7R9I\6.WMFS/=[.;B7OEH0I*A0F58$ZR: M0V3R_%!Y9%1#UZI"?+BX3'H%8*V"YW90RA30(-1N@L.!Q5".XO5I2_TE`E1%2A=D")^_KL3;447H6W M9;6"AKP79RL\5>&/17:A"'<\DX$.#\4\1#-OQ"-S//<43VK/>34W&AO7(F7H M>^ES9&Q45A>/YUCL^:2TK0PYE(/*OG\4TS MBU(`AS.%$F+IYX\2L,94Y3,1>Q$CL9D7[U&DOSO(R3$AOXI=[.$%6=E\/9O@ M!?'FJT]7^"6Q,[$97')K5IEW&Z/7../$BTDB;_],Q"$=!WNK.^SBA1_7 M9QJ`PQ(;OI2('0'LPX66OBI*14)=85$)NC;+2IMX4+^4$T07??*8L"M#,2"L?'8JHZ<%5/JJY\VWX2R0B__IE<'MU M/1I?__.A/_FMO!'^>LK[V<"QR0)B5U5MBX7X#BT>$5T7V,GOZI4O1!Z3)"`DPF!:Z<"SYT1$32JE6&5*^&O=E,O*SA938\TAJ5 M`-5ZT.Y2]'X<9,<.'O]_4!L657YRH&(??C/2>Z@WPNV`"1GZU)IS`8,P9:A6 M"8TMG0&JV!I,5#]?L#?ON==BA-^(_=Q(H/(HD-*CE-@N$[2`HQA"[J=WQ$:.F!=1 M7?$;1DXU;4HH[;?&&TP-95>C[B,Q3FXF&8M;A+S#8BF11MSB*>L6-N6VJUU,=*=>H&M#!/,H_$KPW$S!,IJU M!*R$!)L%+"6!77>_1.1/72UEV(5(+!Q*]!I6?X-KLS;O0B;T?1V?G<;W6";3 M,X=K^-VVE8(Q"YH-,GM$]@6:$HJND"5GS&E7O-Q;R6$,J.U6J9"UH=`Q]&Z% MJEJKOZ(FS.EJ8@U0KN#A@U;,LSL:^\+T' M=PEQO*U0^/@0#[#*5X;YP%PBZO$L:DB)[4L_NB..';Q4K)J2E=%JW,Z^)QZZ M$,5!U'D;\D1;9(YQ!5@,<#"7$!1?8KQAG"RDI&'V_YBO\I;^*-C.@L].$,7%T M:5IM;8%3/ZA]OOH9'M<)HPZ., M?`G"V-`E5.I1;D(\Z$1"W$$[:`!P0\0F,'T!TH!0/2J*Z"]^TS%XIR`IHJ%J M.@*[S&/$I!]?(!=-L86A,WAV$65SO!P&"'"&5.YTA8([16R1E/WX?D(,M=P: MMUT.B3P_7EW*Z)X5*>7;M\9CLCUV.PWBH03C]-'T1=15^L*Y7:`1XAF[>)7= M_!!*):*[W>LA@VG`-SCZ,R'1`4W3O$%#8'_[:-'YEXWVTQ+(^[TVK,IM+6:X M=;[O4IR(C'T>W\6JMP^&D//KG9Q4J^59S\N8\'%TXY'!;)6*!6RLX5,0_2 MW.G.X04:0LSGY]I0@?`CQ!"DUIQ#JYISAH@'.0!#OO!BQ@A=B5X/E]?"W$OM M&T*CLZ+:O,F$7KS4$W9(H7;^[&O7B]*<*RD$J?4=< M;^Y$518WW@U^0O)+V;,<\\DN]]C$->&J$=@<_W]A.+@&O_K.B@M_:J!\(?1! MJIJO1Y<3M.:NB%3G*B<3*^Z>45JKRDXF1!8P2DTW13?0^:P3W)_-/_X7 M4$L!`AX#%`````@`5G!U04:<"F*>8@``%ZH$`!$`&````````0```*2!```` M`'1S;VDM,C`Q,C`V,S`N>&UL550%``-4):U0=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`5G!U0>4S3+5B!```7B8``!4`&````````0```*2!Z6(``'1S M;VDM,C`Q,C`V,S!?8V%L+GAM;%54!0`#5"6M4'5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`%9P=4&@F1;OS1<``-N,`0`5`!@```````$```"D@9IG``!T M`L``00E#@``!#D!``!0 M2P$"'@,4````"`!6<'5!DZK$BV@[``"(N`(`%0`8```````!````I(&V?P`` M='-O:2TR,#$R,#8S,%]L86(N>&UL550%``-4):U0=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`5G!U0`Q0````(`%9P=4&GI&_%^0\``&.D```1`!@```````$```"D@5G9 M``!T XML 51 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6

A summary of the stock options available (Tables)
6 Months Ended

Jun. 30, 2012

A summary of the stock options available

A summary of the stock options available
A summary of the stock options available under the 2009 Stock Incentive Plan at June 30, 2012 and changes during the period then ended is presented below:

Available at December 31, 2011

10,000,000

Option shares granted before December 31, 2011

(7,950,000)

Granted

-

Exercised

-

Canceled

1,050,000

Available at June 30, 2012

3,100,000

X

- Details

Name: fil_ASummaryOfTheStockOptionsAvailableAbstract

Namespace Prefix: fil_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Topic 718

-SubTopic 10

-Publisher FASB

-Number

-Article

-Subparagraph (c)(1)

-Name Accounting Standards Codification

-Paragraph 2

-Section 50

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration